{"instruction": "Describe the molecular properties of Isocephpril.", "response": "Isocephpril (MW: 357.17 Da, C12H10N4O3) exhibits a logP of 1.37 and TPSA of 105.48 \u0172 with 1 H-bond donors and 8 H-bond acceptors.", "metadata": {"compound": "Isocephpril", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 100, "total_score": 98.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000000-bce766c1e1b3b1ef", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.881205", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "b80e461114be336549e6a1e7563fffd6958752bfcef2bb0ad1c84b327630e8ac"}}}}
{"instruction": "How many rotatable bonds does Neobenzpine have?", "response": "Neobenzpine has 9 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Neobenzpine", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 100, "total_score": 97.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000001-ec191fdf925c56d2", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.881275", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "42e8a4dfcae848742056aaf84d5464474aafeb03439ec734b1b02f460810bf88"}}}}
{"instruction": "What is the bioavailability of Neomethmab?", "response": "The predicted oral bioavailability of Neomethmab is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Neomethmab", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 100, "total_score": 92.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000002-8aab6f8d249560ed", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.881321", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "6e99acceae00cded0c7b7557af66a5c3be10a6e13d9472e7ba7645b32cec73d6"}}}}
{"instruction": "Describe the molecular properties of Synsulfib.", "response": "Synsulfib (MW: 276.33 Da, C18H40N4O6) exhibits a logP of 4.62 and TPSA of 35.43 \u0172 with 2 H-bond donors and 4 H-bond acceptors.", "metadata": {"compound": "Synsulfib", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000003-b309d6b5e83d7bfd", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.881377", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "df530f146ba57d453ffd5818dc5a9a3713844185357ceffdcc1bf3d25db165a8"}}}}
{"instruction": "Compare Neocephmab to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Neocephmab has suboptimal drug-like properties with MW=552.43 Da and logP=0.7.", "metadata": {"compound": "Neocephmab", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 100, "total_score": 98.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000004-1a0cf00ddab3bae5", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.881419", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "d37b2c22c85d8384a8fff22fb186bdd3998e4c1111d23eb7f8d995d50daf9e5f"}}}}
{"instruction": "How many aromatic rings does Parasulfcillin have?", "response": "Parasulfcillin contains 1 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Parasulfcillin", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 100, "total_score": 95.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000005-79c2af78f1c0640d", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.881459", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "1d1fa0677181b6d3c43b571bfe974d9a07fbdef7f0828824ff6dd34d8639eda0"}}}}
{"instruction": "What are the pharmacokinetic properties of Neocyclpril?", "response": "The pharmacokinetic properties of Neocyclpril suggest good absorption potential with TPSA=41.45 \u0172 and MW=222.52 Da.", "metadata": {"compound": "Neocyclpril", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 100, "total_score": 95.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000006-74771eb922d05a64", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.881506", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "4f2486cc8c0a067342e1aa92a25288648ebe008a1fc512d7ea6dd7162b6a4011"}}}}
{"instruction": "How many hydrogen bond acceptors does Profluorstatin have?", "response": "Profluorstatin has 5 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Profluorstatin", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 100, "total_score": 97.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000007-9e413d4dff379d6e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.881543", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "0e4eb89829aa8f699f166350389e903af8647df1d3d9c84c5d382b2d0f3de2f2"}}}}
{"instruction": "What is the logP value of Metacephib?", "response": "The logP (partition coefficient) of Metacephib is 2.38. This indicates good lipophilicity for oral bioavailability.", "metadata": {"compound": "Metacephib", "batch": 0, "template": "What is the logP value of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 85.0, "uniqueness_score": 100, "total_score": 96.25, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000008-a0b88709723b6835", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.881667", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "f5d0ab06ae0f3868", "cl_signature": "03f7f271f78fe1bf5863b4922a303cf4a8059d21d179958b32383ff90cc6f104"}}}}
{"instruction": "What is the TPSA of Epiphenmycin?", "response": "The topological polar surface area (TPSA) of Epiphenmycin is 79.43 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Epiphenmycin", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 100, "total_score": 95.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000009-5ac660b13f7272e0", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.881751", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "1e4ea1c925250babccdc84df0594e539443d41da76418dcd3a6461627a2e3c2a"}}}}
{"instruction": "What is the solubility profile of Isomorphazole?", "response": "Isomorphazole exhibits moderate solubility based on its logP value of 1.67.", "metadata": {"compound": "Isomorphazole", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 100, "total_score": 92.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000010-9ca2b348c34dc2cb", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.881805", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "743e735baa6d45c96dcf48167ea35daffbf2ad716623160008722a25110afbb5"}}}}
{"instruction": "How many hydrogen bond donors does Anticyclpril have?", "response": "Anticyclpril has 2 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Anticyclpril", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 100, "total_score": 97.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000011-9a1c2b9a7fbf91d2", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.881850", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "244aeb5b3732fa2604b3af67184e6ac593c045da15125ae005935946b47f9c92"}}}}
{"instruction": "What is the solubility profile of Neosulfcillin?", "response": "Neosulfcillin exhibits high water solubility based on its logP value of -0.07.", "metadata": {"compound": "Neosulfcillin", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000012-d1131ecf2627e339", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.881892", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "5c3e51220cfd886379f24fbd32ea7ded33731c7d4422dd2401cd7f6040ae6c8d"}}}}
{"instruction": "What is the TPSA of Metaphenmab?", "response": "The topological polar surface area (TPSA) of Metaphenmab is 56.2 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Metaphenmab", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000013-eef7172b3804a1c1", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.881940", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "b2cbe4d4a71e010f27b76245b6af97d12d8d2bdcd22da37b4e1aa30e6aa589c8"}}}}
{"instruction": "What is the logP value of Hyperfluormab?", "response": "The logP (partition coefficient) of Hyperfluormab is 3.33. This indicates good lipophilicity for oral bioavailability.", "metadata": {"compound": "Hyperfluormab", "batch": 0, "template": "What is the logP value of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 85.0, "uniqueness_score": 90.0, "total_score": 94.25, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000014-24199e9530558783", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.881977", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "f5d0ab06ae0f3868", "cl_signature": "3810338d5ffd8ff139d4eaef01fa6d5353e9eee3377f17cd9e9937baf16df93f"}}}}
{"instruction": "What is the logP value of Neochlordone?", "response": "The logP (partition coefficient) of Neochlordone is 4.55. This indicates good lipophilicity for oral bioavailability.", "metadata": {"compound": "Neochlordone", "batch": 0, "template": "What is the logP value of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 85.0, "uniqueness_score": 90.0, "total_score": 94.25, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000015-5b92ab656a0e4aae", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.882035", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "f5d0ab06ae0f3868", "cl_signature": "fbf1d788f13e90c36be5d1e6c31a6f5baab2f684aa33239b0b7d10a0d05bbd88"}}}}
{"instruction": "Describe the molecular properties of Metacyclmycin.", "response": "Metacyclmycin (MW: 483.96 Da, C17H49N3O7) exhibits a logP of 4.23 and TPSA of 77.36 \u0172 with 2 H-bond donors and 8 H-bond acceptors.", "metadata": {"compound": "Metacyclmycin", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000016-14ef8adcaa6439ad", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.882087", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "908cae593890ec2ed135c4950252bccda4d5efa529a141e21ae32881f5631b52"}}}}
{"instruction": "What is the bioavailability of Neofluorpine?", "response": "The predicted oral bioavailability of Neofluorpine is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Neofluorpine", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000017-a35c29fc7874c32a", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.882124", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "83998b420040959089fc6b31df6ba928cd00647e83b3bdf6dea4a834b985ea05"}}}}
{"instruction": "What is the bioavailability of Hyperchlorazole?", "response": "The predicted oral bioavailability of Hyperchlorazole is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Hyperchlorazole", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000018-1c5f16039cc610f2", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.882160", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "196d7428769f2fcb364b6d718f66b11b84ef175dfea378967239a8af20c3994c"}}}}
{"instruction": "What is the bioavailability of Hypercyclstatin?", "response": "The predicted oral bioavailability of Hypercyclstatin is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Hypercyclstatin", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000019-ee768c82b25b0039", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.882197", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "20a0da5fef9a52eeafc3664a91cf0ce02f7bdf67fecd8c479e0fd010761bc3b4"}}}}
{"instruction": "How many rotatable bonds does Epichlorpril have?", "response": "Epichlorpril has 14 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Epichlorpril", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000020-505bc012490c9a70", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.882234", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "14b998b90c2db1dd8de2ea1fde868cb5daea04cdd36ee2579567cc79d9348f55"}}}}
{"instruction": "How many hydrogen bond donors does Antimorphazole have?", "response": "Antimorphazole has 2 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Antimorphazole", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000021-2ec390afe557a3bd", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.882271", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "fbcb4f9b569f0a1496bf2128c7c3729878586b335213644efea85c842eb84a73"}}}}
{"instruction": "What are the key structural features of Isomethpril?", "response": "Key structural features of Isomethpril include 4 aromatic rings, 12 rotatable bonds, and a molecular weight of 331.57 Da.", "metadata": {"compound": "Isomethpril", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 100, "total_score": 95.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000022-a24e7395e3ed9418", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.882323", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "8572ced0f468f3206762038f53efcddf1a379902654911084e0b49f5f95d6ec6"}}}}
{"instruction": "What is the TPSA of Hypomorphstatin?", "response": "The topological polar surface area (TPSA) of Hypomorphstatin is 35.36 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Hypomorphstatin", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000023-0ebcc38cbdcff8ef", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.882368", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "a19d469de1bb015cb617cd2c55c355ca0126833afdcfb3eeee67a2758eb0e257"}}}}
{"instruction": "What is the bioavailability of Synphenpine?", "response": "The predicted oral bioavailability of Synphenpine is approximately 80% based on its physicochemical properties.", "metadata": {"compound": "Synphenpine", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000024-696e6f5f8a1b2bf1", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.882404", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "70768902329f3f6a1bc9d71be2015d2e70ee12d80541e1ed31971fa22fb3e339"}}}}
{"instruction": "How many hydrogen bond acceptors does Synfluormab have?", "response": "Synfluormab has 2 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Synfluormab", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000025-9caa80e992598ec9", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.882441", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "19c39a0399b203bddd463d0c382fb5da1bdc7a1e70e21a1586159a5cafea140f"}}}}
{"instruction": "What are the pharmacokinetic properties of Metafluordone?", "response": "The pharmacokinetic properties of Metafluordone suggest limited absorption potential with TPSA=78.73 \u0172 and MW=582.11 Da.", "metadata": {"compound": "Metafluordone", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000026-78ba920d71caa72f", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.882496", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "b6933e48d89d90d3e2aa5123cfe3b0046d5c6c37c27adbbe7b806fc431aabff8"}}}}
{"instruction": "What are the pharmacokinetic properties of Hypomorphdone?", "response": "The pharmacokinetic properties of Hypomorphdone suggest good absorption potential with TPSA=47.68 \u0172 and MW=244.52 Da.", "metadata": {"compound": "Hypomorphdone", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000027-5fa953bacc927653", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.882541", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "283daee2e89ad12cdb218ff2ace75f9b9de13602431e706cb4a9a3bdf859801e"}}}}
{"instruction": "How many rotatable bonds does Prophenstatin have?", "response": "Prophenstatin has 14 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Prophenstatin", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000028-e4ea226949bf2166", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.882577", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "a9217bdea44d4862113d06526b84aef93ac6d54a91107a3ab5aae09e8d3d61e9"}}}}
{"instruction": "Describe the molecular properties of Hypobenzmab.", "response": "Hypobenzmab (MW: 536.84 Da, C10H31N1O1) exhibits a logP of 0.28 and TPSA of 28.87 \u0172 with 4 H-bond donors and 10 H-bond acceptors.", "metadata": {"compound": "Hypobenzmab", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000029-97d0bb65a8df6ee9", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.882635", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "6f0565930201b398deba4015c167c967d548cc4659125f05ed2a7028e29bb517"}}}}
{"instruction": "How many rotatable bonds does Neosulfdone have?", "response": "Neosulfdone has 2 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Neosulfdone", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000030-b3bdbad11a9ebab3", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.882671", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "7be3bb2ddf919d5bfd97660157bed712384ccf607cb6f01174e54350eaaee5bd"}}}}
{"instruction": "Compare Metafluormab to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Metafluormab has favorable drug-like properties with MW=334.15 Da and logP=2.33.", "metadata": {"compound": "Metafluormab", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000031-394a58e8d458cc93", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.882710", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "93e2f6537a2771a00b6e5377bfabcdd9d40a02a51ddcae5023357fe385c7f866"}}}}
{"instruction": "What is the solubility profile of Neomorphpine?", "response": "Neomorphpine exhibits moderate solubility based on its logP value of 2.34.", "metadata": {"compound": "Neomorphpine", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000032-8aee4ef0c369f4a7", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.882746", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "694f249bbb5bdbddc3ff5ef3ccb2dab5e5061115995a6ea7f6b9d76e0b8180d6"}}}}
{"instruction": "What is the logP value of Isomorphib?", "response": "The logP (partition coefficient) of Isomorphib is 4.65. This indicates good lipophilicity for oral bioavailability.", "metadata": {"compound": "Isomorphib", "batch": 0, "template": "What is the logP value of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 85.0, "uniqueness_score": 90.0, "total_score": 94.25, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000033-cf01b7b48420c7f5", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.882780", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "f5d0ab06ae0f3868", "cl_signature": "a88df2e387980e1ba6907addd538caf5b910db178ed68c1a077f5c6c7cfb9587"}}}}
{"instruction": "What is the TPSA of Metamorphmab?", "response": "The topological polar surface area (TPSA) of Metamorphmab is 89.84 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Metamorphmab", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000034-38c2e9446e93dca3", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.882823", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "5011e160e8f462b45f96501621b9be8e1dacfd47e3c1edce805e30d01b17ffc2"}}}}
{"instruction": "How many hydrogen bond acceptors does Hypermorphstatin have?", "response": "Hypermorphstatin has 4 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Hypermorphstatin", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000035-18f229a404b7db8f", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.882859", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "9a64555d8f87025743d41166bfe1c9e04f728272b81c322226d62d55bf172825"}}}}
{"instruction": "Compare Epibarbpril to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Epibarbpril has suboptimal drug-like properties with MW=590.82 Da and logP=0.27.", "metadata": {"compound": "Epibarbpril", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000036-6d6ec5dc12e332d4", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.882907", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "ba112e4b66571304627d6ef73c335a0e6be8a45f81c5b6407281c0c0799b9bc7"}}}}
{"instruction": "How many rotatable bonds does Neomethdone have?", "response": "Neomethdone has 11 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Neomethdone", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000037-fbc8d5330041eb53", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.882942", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "2715fa0fc651e6cfba44021ba0d25e3d759c4ef42959a4b29673babc1a68b346"}}}}
{"instruction": "What is the solubility profile of Neocephib?", "response": "Neocephib exhibits low water solubility based on its logP value of 4.53.", "metadata": {"compound": "Neocephib", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000038-571943f6717d321e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.882977", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "97fa5ddfd9cebfd138f422bf89a2908595b5accaea242f21c3de304d870241ed"}}}}
{"instruction": "What are the pharmacokinetic properties of Probenzib?", "response": "The pharmacokinetic properties of Probenzib suggest good absorption potential with TPSA=78.62 \u0172 and MW=443.47 Da.", "metadata": {"compound": "Probenzib", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000039-576e30e0396d9a51", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.883020", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "04edaa647ef44fe30d6023252492bfef6467859d4933ebf5c52baed9f3788f83"}}}}
{"instruction": "How many hydrogen bond donors does Parafluormycin have?", "response": "Parafluormycin has 5 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Parafluormycin", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000041-4c8e22fe78b38d53", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.883092", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "d37c739006aeca09a5035f26a2283a6f86b46c77441d880c1292c89cd548c58e"}}}}
{"instruction": "How many aromatic rings does Hypocyclpril have?", "response": "Hypocyclpril contains 1 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Hypocyclpril", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000042-56478585eca183e7", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.883128", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "e495a4367c31cb84df38aaa7203d310ca7f17d9355952614776328c205f6c3b9"}}}}
{"instruction": "What are the pharmacokinetic properties of Isophenstatin?", "response": "The pharmacokinetic properties of Isophenstatin suggest good absorption potential with TPSA=78.92 \u0172 and MW=379.55 Da.", "metadata": {"compound": "Isophenstatin", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000043-45cc203a877924c5", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.883171", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "11ccbba50f9b25974855945c4e8869f6c22e652652d7cd24adecc1ceee428956"}}}}
{"instruction": "What are the key structural features of Paracyclib?", "response": "Key structural features of Paracyclib include 2 aromatic rings, 5 rotatable bonds, and a molecular weight of 338.29 Da.", "metadata": {"compound": "Paracyclib", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000044-1d17fa5d107cfd67", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.883217", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "6f9684280815ca76b468c8c41b508b0256ba10844ab0089fa075dc81d3d3f1df"}}}}
{"instruction": "How many hydrogen bond donors does Paracephazole have?", "response": "Paracephazole has 5 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Paracephazole", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000045-c192c4b7b35a890d", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.883253", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "f85eb789fe6431e136dcf965faea650afb6ba4caa2e356d3fb319989482ec0d5"}}}}
{"instruction": "What is the bioavailability of Metacephdone?", "response": "The predicted oral bioavailability of Metacephdone is approximately 80% based on its physicochemical properties.", "metadata": {"compound": "Metacephdone", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000047-f5616100c91bd115", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.883330", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "2c7e78e1228497001f2f690b50a94a66108a4f2d3dc54e43ef01dc90ee59c5b8"}}}}
{"instruction": "What are the pharmacokinetic properties of Prochlormycin?", "response": "The pharmacokinetic properties of Prochlormycin suggest limited absorption potential with TPSA=135.44 \u0172 and MW=513.37 Da.", "metadata": {"compound": "Prochlormycin", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000049-2bd40d5703a616ec", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.883408", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "09fa49e0b07bf5ad39439f257bf00d0fc27136bc950a286d07956815aef4d253"}}}}
{"instruction": "How many rotatable bonds does Isocephdone have?", "response": "Isocephdone has 13 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Isocephdone", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000050-5d4fc0f8001fe738", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.883442", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "260f729f106c9e831f2612abd4312772afeefa640c3f99d3237d39893b769b5d"}}}}
{"instruction": "What is the bioavailability of Hypermorpholol?", "response": "The predicted oral bioavailability of Hypermorpholol is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Hypermorpholol", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000051-f2f6e20c1be577e4", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.883475", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "6d67b0ae4ec9ee79ce0163e6744e48224e44739940384eb0df12510b9b37f9e6"}}}}
{"instruction": "What is the bioavailability of Anticephmycin?", "response": "The predicted oral bioavailability of Anticephmycin is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Anticephmycin", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000052-b4df70bca191d037", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.883509", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "8eef755c6241423de9fe90397e2890ca35d8e6c3a3d7c8ace6daf3a898aac583"}}}}
{"instruction": "What is the molecular weight of Synchlorib?", "response": "The molecular weight of Synchlorib is 428.39 Da.", "metadata": {"compound": "Synchlorib", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 100, "total_score": 92.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000053-66ac50feb48fc829", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.883549", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "12f9f479a35b4a4f7430c30d680221316b63e27dba630e8fd285bbfc19e62484"}}}}
{"instruction": "What is the TPSA of Hypercephcillin?", "response": "The topological polar surface area (TPSA) of Hypercephcillin is 124.56 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Hypercephcillin", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000054-ea577dcd7ca43263", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.883833", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "97d7d28be4e0d622fc298d4d3945fe26deb9f40d8d8742e884c05f2e7970f24d"}}}}
{"instruction": "What is the TPSA of Prosulfstatin?", "response": "The topological polar surface area (TPSA) of Prosulfstatin is 112.25 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Prosulfstatin", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000057-c34557afca828a7c", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.883973", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "105bfc08b4c2f5f209bf2685e03924fbb994a8f3f775fa10a933cfb05c054cf2"}}}}
{"instruction": "What are the pharmacokinetic properties of Epimorphpine?", "response": "The pharmacokinetic properties of Epimorphpine suggest limited absorption potential with TPSA=131.5 \u0172 and MW=577.37 Da.", "metadata": {"compound": "Epimorphpine", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000058-15a1703894b943e1", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.884021", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "7d1a029509c23a406ff3d5457f7c1f1d930fe034442f2f66e4f4d937dbcfb659"}}}}
{"instruction": "What are the pharmacokinetic properties of Probarbib?", "response": "The pharmacokinetic properties of Probarbib suggest good absorption potential with TPSA=26.75 \u0172 and MW=229.78 Da.", "metadata": {"compound": "Probarbib", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000059-7a98a94498e93025", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.884066", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "4fd244c1c7c81759f4456bfeb89a74f2d60aab07f2e9f80fa994cde304773522"}}}}
{"instruction": "What is the molecular formula of Hypersulfpine?", "response": "The molecular formula of Hypersulfpine is C14H47N3O3.", "metadata": {"compound": "Hypersulfpine", "batch": 0, "template": "What is the molecular formula of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 100, "total_score": 95.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000060-a1141df77de5e48f", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.884100", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "4c3085b3983afa78", "cl_signature": "83c35b93e1330f1a0cbcca6cb647a32e691d3a8e5a5945e060146d0dd5d7c758"}}}}
{"instruction": "What is the molecular formula of Promethpril?", "response": "The molecular formula of Promethpril is C29H33N5O7.", "metadata": {"compound": "Promethpril", "batch": 0, "template": "What is the molecular formula of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000061-0f7af64b12901049", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.884132", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "4c3085b3983afa78", "cl_signature": "5755199d85346bf89b1233fb2bb4f4320bce001ae1b4d6bed7aad712ef732594"}}}}
{"instruction": "What is the solubility profile of Epifluorpine?", "response": "Epifluorpine exhibits moderate solubility based on its logP value of 1.58.", "metadata": {"compound": "Epifluorpine", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000062-074c7632b76d4915", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.884187", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "e9ddd90e4eb27a4308bc0da294cac7ea5588e9d927ce7d2c3b571e9ce51a0d44"}}}}
{"instruction": "How many rotatable bonds does Neocyclpril have?", "response": "Neocyclpril has 15 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Neocyclpril", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000063-4d7de6ff087cd0f7", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.884224", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "649f91967a831b26b236f8206aed60a1ce86a0e59dfdf30643c441237de5201d"}}}}
{"instruction": "Does Probenzazole satisfy Lipinski's Rule of Five?", "response": "Probenzazole satisfies Lipinski's Rule of Five with no violations, suggesting good oral bioavailability potential.", "metadata": {"compound": "Probenzazole", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 100, "total_score": 92.5, "domain": "drug_likeness", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000064-fa9f9c6c3fa762a8", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.884261", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "f8468c374679bee0c8b50a9cdc849ef5fbf21f9acc7cbba587d7db6717875774"}}}}
{"instruction": "What is the TPSA of Metamethmab?", "response": "The topological polar surface area (TPSA) of Metamethmab is 112.13 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Metamethmab", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000065-aeb9511214a524cc", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.884305", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "f80f4610a8a998e790f50791bdd2215b9f610404e6896cb71055ee123d38ced2"}}}}
{"instruction": "How many hydrogen bond donors does Isomorphib have?", "response": "Isomorphib has 1 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Isomorphib", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000066-dd42cba82290801e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.884341", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "d69d063010a0c476cc539453057c0c2200bf7b45aba4c4ed6ae2a6059ece678c"}}}}
{"instruction": "What are the key structural features of Prosulfmycin?", "response": "Key structural features of Prosulfmycin include 3 aromatic rings, 9 rotatable bonds, and a molecular weight of 355.9 Da.", "metadata": {"compound": "Prosulfmycin", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000067-330674ba8d98967e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.884379", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "1baffcbb64c422bf9ca71c4bdc13022b5ad62bf157e6e2fbfd3857a2fb758d61"}}}}
{"instruction": "Compare Isobarbpril to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Isobarbpril has favorable drug-like properties with MW=248.15 Da and logP=-1.55.", "metadata": {"compound": "Isobarbpril", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000068-24cd9a617642749c", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.884417", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "4c883e4178c85dbd03e5138f14045576ab16329a8d7f691f9ce21e2f745e3d50"}}}}
{"instruction": "What is the molecular weight of Isochlormycin?", "response": "The molecular weight of Isochlormycin is 358.64 Da.", "metadata": {"compound": "Isochlormycin", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000069-d5e6fe7fe55885d9", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.884461", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "ce38ea47ca88b438216533f60cd4961e70f3b480ef247bc70fd758ef5808d26c"}}}}
{"instruction": "What is the molecular formula of Isomorphmycin?", "response": "The molecular formula of Isomorphmycin is C28H19N1O8.", "metadata": {"compound": "Isomorphmycin", "batch": 0, "template": "What is the molecular formula of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000070-49611bc910d299e0", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.884493", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "4c3085b3983afa78", "cl_signature": "3f40c6abf3ccb44d4f94f60ed160f0a2bcba764e4e2c4e55dfc1c93ffe576012"}}}}
{"instruction": "What is the bioavailability of Syncyclmab?", "response": "The predicted oral bioavailability of Syncyclmab is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Syncyclmab", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000071-bf0b56b0741bd47b", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.884528", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "66803c7300c0f4222b6af861171ab6ab109efb2afdafc9a0197df2aef42e9534"}}}}
{"instruction": "What is the molecular formula of Synphenmab?", "response": "The molecular formula of Synphenmab is C15H49N1O5.", "metadata": {"compound": "Synphenmab", "batch": 0, "template": "What is the molecular formula of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000072-70e6de04d4cca922", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.884559", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "4c3085b3983afa78", "cl_signature": "a62faa748d7c5d40cc1321ae3106a70715db1e26626c166f0e8a80fe61125ad2"}}}}
{"instruction": "What is the molecular weight of Hypobarbolol?", "response": "The molecular weight of Hypobarbolol is 221.52 Da.", "metadata": {"compound": "Hypobarbolol", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000073-b371aa2744992694", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.884589", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "4dfadfae24b69784df87cc874337174240e39f20fb49ebbd3dd7abdc5c9a2425"}}}}
{"instruction": "What is the bioavailability of Synfluorpine?", "response": "The predicted oral bioavailability of Synfluorpine is approximately 80% based on its physicochemical properties.", "metadata": {"compound": "Synfluorpine", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000074-a4da157e79b3b2a1", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.884623", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "264f129426d03bc45a4ad6ac9bb6c6e7e2b4e9c7da91d7804050886625f5948f"}}}}
{"instruction": "What is the solubility profile of Neobenzmab?", "response": "Neobenzmab exhibits low water solubility based on its logP value of 3.81.", "metadata": {"compound": "Neobenzmab", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000075-66dd2112328b6ee3", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.884659", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "77d24867d5d7d7243d0442213fa1c3126d44904e5557b563c19f94e4aac4f755"}}}}
{"instruction": "How many rotatable bonds does Profluorpine have?", "response": "Profluorpine has 15 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Profluorpine", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000076-7b85ed7cfac6ef8e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.884693", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "c391086be49d4f91ed88bbd9dec289d61d152e10b0a432d02e086e39a7fb8555"}}}}
{"instruction": "How many rotatable bonds does Profluormycin have?", "response": "Profluormycin has 1 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Profluormycin", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000077-eb84271ce378ccb5", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.884739", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "1f697cb1b1593eb4cacb9433e23d29377fba447fa5e25fbbbffc25aecf9e3375"}}}}
{"instruction": "How many hydrogen bond donors does Antichlordone have?", "response": "Antichlordone has 3 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Antichlordone", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000078-be6357cad1f84332", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.884776", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "44883b18d2ad85e77569e4e57584eb86408abfa1b5c8192086534f8b4d7b3862"}}}}
{"instruction": "How many hydrogen bond donors does Parachlorpril have?", "response": "Parachlorpril has 5 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Parachlorpril", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000079-fb5244927347f2ba", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.884821", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "859eff393a9742a925fc4b4257bffe1576e364ff095adcc0db9662b3b9ec6915"}}}}
{"instruction": "What is the solubility profile of Antiphenpril?", "response": "Antiphenpril exhibits low water solubility based on its logP value of 4.65.", "metadata": {"compound": "Antiphenpril", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000080-6b8e931131b4a667", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.884858", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "9e94a8d8c773c8ac699ebecb596ec58080f2785c1f9fb7bb7ccc321770714b75"}}}}
{"instruction": "How many hydrogen bond acceptors does Isochlorstatin have?", "response": "Isochlorstatin has 8 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Isochlorstatin", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000081-60cd691066672479", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.884894", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "72e9596eaef1ab771d9b358cf3ae80a8142638070d4a18f8e64c4a07c19c4eac"}}}}
{"instruction": "Compare Antifluordone to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Antifluordone has favorable drug-like properties with MW=385.04 Da and logP=-0.39.", "metadata": {"compound": "Antifluordone", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000082-f3794024703c29d9", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.884948", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "2c9f020920887506e0b5f3bea90e806e1de7dc84453bab169e91dd5ee27b2de5"}}}}
{"instruction": "What are the key structural features of Hyperbenzib?", "response": "Key structural features of Hyperbenzib include 1 aromatic rings, 2 rotatable bonds, and a molecular weight of 229.89 Da.", "metadata": {"compound": "Hyperbenzib", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000083-6e9daa57c69c66fa", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.884990", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "84ea52b2cd40f9e2febb25177adb5f3f1b454835574cecfa00135289a51b6175"}}}}
{"instruction": "What is the molecular weight of Prophencillin?", "response": "The molecular weight of Prophencillin is 536.1 Da.", "metadata": {"compound": "Prophencillin", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000084-cfab83ea108b9bb7", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.885031", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "e080136e516f76b0dd028b59896b039c792a66f73bb7bdf32cfd45deebaba8be"}}}}
{"instruction": "What is the logP value of Parasulfolol?", "response": "The logP (partition coefficient) of Parasulfolol is 3.96. This indicates good lipophilicity for oral bioavailability.", "metadata": {"compound": "Parasulfolol", "batch": 0, "template": "What is the logP value of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 85.0, "uniqueness_score": 90.0, "total_score": 94.25, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000085-43f77ba57207a62c", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.885066", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "f5d0ab06ae0f3868", "cl_signature": "bc217fd15cfa4a63c113d6163d62087a3b7e3ed69c848763e9be3398350cb361"}}}}
{"instruction": "How many rotatable bonds does Prophenmab have?", "response": "Prophenmab has 7 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Prophenmab", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000086-03ef934db32be7c0", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.885101", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "0e2110b8eb35530ecfa4a35f7d085e18e8229e24980b27c0a48016e068f65908"}}}}
{"instruction": "Compare Hypercephmab to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Hypercephmab has favorable drug-like properties with MW=323.19 Da and logP=2.83.", "metadata": {"compound": "Hypercephmab", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000087-a12ad02c09bb1bbe", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.885139", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "4164291f88f0f6695b54af0af3c3e2397b85bdfa342d342cc666b1a691640474"}}}}
{"instruction": "Compare Metafluorpine to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Metafluorpine has favorable drug-like properties with MW=432.44 Da and logP=0.5.", "metadata": {"compound": "Metafluorpine", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000088-994dcc975facb9fa", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.885176", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "40bc40dfabea93f6c11e0b023d9d671fdf1849e684194684526f0319e9218c39"}}}}
{"instruction": "What is the logP value of Anticepholol?", "response": "The logP (partition coefficient) of Anticepholol is 3.73. This indicates good lipophilicity for oral bioavailability.", "metadata": {"compound": "Anticepholol", "batch": 0, "template": "What is the logP value of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 85.0, "uniqueness_score": 90.0, "total_score": 94.25, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000089-2bff2466942a1a39", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.885211", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "f5d0ab06ae0f3868", "cl_signature": "fd8bd18383157dd96136ddba2d7be13657c50ad9f13bec0e495011c2533f35da"}}}}
{"instruction": "Describe the molecular properties of Hypersulfstatin.", "response": "Hypersulfstatin (MW: 532.8 Da, C25H27N2O4) exhibits a logP of 0.18 and TPSA of 52.69 \u0172 with 3 H-bond donors and 3 H-bond acceptors.", "metadata": {"compound": "Hypersulfstatin", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000090-c760365a2a2dbe5e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.885261", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "b07b68361669d2382633d25e07b00daacfe5d3a301dedc9a158630593b72398f"}}}}
{"instruction": "Compare Epibarbmab to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Epibarbmab has favorable drug-like properties with MW=259.91 Da and logP=1.66.", "metadata": {"compound": "Epibarbmab", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000091-345db6de90f4cd7b", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.885307", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "56c1eafd6c7318c9dcf1689dcc38a931330d42b635ecee3c3dd55319df2beb59"}}}}
{"instruction": "How many hydrogen bond acceptors does Hyperbarbstatin have?", "response": "Hyperbarbstatin has 9 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Hyperbarbstatin", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000092-409bdbd2f2a3335b", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.885344", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "9a6c10e912146e4317d5edf43f805c4e9702a8e1693e50a8802615d8a1bbd76a"}}}}
{"instruction": "How many hydrogen bond acceptors does Isobarbib have?", "response": "Isobarbib has 2 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Isobarbib", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000093-1ac65a460899c78b", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.885380", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "d3d569749ade7344ca068f44b04cc02a9ad514093991e27f1a630b3e4e465634"}}}}
{"instruction": "What are the key structural features of Parasulfpine?", "response": "Key structural features of Parasulfpine include 2 aromatic rings, 12 rotatable bonds, and a molecular weight of 265.96 Da.", "metadata": {"compound": "Parasulfpine", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000094-61d67831a9939483", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.885445", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "1848c66fdddf3c1f3077050e3ef8b3706dc3246612fe2f62233314b58ff766ea"}}}}
{"instruction": "What is the bioavailability of Anticephcillin?", "response": "The predicted oral bioavailability of Anticephcillin is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Anticephcillin", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000095-aa58654fcb4fb96a", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.885498", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "6f294ee8ffaa568683a0bbaf3e4372e47b5858bed3e10c2e8c238edf1f19eaa7"}}}}
{"instruction": "What is the solubility profile of Epibarbcillin?", "response": "Epibarbcillin exhibits moderate solubility based on its logP value of 1.54.", "metadata": {"compound": "Epibarbcillin", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000096-58e778eafc100f26", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.885536", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "9c56305c660a036afd89b3a68a762753b62084cc591a5307d267fdef0a70525a"}}}}
{"instruction": "How many hydrogen bond acceptors does Episulfpine have?", "response": "Episulfpine has 2 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Episulfpine", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000097-a51cea4668124e72", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.885573", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "00da501e162aea19bfb08cbe17c753e3903b555b9792c0b3dc5ab830eaeb232d"}}}}
{"instruction": "How many rotatable bonds does Hyperfluormab have?", "response": "Hyperfluormab has 1 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Hyperfluormab", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000098-7ebf3a647d4a7e96", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.885625", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "3195b8af2dec5b6263dc9fc0bb14a449e5ec4bf8d44076e90c5c9105c4c2a3ca"}}}}
{"instruction": "What is the bioavailability of Hyperchlormab?", "response": "The predicted oral bioavailability of Hyperchlormab is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Hyperchlormab", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000099-7e32e72d60993e44", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.885679", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "b7e344fdc3f054743d39fbcc397802bf0680e34d33685b8cee80e704a079d4bb"}}}}
{"instruction": "How many aromatic rings does Antimorphmycin have?", "response": "Antimorphmycin contains 4 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Antimorphmycin", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000100-6fd2f0299cc2d546", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.885721", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "5157584428cca4688c8b23de4c57127b1b8b0701ca62136d04827ab8dc092923"}}}}
{"instruction": "What is the solubility profile of Parafluorolol?", "response": "Parafluorolol exhibits moderate solubility based on its logP value of 0.33.", "metadata": {"compound": "Parafluorolol", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000101-6f2296fb0d9e8807", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.885760", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "f3a4adfd1c203397e59690af7767ad75e0a43a1d3085c68f41a567f41fc692bf"}}}}
{"instruction": "How many hydrogen bond acceptors does Antichlorib have?", "response": "Antichlorib has 5 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Antichlorib", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000102-8c9caf9c8d2f304e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.885797", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "dd3c0025eb9b337a34c5d1c0c76d4c9dd43e071c3675b3171cd20e858ea66d9f"}}}}
{"instruction": "What is the TPSA of Hypercephstatin?", "response": "The topological polar surface area (TPSA) of Hypercephstatin is 118.81 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Hypercephstatin", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000103-a3dacf8fdaaca60e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.885842", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "6e8eebe1ee89ca2bbc1fc272220675db8a81af27eae73a6983282a48bf26fad4"}}}}
{"instruction": "What is the logP value of Anticephpril?", "response": "The logP (partition coefficient) of Anticephpril is -1.24. This indicates good lipophilicity for oral bioavailability.", "metadata": {"compound": "Anticephpril", "batch": 0, "template": "What is the logP value of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 85.0, "uniqueness_score": 90.0, "total_score": 94.25, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000104-005db1ae179fd9f0", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.885878", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "f5d0ab06ae0f3868", "cl_signature": "fc4c3c65a531a7dab9f65b88fbcb40d7d8c613b4f6ae4f82745be5075dc8837a"}}}}
{"instruction": "What is the logP value of Hyperfluorpine?", "response": "The logP (partition coefficient) of Hyperfluorpine is -0.05. This indicates good lipophilicity for oral bioavailability.", "metadata": {"compound": "Hyperfluorpine", "batch": 0, "template": "What is the logP value of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 85.0, "uniqueness_score": 90.0, "total_score": 94.25, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000105-448edb7903d5ee60", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.885927", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "f5d0ab06ae0f3868", "cl_signature": "3e00eaa74e34f1a9c40e2eeaafd775edfcd277f1c2ed327315a5f38665017fe5"}}}}
{"instruction": "What is the solubility profile of Metamorphmycin?", "response": "Metamorphmycin exhibits moderate solubility based on its logP value of 2.63.", "metadata": {"compound": "Metamorphmycin", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000106-c74e77daacf63a9d", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.885963", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "ad2a2288f1c3870307c3bc64cf6853c2e454ac8cd2c7296030f7f82d383e03b0"}}}}
{"instruction": "How many aromatic rings does Antisulfmycin have?", "response": "Antisulfmycin contains 1 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Antisulfmycin", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000107-738f1b1c5c7bb303", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.886000", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "aeb846a84a6da217cbc16922bccba38d2ff4faf34c2bf7108598d8466f45921c"}}}}
{"instruction": "What are the pharmacokinetic properties of Antifluorazole?", "response": "The pharmacokinetic properties of Antifluorazole suggest good absorption potential with TPSA=87.08 \u0172 and MW=180.17 Da.", "metadata": {"compound": "Antifluorazole", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000108-eb53e0d0ee604c8b", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.886044", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "d74b2aa7822cd8d3768a38b2a283b07ac1838ac1eb88f7e07528c8a67ffc0b73"}}}}
{"instruction": "What is the solubility profile of Hypermethcillin?", "response": "Hypermethcillin exhibits high water solubility based on its logP value of -0.95.", "metadata": {"compound": "Hypermethcillin", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000109-9be8bc313a291aa2", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.886088", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "ad76fb763b6fc9e9a3849300f3f99568d412cf55a3226a7508e1a5a8838fa8aa"}}}}
{"instruction": "What are the key structural features of Antibenzmycin?", "response": "Key structural features of Antibenzmycin include 2 aromatic rings, 1 rotatable bonds, and a molecular weight of 548.69 Da.", "metadata": {"compound": "Antibenzmycin", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000110-e273847821a44f4b", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.886126", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "39bc542ba76e07685b9b8f912b14cae04000979e0b031a6568f2859cb7f04c5a"}}}}
{"instruction": "How many aromatic rings does Antiphenmycin have?", "response": "Antiphenmycin contains 4 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Antiphenmycin", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000111-95f0cc09dd621fc2", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.886162", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "0a7db241404b21875151d06a7f21b0b54ff23d24ae7e64447cebd5cd46943aed"}}}}
{"instruction": "How many hydrogen bond donors does Neofluorib have?", "response": "Neofluorib has 0 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Neofluorib", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000112-faea7e2d857b5125", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.886208", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "36de023c8668d21b7fce6200f6c05379151b1b318e7ad0ca08e86a296c820c95"}}}}
{"instruction": "How many aromatic rings does Antifluorpril have?", "response": "Antifluorpril contains 2 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Antifluorpril", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000113-60fd8863937ec176", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.886244", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "61b3a803e9669006c0cb1de0e1d4e5e71f95f62afd4329207e201f4595bb301a"}}}}
{"instruction": "What is the solubility profile of Antibenzib?", "response": "Antibenzib exhibits moderate solubility based on its logP value of 2.03.", "metadata": {"compound": "Antibenzib", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000114-a9abaa5f2c5cdaa0", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.886280", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "e2198ec8a0cfa6dc060baefbec0dd0b1137ad803d677b74341ad165b90745f72"}}}}
{"instruction": "How many hydrogen bond donors does Hypometholol have?", "response": "Hypometholol has 2 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Hypometholol", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000115-2d4cde00e96c0cf2", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.886315", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "9a2990276b2a1f736c746ef6a73e7c9db43c81eeda7cab47d6a2aefe54041106"}}}}
{"instruction": "Compare Antifluordone to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Antifluordone has favorable drug-like properties with MW=424.22 Da and logP=-1.84.", "metadata": {"compound": "Antifluordone", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000116-2d1765cdd4672446", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.886354", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "2da8616816ecb544a4820161985d3537f43ef23e694a4baf46afaa9415d2d1d2"}}}}
{"instruction": "Compare Hypocyclpine to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Hypocyclpine has suboptimal drug-like properties with MW=516.71 Da and logP=-1.59.", "metadata": {"compound": "Hypocyclpine", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000117-a3ad5cfd1bee1936", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.886392", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "7855b2c9a8c962769b6c43f7b5451421cb5e0fb395511b5edd2e1291095b8317"}}}}
{"instruction": "How many hydrogen bond donors does Hypercephmycin have?", "response": "Hypercephmycin has 0 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Hypercephmycin", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000118-e6c3c47d76c1d454", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.886428", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "e68b3eb31e5222e0f81a915fb46ef7c59eb738060877dcaef832aa876aaeb891"}}}}
{"instruction": "How many aromatic rings does Neofluorpril have?", "response": "Neofluorpril contains 0 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Neofluorpril", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000119-e41552f22ffc95b0", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.886474", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "df9a47a4eaf1e3784e75ef0214f31986151f1c3715a8c22667f0c7d68a9eddcf"}}}}
{"instruction": "How many hydrogen bond acceptors does Prophencillin have?", "response": "Prophencillin has 4 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Prophencillin", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000120-d0a6faf8c735bcbd", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.886509", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "f9aa61a2840ca322fffb61449f6522dbcdde0c90528d9a94e9672fa0dbaaba7f"}}}}
{"instruction": "What is the bioavailability of Paracyclstatin?", "response": "The predicted oral bioavailability of Paracyclstatin is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Paracyclstatin", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000121-f8d3b3537740eb74", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.886544", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "c3f0e12623b1219509e51ab3f7db6a1a5019f0e340b054565ed955798c9aaae9"}}}}
{"instruction": "How many aromatic rings does Isobarbstatin have?", "response": "Isobarbstatin contains 0 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Isobarbstatin", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000123-97da1ce4d7ff05cb", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.886623", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "7afa647df90f90c86d96afffc59d555ecf9894f7d1d940d40f50a010bb7d0141"}}}}
{"instruction": "How many hydrogen bond donors does Parachlorcillin have?", "response": "Parachlorcillin has 2 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Parachlorcillin", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000124-a4807a7c1f2e4653", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.886659", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "a76c0a0feac88d15cd28a0c6387a4ce4953f8ec067a0a9adce71cb7d43ecb58f"}}}}
{"instruction": "Describe the molecular properties of Paracyclstatin.", "response": "Paracyclstatin (MW: 423.93 Da, C13H22O9) exhibits a logP of 0.82 and TPSA of 77.5 \u0172 with 1 H-bond donors and 9 H-bond acceptors.", "metadata": {"compound": "Paracyclstatin", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000125-ca680fd0a1443ff8", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.886734", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "1e3c37f1772c56987eb4b325e4dde38d0a549d9741e638b65ebb3467c46d7a5b"}}}}
{"instruction": "How many rotatable bonds does Prosulfmab have?", "response": "Prosulfmab has 12 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Prosulfmab", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000126-aec51bb90e909c96", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.886776", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "361489cbebd8c2227fc686c9ca96bd085f117123e123de702a4d80bfec5d1fd9"}}}}
{"instruction": "What is the molecular formula of Isocyclpine?", "response": "The molecular formula of Isocyclpine is C11H41N2O10.", "metadata": {"compound": "Isocyclpine", "batch": 0, "template": "What is the molecular formula of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000127-382faa407a4b1138", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.886828", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "4c3085b3983afa78", "cl_signature": "94423e2ed3520fe8973c8d9edc371578dbff2f9144751f126da2514a93164dab"}}}}
{"instruction": "How many hydrogen bond donors does Promorphstatin have?", "response": "Promorphstatin has 1 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Promorphstatin", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000128-3442924bb8eb9935", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.886867", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "39b0102935b4068ac042af1a368ad95b9466faf45191e44a75fa0aa8efc37e85"}}}}
{"instruction": "Does Epicyclazole satisfy Lipinski's Rule of Five?", "response": "Epicyclazole satisfies Lipinski's Rule of Five with no violations, suggesting good oral bioavailability potential.", "metadata": {"compound": "Epicyclazole", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "drug_likeness", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000129-100dc92b1e50f3fb", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.886904", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "630ad11783b54dd102d750ebc3d12de981d35bf09454801970dfc0fa23144221"}}}}
{"instruction": "What are the pharmacokinetic properties of Isobenzpine?", "response": "The pharmacokinetic properties of Isobenzpine suggest good absorption potential with TPSA=118.86 \u0172 and MW=390.68 Da.", "metadata": {"compound": "Isobenzpine", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000130-d5b1d6e25a6e5d26", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.886951", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "afb2bcd1e54fe4255f501b9bff5fca8677764526948beb9b2b50763957039e7e"}}}}
{"instruction": "What is the logP value of Hyperfluorib?", "response": "The logP (partition coefficient) of Hyperfluorib is 1.62. This indicates good lipophilicity for oral bioavailability.", "metadata": {"compound": "Hyperfluorib", "batch": 0, "template": "What is the logP value of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 85.0, "uniqueness_score": 90.0, "total_score": 94.25, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000131-e777fc5b20d68202", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.886987", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "f5d0ab06ae0f3868", "cl_signature": "5452db1de2c24724911d6ed9b5eea9c64efee33402d4a7e9cbab5ea43295a064"}}}}
{"instruction": "What are the key structural features of Neobarbib?", "response": "Key structural features of Neobarbib include 0 aromatic rings, 1 rotatable bonds, and a molecular weight of 228.35 Da.", "metadata": {"compound": "Neobarbib", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000132-d9a761fecc3c3fbc", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.887025", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "31598813f05f72c9004acdde227912890647186dd8e5a3cf258f9acf2ccc4772"}}}}
{"instruction": "How many rotatable bonds does Syncycldone have?", "response": "Syncycldone has 2 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Syncycldone", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000133-d4ff63ba99e26bc3", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.887061", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "13c9b91db8e85dc0b8f01f4c7bb854d9646aeacb1c1b8a6216e17b714c7590b0"}}}}
{"instruction": "Describe the molecular properties of Hypersulfib.", "response": "Hypersulfib (MW: 385.97 Da, C17H16N5O7) exhibits a logP of 4.01 and TPSA of 139.8 \u0172 with 2 H-bond donors and 6 H-bond acceptors.", "metadata": {"compound": "Hypersulfib", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000134-6b208ee1ff7bfb92", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.887125", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "c9b94c4f379a1ac24d7daa43baaed72082205b850969bfabcfc0cc27821de918"}}}}
{"instruction": "What is the bioavailability of Hypermorphdone?", "response": "The predicted oral bioavailability of Hypermorphdone is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Hypermorphdone", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000135-9487b9085479c5c6", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.887161", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "eef2016aead539db85608f0ef98aa24e9ddbb934122f10f64c33e4ca4603cadc"}}}}
{"instruction": "What is the logP value of Neocyclolol?", "response": "The logP (partition coefficient) of Neocyclolol is 3.87. This indicates good lipophilicity for oral bioavailability.", "metadata": {"compound": "Neocyclolol", "batch": 0, "template": "What is the logP value of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 85.0, "uniqueness_score": 90.0, "total_score": 94.25, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000136-0db0e89c05c526cd", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.887195", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "f5d0ab06ae0f3868", "cl_signature": "fa2fa238699e2ecd915b03fbb06fb3e624c041cda15f1ab728dda0d94b0f4cbd"}}}}
{"instruction": "Compare Isocepholol to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Isocepholol has favorable drug-like properties with MW=441.0 Da and logP=3.75.", "metadata": {"compound": "Isocepholol", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000137-4dd507f76e471a0e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.887256", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "81cc4ec4e33246285097c1895c01e4578bdbd7d0a32b34e546b720a4d9c0a6b9"}}}}
{"instruction": "What is the logP value of Neobenzolol?", "response": "The logP (partition coefficient) of Neobenzolol is 4.32. This indicates good lipophilicity for oral bioavailability.", "metadata": {"compound": "Neobenzolol", "batch": 0, "template": "What is the logP value of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 85.0, "uniqueness_score": 90.0, "total_score": 94.25, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000138-89b7860855d6fd66", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.887290", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "f5d0ab06ae0f3868", "cl_signature": "0d92737e0a943f647a4e40b79215767243f701407b0759f2bd87abf68759a34e"}}}}
{"instruction": "Compare Neomorphcillin to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Neomorphcillin has suboptimal drug-like properties with MW=560.08 Da and logP=2.0.", "metadata": {"compound": "Neomorphcillin", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000139-dcb3f0833a962b51", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.887328", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "40eeaef60e4a3cdd4daafb17473b4bbab2bf3d97c2c429a5860999b3ff1e4c6d"}}}}
{"instruction": "How many hydrogen bond acceptors does Antibenzcillin have?", "response": "Antibenzcillin has 3 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Antibenzcillin", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000140-0a43a0153f69807c", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.887365", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "3df1e145c50cd17862d2be80f95da26970d50b5a1d31de9fe2bc3cb1036fbab8"}}}}
{"instruction": "What are the pharmacokinetic properties of Antibenzolol?", "response": "The pharmacokinetic properties of Antibenzolol suggest limited absorption potential with TPSA=80.2 \u0172 and MW=591.61 Da.", "metadata": {"compound": "Antibenzolol", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000141-26286895c6f6dc79", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.887420", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "b3efcb31e794ffbe4b1b981cda7f008676487ed6c2572863fb4cc3d3f58ab67e"}}}}
{"instruction": "What is the logP value of Synbenzpril?", "response": "The logP (partition coefficient) of Synbenzpril is -0.25. This indicates good lipophilicity for oral bioavailability.", "metadata": {"compound": "Synbenzpril", "batch": 0, "template": "What is the logP value of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 85.0, "uniqueness_score": 90.0, "total_score": 94.25, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000142-06e89423b5ffc7b7", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.887454", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "f5d0ab06ae0f3868", "cl_signature": "e509367f947f1563110df7e05bb7f68304578fbdf1c287af08558469eb3fadd6"}}}}
{"instruction": "How many rotatable bonds does Epibenzib have?", "response": "Epibenzib has 4 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Epibenzib", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000143-62a0e4a1884f12aa", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.887489", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "965f3ef4959c86161049cd71d9b87ebf0d3db2154ee873165a0579bc4ca72b69"}}}}
{"instruction": "How many rotatable bonds does Hypersulfcillin have?", "response": "Hypersulfcillin has 5 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Hypersulfcillin", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000144-01bd28c30c62ae50", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.887524", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "2e2390b4e70bc7e60627be9875c94374a996f2929d817010bb025d7b489a90e9"}}}}
{"instruction": "What is the TPSA of Epibarbpine?", "response": "The topological polar surface area (TPSA) of Epibarbpine is 114.31 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Epibarbpine", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000145-6b9c92e978bfccd7", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.887568", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "809fcff3d5ca26c3e2a3f19171cc53997d57d9184a5e330326c17db9205e6d05"}}}}
{"instruction": "What are the pharmacokinetic properties of Paramethib?", "response": "The pharmacokinetic properties of Paramethib suggest good absorption potential with TPSA=125.63 \u0172 and MW=271.1 Da.", "metadata": {"compound": "Paramethib", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000146-338bc32383dba892", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.887611", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "98319806f36150b44532fb0687f82ff721caeba3f4552c1bd21b26e227ddb543"}}}}
{"instruction": "What is the bioavailability of Synfluorcillin?", "response": "The predicted oral bioavailability of Synfluorcillin is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Synfluorcillin", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000147-e723da8c31fbe000", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.887646", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "e428eb6e1c0726fb82e10168585e88a45838e69c083bccce6091ad81bb002f2f"}}}}
{"instruction": "What is the logP value of Epicephmycin?", "response": "The logP (partition coefficient) of Epicephmycin is 4.28. This indicates good lipophilicity for oral bioavailability.", "metadata": {"compound": "Epicephmycin", "batch": 0, "template": "What is the logP value of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 85.0, "uniqueness_score": 90.0, "total_score": 94.25, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000148-d8847d420f0f4960", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.887691", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "f5d0ab06ae0f3868", "cl_signature": "be2403379dd378d023bdb7c80235b42401ca6d51dd12c1c47ac6b6fd9a15ae44"}}}}
{"instruction": "How many aromatic rings does Metabarbdone have?", "response": "Metabarbdone contains 2 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Metabarbdone", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000149-f9c51737f1869cb5", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.887729", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "5fde9a52a70249ffd39253a172ee595912b95a39bbcbb2256e9582850a2ba7e0"}}}}
{"instruction": "What are the key structural features of Metabarbstatin?", "response": "Key structural features of Metabarbstatin include 1 aromatic rings, 8 rotatable bonds, and a molecular weight of 506.01 Da.", "metadata": {"compound": "Metabarbstatin", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000150-fc6960900bf543ac", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.887767", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "93ff30d6d7a0ea224643c8331cd4d2fbca2f3f30d17448f1b7214440e20c7528"}}}}
{"instruction": "What are the pharmacokinetic properties of Anticyclazole?", "response": "The pharmacokinetic properties of Anticyclazole suggest good absorption potential with TPSA=64.49 \u0172 and MW=499.53 Da.", "metadata": {"compound": "Anticyclazole", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000151-f68ea11d9b1294b6", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.887811", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "03b55e9f900e7e794a428b862a198835cae8300d276297782ff2ff6b64b97ee3"}}}}
{"instruction": "Describe the molecular properties of Isomethmycin.", "response": "Isomethmycin (MW: 583.71 Da, C12H36N3O3) exhibits a logP of 2.07 and TPSA of 99.19 \u0172 with 1 H-bond donors and 3 H-bond acceptors.", "metadata": {"compound": "Isomethmycin", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000152-40a862896be5e472", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.887860", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "48f89c5e0c0d0158fbfae3b3ecf75b3c68a050b2589eddeda3034fc3da571b91"}}}}
{"instruction": "What is the TPSA of Procyclcillin?", "response": "The topological polar surface area (TPSA) of Procyclcillin is 124.05 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Procyclcillin", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000154-015bb2fa833d75fc", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.887940", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "9198990b7699ba584f81622497f226236d58aef340122010f36509abc3190f49"}}}}
{"instruction": "What is the molecular formula of Antifluorolol?", "response": "The molecular formula of Antifluorolol is C28H49N1O8.", "metadata": {"compound": "Antifluorolol", "batch": 0, "template": "What is the molecular formula of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000155-f58988c49340b1e5", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.887972", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "4c3085b3983afa78", "cl_signature": "5745612d3a061c0fc2d745062b9818e4b48c1ae4db366f2dd2b71ec0a2bd4027"}}}}
{"instruction": "How many hydrogen bond donors does Promorphcillin have?", "response": "Promorphcillin has 4 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Promorphcillin", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000156-494ed36d1f3eae80", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.888018", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "a8cd7ede4b1a326a8fc356854de36816004f27aab43e0b9b3812b07e23ec3842"}}}}
{"instruction": "How many aromatic rings does Syncephmab have?", "response": "Syncephmab contains 2 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Syncephmab", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000157-0cb9db6743b8a8d4", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.888054", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "d73a2758a9022d2ced721be4839712a7bc3de1401fb2f46cf7517a5e39eb1839"}}}}
{"instruction": "What is the solubility profile of Synmorphpril?", "response": "Synmorphpril exhibits low water solubility based on its logP value of 4.98.", "metadata": {"compound": "Synmorphpril", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000158-f56f7bcfd733ea48", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.888091", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "3b42edda420fb63c9654c4c78355e843ea28bab1036f360a073ed2cfe25e1923"}}}}
{"instruction": "What is the bioavailability of Paramorphib?", "response": "The predicted oral bioavailability of Paramorphib is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Paramorphib", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000159-a9fdbc7f25a7f376", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.888126", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "b603dd7219588b7216aded84614563286996789e5acee9e910f60b13a11503fd"}}}}
{"instruction": "What is the bioavailability of Anticephdone?", "response": "The predicted oral bioavailability of Anticephdone is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Anticephdone", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000160-b9699ba0a56774f0", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.888161", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "c8db73cce98cf85a330a9958d59bdbba7660a73acee14aff2451a1cbce17b98f"}}}}
{"instruction": "What are the pharmacokinetic properties of Antichlorazole?", "response": "The pharmacokinetic properties of Antichlorazole suggest good absorption potential with TPSA=34.81 \u0172 and MW=405.61 Da.", "metadata": {"compound": "Antichlorazole", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000161-0f4721d039f2bd67", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.888205", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "684528f9d37082b88a0fd7331614227b38d31d0c9d2e0dbc80085adb3526b584"}}}}
{"instruction": "Compare Isophenmycin to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Isophenmycin has favorable drug-like properties with MW=441.61 Da and logP=4.08.", "metadata": {"compound": "Isophenmycin", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000162-b7cfab714e18db46", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.888243", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "b392b7b5a34551460d4dff0d9839d08f479609e7fd391b00b7ce2f47c7194793"}}}}
{"instruction": "What is the bioavailability of Isochlorcillin?", "response": "The predicted oral bioavailability of Isochlorcillin is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Isochlorcillin", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000164-6c21e497305bb8d6", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.888329", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "b74e08c5c76045ea016db42261f215c4aa7e95d3f4bdf5fd730031122f521ef9"}}}}
{"instruction": "What is the TPSA of Anticyclcillin?", "response": "The topological polar surface area (TPSA) of Anticyclcillin is 42.61 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Anticyclcillin", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000165-7d89085360a60034", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.888373", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "afaa076f3f55bf8e893be04f712c331b227b99f12383529e0419a1a812f37bdc"}}}}
{"instruction": "How many aromatic rings does Paraphenolol have?", "response": "Paraphenolol contains 1 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Paraphenolol", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000166-40bf9ebcea7ced79", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.888410", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "1706dc8175cdae5c3393f57ae0f60cb4e0cecb994d87b021efb161f3b2832c5f"}}}}
{"instruction": "How many hydrogen bond acceptors does Episulfdone have?", "response": "Episulfdone has 7 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Episulfdone", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000168-9108b75b74ec7159", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.888518", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "cb5f22579eb3eb6fca887ebb7c6f71bf345c8f9ac4c6637b981851936dddc41e"}}}}
{"instruction": "How many aromatic rings does Procyclstatin have?", "response": "Procyclstatin contains 4 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Procyclstatin", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000169-7ebd34496da62b45", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.888556", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "e23b7fbbf285a1c4468b8901c2ef1f1500e79cf680546cd18997958bcbde8d70"}}}}
{"instruction": "How many rotatable bonds does Hypermorphmab have?", "response": "Hypermorphmab has 10 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Hypermorphmab", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000171-ebde57fbca4e70ea", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.888627", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "502c1ee8a319c4d4b1f08f329859c2f7c563fb78a998184b461ef55c868e6a17"}}}}
{"instruction": "What are the pharmacokinetic properties of Parachlorpine?", "response": "The pharmacokinetic properties of Parachlorpine suggest good absorption potential with TPSA=33.05 \u0172 and MW=301.39 Da.", "metadata": {"compound": "Parachlorpine", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000173-aa4e868c7e6552de", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.888703", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "17096ffdc2def6c3c138f0f0aa615831ed3031ccc28c6b043c225c442d4b54a8"}}}}
{"instruction": "What are the key structural features of Prophenolol?", "response": "Key structural features of Prophenolol include 3 aromatic rings, 2 rotatable bonds, and a molecular weight of 568.7 Da.", "metadata": {"compound": "Prophenolol", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000174-478fc130034e667f", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.888751", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "4ed059a202ee6139cce1032fdb12b1ebd7de3036996dbb36ea5bdc7e84870245"}}}}
{"instruction": "How many hydrogen bond acceptors does Epicyclstatin have?", "response": "Epicyclstatin has 7 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Epicyclstatin", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000175-fbfed94996e7c81e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.888787", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "ca831b893dc559f975f831a89ad39f6c7f9bd2e6cc2bf47e31ab30c2eb7f7803"}}}}
{"instruction": "What are the pharmacokinetic properties of Hyperfluorstatin?", "response": "The pharmacokinetic properties of Hyperfluorstatin suggest good absorption potential with TPSA=51.46 \u0172 and MW=252.46 Da.", "metadata": {"compound": "Hyperfluorstatin", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000176-0cae6453b78dae78", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.888831", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "ba81f1378b0faa49a92c3fc285ceb82d533f4d8be11b16286de3659fd6b60d9f"}}}}
{"instruction": "What is the logP value of Isocephib?", "response": "The logP (partition coefficient) of Isocephib is 3.2. This indicates good lipophilicity for oral bioavailability.", "metadata": {"compound": "Isocephib", "batch": 0, "template": "What is the logP value of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 85.0, "uniqueness_score": 90.0, "total_score": 94.25, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000177-d1c94749400a38bf", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.888865", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "f5d0ab06ae0f3868", "cl_signature": "7dc10202cd12751578e5221149c6a4fc184a96e5bb773a7dc67737924fdb6f84"}}}}
{"instruction": "What is the molecular weight of Epiphenpine?", "response": "The molecular weight of Epiphenpine is 266.51 Da.", "metadata": {"compound": "Epiphenpine", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000178-28aff87b08f219a4", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.888896", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "0311306ae3ad24d10c63bb1f4a09c95d5e3e363a8637b65b5f02c2cec93ce83d"}}}}
{"instruction": "Compare Metabarbmab to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Metabarbmab has favorable drug-like properties with MW=351.43 Da and logP=4.49.", "metadata": {"compound": "Metabarbmab", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000179-59e1b20954b50390", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.888933", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "e39c93cffb47b64d224b19243bf5c6b14d9aac0c1f8a94cbe0e44bc8f69a9143"}}}}
{"instruction": "What are the key structural features of Isochlormab?", "response": "Key structural features of Isochlormab include 4 aromatic rings, 5 rotatable bonds, and a molecular weight of 254.27 Da.", "metadata": {"compound": "Isochlormab", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000180-a4a89b08d532d559", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.888970", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "199dbe6ddbbba7f710734d4b079d9d7650bbc0161c93093b79bf9da935615414"}}}}
{"instruction": "How many hydrogen bond acceptors does Prochlordone have?", "response": "Prochlordone has 2 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Prochlordone", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000181-756aede879365e68", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.889014", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "1d483f629fccb7a13b0168d44258e0883c31d091611970e35afbf20952b4a26f"}}}}
{"instruction": "What is the molecular formula of Metasulfstatin?", "response": "The molecular formula of Metasulfstatin is C11H49O8.", "metadata": {"compound": "Metasulfstatin", "batch": 0, "template": "What is the molecular formula of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000182-684f724b91c35feb", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.889045", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "4c3085b3983afa78", "cl_signature": "1413c75baa752f7515a923aee3d41f5ca1828e58b687b8a65c74dd4f51e4c8bd"}}}}
{"instruction": "How many aromatic rings does Neocyclmycin have?", "response": "Neocyclmycin contains 4 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Neocyclmycin", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000183-32537be61478effc", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.889080", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "1a43ba2229e3a214332c13c4053a141d438a40b772fd8545774ad81b23b19b98"}}}}
{"instruction": "What is the molecular formula of Hyperfluordone?", "response": "The molecular formula of Hyperfluordone is C20H33N2O1.", "metadata": {"compound": "Hyperfluordone", "batch": 0, "template": "What is the molecular formula of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000184-0eb8428e7b38d795", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.889110", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "4c3085b3983afa78", "cl_signature": "63b50740e5ffc95f74937a673d0052a35cd298998c64154bb5ed4baf5a13df88"}}}}
{"instruction": "How many rotatable bonds does Synfluorib have?", "response": "Synfluorib has 1 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Synfluorib", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000185-6abf7018410bf7fc", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.889145", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "ab9272a9f1e60a30212851cdf386dc56bd664410de70263aa3ebbd9dbdfa6402"}}}}
{"instruction": "What is the TPSA of Isosulfmab?", "response": "The topological polar surface area (TPSA) of Isosulfmab is 59.17 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Isosulfmab", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000186-3ce2ed094423c92e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.889187", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "bba77298575849bec3d4a3a81f0f5c8857d112f75ab6762a5578ca38057204d3"}}}}
{"instruction": "How many hydrogen bond acceptors does Synbarbstatin have?", "response": "Synbarbstatin has 3 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Synbarbstatin", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000187-c604394e89e151df", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.889222", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "7b4e1a7618c9cf2418232f93dc8dc1b5a225c8f25a9548314a9d7d7e079e94a7"}}}}
{"instruction": "What are the key structural features of Paracyclpril?", "response": "Key structural features of Paracyclpril include 4 aromatic rings, 12 rotatable bonds, and a molecular weight of 278.67 Da.", "metadata": {"compound": "Paracyclpril", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000188-acacbc601ce9b67e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.889269", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "5e6790f7ea8ed08e5fc9a1617cd82dfe31e8ba9c4db7d851d8fe02ffb105c11d"}}}}
{"instruction": "What is the molecular formula of Episulfcillin?", "response": "The molecular formula of Episulfcillin is C17H17N4O2.", "metadata": {"compound": "Episulfcillin", "batch": 0, "template": "What is the molecular formula of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000189-a93cabd7228584e5", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.889300", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "4c3085b3983afa78", "cl_signature": "530d36a71b9ff01c8ce6ab81cbbaa4c414eec0e50ae38718dc0c48171a40b4c6"}}}}
{"instruction": "What is the bioavailability of Paracephib?", "response": "The predicted oral bioavailability of Paracephib is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Paracephib", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000190-15d3fe5a213bcb26", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.889335", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "400856d2062c87a0d532db1e5186dc3d4ce79fc1f6929bf4420aea7f721fd5d0"}}}}
{"instruction": "What is the logP value of Hypofluorcillin?", "response": "The logP (partition coefficient) of Hypofluorcillin is 0.7. This indicates good lipophilicity for oral bioavailability.", "metadata": {"compound": "Hypofluorcillin", "batch": 0, "template": "What is the logP value of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 85.0, "uniqueness_score": 90.0, "total_score": 94.25, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000191-e79144e0a0202d2d", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.889385", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "f5d0ab06ae0f3868", "cl_signature": "54e7e3b9f96dbba727733aa4e35159d80f382736a4cbce27bc67b322735e1b8b"}}}}
{"instruction": "How many rotatable bonds does Paraphenmab have?", "response": "Paraphenmab has 15 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Paraphenmab", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000192-5543aa896691a5f4", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.889421", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "4de801642575d469270361326648271ce4c6100c1788e5336301eed5350382b0"}}}}
{"instruction": "What are the key structural features of Procyclolol?", "response": "Key structural features of Procyclolol include 1 aromatic rings, 2 rotatable bonds, and a molecular weight of 530.26 Da.", "metadata": {"compound": "Procyclolol", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000193-e4fff5117b905aa3", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.889458", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "1e94cc785fbc8804fc759442dc3b5decb46a1f2bdece4df6add35cc361fe3143"}}}}
{"instruction": "How many aromatic rings does Synbarbib have?", "response": "Synbarbib contains 1 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Synbarbib", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000194-c9f330fa2bdf5a33", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.889494", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "b1c6d12bc7b764bce34618b4446be6724192f467d431ef2ef59aeee72234a98f"}}}}
{"instruction": "How many rotatable bonds does Neophenazole have?", "response": "Neophenazole has 11 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Neophenazole", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000196-4d65cf46e503be46", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.889568", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "7521b122f13e65cd03f6d408f74f8673b6819a405731cbc73d4b8fa60e304846"}}}}
{"instruction": "How many hydrogen bond acceptors does Synfluormab have?", "response": "Synfluormab has 3 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Synfluormab", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000197-7e096fcbd1db73df", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.889604", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "63eb8c73d707ab903708730eace24d0cb5db7877d34dd011a18a84d09f0422ac"}}}}
{"instruction": "Describe the molecular properties of Metabenzazole.", "response": "Metabenzazole (MW: 397.64 Da, C16H28O7) exhibits a logP of -1.13 and TPSA of 41.99 \u0172 with 3 H-bond donors and 6 H-bond acceptors.", "metadata": {"compound": "Metabenzazole", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000198-81071fc61af474b9", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.889653", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "1a15f2be39042321052885f72d883a7748a8e8e0caa379d4c0392cd8de09f309"}}}}
{"instruction": "How many hydrogen bond donors does Probarbpine have?", "response": "Probarbpine has 4 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Probarbpine", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000199-f75d138c38d65f5d", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.889690", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "4a600f775173f4b6d1cd1a7542b274d098d4b117e4b7c1b9a8c31f650f54fb4f"}}}}
{"instruction": "What are the key structural features of Neocephazole?", "response": "Key structural features of Neocephazole include 0 aromatic rings, 7 rotatable bonds, and a molecular weight of 162.9 Da.", "metadata": {"compound": "Neocephazole", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000200-463ba108b8087954", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.889727", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "a7f9c34e1419ca5953f3b1ab976138d83f172e086f347356f9f1d661fb23a90e"}}}}
{"instruction": "How many hydrogen bond acceptors does Promorphpril have?", "response": "Promorphpril has 2 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Promorphpril", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000201-f1c09037aff4b408", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.889762", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "938c9d88ba5d4bb304bb5099be27c3183f9caae0fbe72ee4f42eb98497a25e3a"}}}}
{"instruction": "How many hydrogen bond acceptors does Isosulfolol have?", "response": "Isosulfolol has 2 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Isosulfolol", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000202-e98471df9b343db0", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.889798", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "5ca9592441f33c441be7aeb86a63cd036e26a72f0de93b9a4774120e206b1273"}}}}
{"instruction": "What are the key structural features of Neomorphmycin?", "response": "Key structural features of Neomorphmycin include 4 aromatic rings, 12 rotatable bonds, and a molecular weight of 262.45 Da.", "metadata": {"compound": "Neomorphmycin", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000203-a7aba86bb11a3d77", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.889849", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "341b2f8a572cda181321f890963ee5d5692cdbc43a94251b1f1b43df61ca20bd"}}}}
{"instruction": "Does Procephib satisfy Lipinski's Rule of Five?", "response": "Procephib satisfies Lipinski's Rule of Five with no violations, suggesting good oral bioavailability potential.", "metadata": {"compound": "Procephib", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "drug_likeness", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000204-82cb4d9ed427527b", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.889885", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "46458dfc1b90afc32bba55e7373b96d16a956b27517ca3d51000cdcced656085"}}}}
{"instruction": "Does Hypermethpril satisfy Lipinski's Rule of Five?", "response": "Hypermethpril satisfies Lipinski's Rule of Five with no violations, suggesting good oral bioavailability potential.", "metadata": {"compound": "Hypermethpril", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "drug_likeness", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000206-b13335831eaf6050", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.889952", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "1ae169c8c40a0fc9fc8a6790af1a7143925a69c06a4396fe2e0a6391b88e71be"}}}}
{"instruction": "Compare Parasulfazole to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Parasulfazole has favorable drug-like properties with MW=238.5 Da and logP=0.71.", "metadata": {"compound": "Parasulfazole", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000207-39a6e9e66d5ee721", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.889990", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "e7dd0722f9a03bcd3b14f055eb6d521a5f30fd2339a41e072d3e80c5f2448e39"}}}}
{"instruction": "How many rotatable bonds does Prochlordone have?", "response": "Prochlordone has 8 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Prochlordone", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000208-7fe67731fa0f1631", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.890026", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "c9b0253eebedb03676800fe1cf3a9b509aa63f5a100219c6b5e74780539c82ab"}}}}
{"instruction": "Does Synmethmab satisfy Lipinski's Rule of Five?", "response": "Synmethmab satisfies Lipinski's Rule of Five with no violations, suggesting good oral bioavailability potential.", "metadata": {"compound": "Synmethmab", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "drug_likeness", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000209-beacd77739aabc8d", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.890060", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "1237f9e8108cc8a58d39517b293821ec77867be8ca03a5b19fa04e8b30e5dec2"}}}}
{"instruction": "What is the TPSA of Synsulfolol?", "response": "The topological polar surface area (TPSA) of Synsulfolol is 24.22 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Synsulfolol", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000210-7cfa4476de777e16", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.890104", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "c193b141aca53aecdeda1f843b3973c2a1dc39da9de05971d5ea0aca471e5ee7"}}}}
{"instruction": "How many aromatic rings does Hypomorpholol have?", "response": "Hypomorpholol contains 4 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Hypomorpholol", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000212-8db6146fcdf47281", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.890186", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "c09d998e462e176aec1d3b37e2491a3fb4a5fd8ec1ebedd71b3007515e2ed8de"}}}}
{"instruction": "Describe the molecular properties of Prochlorazole.", "response": "Prochlorazole (MW: 168.37 Da, C22H36N4O10) exhibits a logP of 2.46 and TPSA of 54.51 \u0172 with 0 H-bond donors and 5 H-bond acceptors.", "metadata": {"compound": "Prochlorazole", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000213-ee52b6a52813f041", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.890235", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "1d3a0cdeaec2c0e4de5e78b9fd51eb4cc7486594e59b165868ed9ddbbebc2827"}}}}
{"instruction": "How many aromatic rings does Probarbstatin have?", "response": "Probarbstatin contains 4 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Probarbstatin", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000214-9dcbf9624c66626e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.890272", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "914ee2304b616d143a76fb362ba24fed1e1f88a34609129f7aef01db03695d19"}}}}
{"instruction": "Describe the molecular properties of Isomethdone.", "response": "Isomethdone (MW: 232.23 Da, C27H50N4O10) exhibits a logP of 1.0 and TPSA of 102.26 \u0172 with 3 H-bond donors and 4 H-bond acceptors.", "metadata": {"compound": "Isomethdone", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000215-5f58278b195cb1ed", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.890355", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "c0292f18d2b14f621e59a80add7acb3e33c84bece7866e6996e1c0c6fc6f34f6"}}}}
{"instruction": "What is the molecular weight of Parabarbpril?", "response": "The molecular weight of Parabarbpril is 571.32 Da.", "metadata": {"compound": "Parabarbpril", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000217-d928be12a17c4762", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.890423", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "062eb15a6823837770a8b3105534aee7338330ae6a5ddff81298d3be17110d4c"}}}}
{"instruction": "Describe the molecular properties of Antimethpril.", "response": "Antimethpril (MW: 150.83 Da, C21H26N3O9) exhibits a logP of -0.55 and TPSA of 139.79 \u0172 with 0 H-bond donors and 1 H-bond acceptors.", "metadata": {"compound": "Antimethpril", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000218-925d39f36cd92655", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.890471", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "72f049c3df1c3d8dd619fe8e3f264674575e1e433e0866f9c36416d9dedff6c6"}}}}
{"instruction": "What is the TPSA of Epifluormycin?", "response": "The topological polar surface area (TPSA) of Epifluormycin is 133.27 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Epifluormycin", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000219-7946a8dffe80ce5a", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.890605", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "208b9631723fb0667b57684c15635598236a917d9a341a02f6843cae4571b998"}}}}
{"instruction": "What is the TPSA of Hyperbenzdone?", "response": "The topological polar surface area (TPSA) of Hyperbenzdone is 26.74 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Hyperbenzdone", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000220-80fbd52013a1b56e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.890720", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "62f9609995553b7997bc72f76c68520dda0e7888e9a3d2108c304f357df7e75f"}}}}
{"instruction": "What is the logP value of Epicephstatin?", "response": "The logP (partition coefficient) of Epicephstatin is 0.65. This indicates good lipophilicity for oral bioavailability.", "metadata": {"compound": "Epicephstatin", "batch": 0, "template": "What is the logP value of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 85.0, "uniqueness_score": 90.0, "total_score": 94.25, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000221-868695eb2ac6cdd4", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.890758", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "f5d0ab06ae0f3868", "cl_signature": "3c8fd1140c069df6c90f2540d79ede6151032e3d763ca4c5c1f32a6885b5800b"}}}}
{"instruction": "Does Synchlorazole satisfy Lipinski's Rule of Five?", "response": "Synchlorazole has 1 Lipinski violations: MW=583.92 > 500. This may affect oral bioavailability.", "metadata": {"compound": "Synchlorazole", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "drug_likeness", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000222-c6b86f02a91a39eb", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.890793", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "e1a05f32bbddbd17cc8479d594f08eeefd6c44282f798764edafc15009572f5c"}}}}
{"instruction": "What is the TPSA of Isobenzazole?", "response": "The topological polar surface area (TPSA) of Isobenzazole is 86.31 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Isobenzazole", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000224-118e8e9166242a80", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.890880", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "c194c53463b918dc902ac0af562644a73b3f46932ddbf9ce664f88b65e03a77e"}}}}
{"instruction": "Does Epifluorazole satisfy Lipinski's Rule of Five?", "response": "Epifluorazole has 1 Lipinski violations: MW=525.41 > 500. This may affect oral bioavailability.", "metadata": {"compound": "Epifluorazole", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "drug_likeness", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000225-daefd11e11d94759", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.890915", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "b89ebe766a84f6c5674385af5cb595870b9882df2934fe387df889598781554e"}}}}
{"instruction": "Does Antimorpholol satisfy Lipinski's Rule of Five?", "response": "Antimorpholol satisfies Lipinski's Rule of Five with no violations, suggesting good oral bioavailability potential.", "metadata": {"compound": "Antimorpholol", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "drug_likeness", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000226-d03adf4f57d5c0a9", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.890950", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "4ddf579e43cbbccb3f4ed7152290834400ccac11a3f08a50947f84547926af43"}}}}
{"instruction": "How many hydrogen bond donors does Hypermorphazole have?", "response": "Hypermorphazole has 2 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Hypermorphazole", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000228-934b65d819919cbd", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.891036", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "e5d709ba7ec1e0bf5b1c8d6a16404c6fe880bafc96ed1397f30da70abf754ce6"}}}}
{"instruction": "What is the solubility profile of Paracyclolol?", "response": "Paracyclolol exhibits moderate solubility based on its logP value of 0.39.", "metadata": {"compound": "Paracyclolol", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000230-feb46878ad1bf39c", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.891119", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "0b68853a1b3f3df394f3259d67ee592f208b4b49dd58c758ccedf9233bc1ca08"}}}}
{"instruction": "How many aromatic rings does Antiphenib have?", "response": "Antiphenib contains 1 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Antiphenib", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000231-53935d7d1ecccb7c", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.891156", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "f632bff6a3a78a4f643119147ae39249f150798dbf92ecb30cb49c1353280ab1"}}}}
{"instruction": "What are the pharmacokinetic properties of Epibenzmab?", "response": "The pharmacokinetic properties of Epibenzmab suggest limited absorption potential with TPSA=83.36 \u0172 and MW=546.02 Da.", "metadata": {"compound": "Epibenzmab", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000232-2e77d3a9c711199a", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.891208", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "b80796c34a650d45aa6059d0b5759e0e35cbbb2afecd9f737181561a736108ff"}}}}
{"instruction": "How many hydrogen bond donors does Neochlordone have?", "response": "Neochlordone has 5 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Neochlordone", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000233-6cda166cb13f22df", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.891246", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "73011200b3549843fa0d5d9d07c8558fa44ea5b37cdcbfbaeae8fa63edc226ca"}}}}
{"instruction": "What is the TPSA of Probarbmab?", "response": "The topological polar surface area (TPSA) of Probarbmab is 34.51 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Probarbmab", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000234-bfaf5c133dc37367", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.891289", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "aa6bd57b503399b083f7b5af4ccd5e34c58b9e03d9b9d42dda57ded5d9030a86"}}}}
{"instruction": "Describe the molecular properties of Neocyclazole.", "response": "Neocyclazole (MW: 432.19 Da, C14H23N5O5) exhibits a logP of -1.63 and TPSA of 69.18 \u0172 with 1 H-bond donors and 5 H-bond acceptors.", "metadata": {"compound": "Neocyclazole", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000235-77c9bd89344bfd3b", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.891339", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "c689454d93cde26058b522e5a829631b41787a58ded1f7bff5d1c1206fce2302"}}}}
{"instruction": "What is the bioavailability of Anticyclmab?", "response": "The predicted oral bioavailability of Anticyclmab is approximately 80% based on its physicochemical properties.", "metadata": {"compound": "Anticyclmab", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000236-115bd19c859595db", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.891375", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "ed586623ee186cf8a948841d6dcad727665f9743b37de640529d9870171b802a"}}}}
{"instruction": "What are the key structural features of Parafluorcillin?", "response": "Key structural features of Parafluorcillin include 1 aromatic rings, 1 rotatable bonds, and a molecular weight of 420.05 Da.", "metadata": {"compound": "Parafluorcillin", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000237-818874ac28103575", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.891603", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "cef4d05bdb57bc572db3bf1a3f0f20c2cae7d8a74e28e9772dd5c23e60d44e0e"}}}}
{"instruction": "What are the key structural features of Hypercyclcillin?", "response": "Key structural features of Hypercyclcillin include 3 aromatic rings, 2 rotatable bonds, and a molecular weight of 359.42 Da.", "metadata": {"compound": "Hypercyclcillin", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000238-904da77bac06fdd2", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.891666", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "dbda0aeb06c1a14b57c852a27a9fc786271720152b7ace445fce07f533ace6f1"}}}}
{"instruction": "What is the logP value of Hyperchlorpine?", "response": "The logP (partition coefficient) of Hyperchlorpine is 4.4. This indicates good lipophilicity for oral bioavailability.", "metadata": {"compound": "Hyperchlorpine", "batch": 0, "template": "What is the logP value of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 85.0, "uniqueness_score": 90.0, "total_score": 94.25, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000239-07cc9b64cf4dd366", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.891710", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "f5d0ab06ae0f3868", "cl_signature": "39fb1f1708b4b5d3880a7a8177755db63d34aab6fdb6c19ebf8ea48e7acd0c16"}}}}
{"instruction": "What are the key structural features of Episulfpril?", "response": "Key structural features of Episulfpril include 4 aromatic rings, 10 rotatable bonds, and a molecular weight of 423.04 Da.", "metadata": {"compound": "Episulfpril", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000241-b51811b32b1e95c4", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.891792", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "e5e3897de9c3e99154a058e086a98bb5eef421a620347a047fa3281850c64492"}}}}
{"instruction": "What are the pharmacokinetic properties of Metabarbpine?", "response": "The pharmacokinetic properties of Metabarbpine suggest good absorption potential with TPSA=71.79 \u0172 and MW=200.88 Da.", "metadata": {"compound": "Metabarbpine", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000242-fc706d3ebe10ea2b", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.891841", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "7b1bac728eefc02a6804160729d9b9148dc3bd2fdb0566c59d606a1df05308b1"}}}}
{"instruction": "What is the TPSA of Isofluorcillin?", "response": "The topological polar surface area (TPSA) of Isofluorcillin is 113.44 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Isofluorcillin", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000243-a3ad3d0132e8f1d4", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.891889", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "a7e6e6319d0487f0c64908d762283eb88351fa91169a2f818f1844d56536633a"}}}}
{"instruction": "Compare Episulfmab to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Episulfmab has favorable drug-like properties with MW=230.14 Da and logP=4.28.", "metadata": {"compound": "Episulfmab", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000244-85e053c8dfad5632", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.891929", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "20f3145769f0c95c8f8c6f88013484a89def3ecd3b1afeb456e9a832f6a51628"}}}}
{"instruction": "How many aromatic rings does Hypomorphpril have?", "response": "Hypomorphpril contains 2 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Hypomorphpril", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000245-24092cc01450a0ec", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.891987", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "24e21739eb6e52b2ff454cc7cc6a860512baaa7c977079f8127a4e81d26be9bb"}}}}
{"instruction": "What is the logP value of Metachlormycin?", "response": "The logP (partition coefficient) of Metachlormycin is 3.93. This indicates good lipophilicity for oral bioavailability.", "metadata": {"compound": "Metachlormycin", "batch": 0, "template": "What is the logP value of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 85.0, "uniqueness_score": 90.0, "total_score": 94.25, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000246-c76547f96951fa9f", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.892032", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "f5d0ab06ae0f3868", "cl_signature": "51d0b3ef851439643ae7dbfb06a80ef80147ba63bbf8c9fb20f8ff3bf56408b2"}}}}
{"instruction": "What are the key structural features of Hypocephazole?", "response": "Key structural features of Hypocephazole include 2 aromatic rings, 4 rotatable bonds, and a molecular weight of 219.59 Da.", "metadata": {"compound": "Hypocephazole", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000247-9deac9dfcc7f124e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.892070", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "3ac0788a43f63eaaca4cb53f40265e7edd894159bb6ba7be703de47f80a658fb"}}}}
{"instruction": "What are the pharmacokinetic properties of Hypocephstatin?", "response": "The pharmacokinetic properties of Hypocephstatin suggest good absorption potential with TPSA=48.38 \u0172 and MW=343.12 Da.", "metadata": {"compound": "Hypocephstatin", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000248-8f27587cd9499e91", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.892124", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "25eb1dea05f678d8195634a89d5ea99d42213ec5c9a0764e717b141d8f68c462"}}}}
{"instruction": "What is the molecular formula of Hyperphenazole?", "response": "The molecular formula of Hyperphenazole is C28H35N1O5.", "metadata": {"compound": "Hyperphenazole", "batch": 0, "template": "What is the molecular formula of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000249-052722da5bae9b84", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.892159", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "4c3085b3983afa78", "cl_signature": "4a9cb0e0d8846520c6167bdb4e625298bd90edd22696924b202a978d205b35fc"}}}}
{"instruction": "How many aromatic rings does Neomethstatin have?", "response": "Neomethstatin contains 1 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Neomethstatin", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000250-db556ea928305e3b", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.892215", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "d65403929214d574decb802059b60fb6c79628defce567cd653a06231d56b9ae"}}}}
{"instruction": "How many aromatic rings does Epifluorstatin have?", "response": "Epifluorstatin contains 1 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Epifluorstatin", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000251-d0960551836b95b7", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.892269", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "afb30ff2e93bd92e8f3b7536efccd8f1261c6dcc43d6e6a8a23c94a9677e0ea3"}}}}
{"instruction": "What is the solubility profile of Synchlormycin?", "response": "Synchlormycin exhibits moderate solubility based on its logP value of 2.49.", "metadata": {"compound": "Synchlormycin", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000252-6faae65a5e692307", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.892330", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "139aa3fc419f5b4a43f326f923ba9546e632b9332a877a5cf61ad70c4617b8af"}}}}
{"instruction": "What is the molecular formula of Paramorphstatin?", "response": "The molecular formula of Paramorphstatin is C21H39N4O5.", "metadata": {"compound": "Paramorphstatin", "batch": 0, "template": "What is the molecular formula of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000253-852bdd70478f9f88", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.892370", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "4c3085b3983afa78", "cl_signature": "701e9e512732257b8786321445eff9864cbc781b1109e32b169a37d496b182da"}}}}
{"instruction": "Compare Paramorphmycin to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Paramorphmycin has favorable drug-like properties with MW=315.33 Da and logP=4.99.", "metadata": {"compound": "Paramorphmycin", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000254-a1216c32592da2da", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.892412", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "dd1341b9820c7f7400332cba49db2dc9a07778d173d6e08fe2500e13741c28e0"}}}}
{"instruction": "Describe the molecular properties of Hypomorphcillin.", "response": "Hypomorphcillin (MW: 573.13 Da, C24H16N3O8) exhibits a logP of 1.63 and TPSA of 24.51 \u0172 with 0 H-bond donors and 6 H-bond acceptors.", "metadata": {"compound": "Hypomorphcillin", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000255-c093071226842172", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.892469", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "770e0e0f1bd248ef8d413f8e153ba64c6c3d0cdf4fad124de6d55b5ef160bc73"}}}}
{"instruction": "How many rotatable bonds does Synbarbmycin have?", "response": "Synbarbmycin has 11 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Synbarbmycin", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000256-f0e16480891fc67f", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.892508", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "5353c6b791e545e30a6b661c8b270b89f261a52d7cd4e139d0bbd18c11e4983c"}}}}
{"instruction": "What is the bioavailability of Metachlordone?", "response": "The predicted oral bioavailability of Metachlordone is approximately 80% based on its physicochemical properties.", "metadata": {"compound": "Metachlordone", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000257-531c86c9affd30e0", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.892546", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "a5979ced396bc9b8b2e6db75a8b1dd4579d8a8c5f805f21af7e35adb27999c9c"}}}}
{"instruction": "How many rotatable bonds does Antibenzdone have?", "response": "Antibenzdone has 3 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Antibenzdone", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000258-78c809fe9cc37684", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.892583", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "62b2555ff29a533f0f30510092f045f7f74410a2d9addbd3345b44b4c3a903ec"}}}}
{"instruction": "How many hydrogen bond acceptors does Antimorphcillin have?", "response": "Antimorphcillin has 9 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Antimorphcillin", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000259-6f334a9e923964ce", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.892664", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "c29025bf81f4f39eb897b8f9bed760cfe13993a420a57bf2f0bae4fc16e1096e"}}}}
{"instruction": "Describe the molecular properties of Neocephdone.", "response": "Neocephdone (MW: 422.65 Da, C26H48N4O6) exhibits a logP of 2.81 and TPSA of 72.1 \u0172 with 4 H-bond donors and 3 H-bond acceptors.", "metadata": {"compound": "Neocephdone", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000260-16a717bdd8b0ec89", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.892715", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "4d60206b2cc6f6732848ccf62dcfa72aec5af72119822e99c4ffd55db4228966"}}}}
{"instruction": "What is the solubility profile of Hypermethmab?", "response": "Hypermethmab exhibits low water solubility based on its logP value of 4.01.", "metadata": {"compound": "Hypermethmab", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000261-264250ed7dfc28b6", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.892755", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "b8ede1df5bc6a4507155c1650b1e858a8023d84354f89f674f4545695d636325"}}}}
{"instruction": "How many hydrogen bond acceptors does Prosulfolol have?", "response": "Prosulfolol has 7 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Prosulfolol", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000262-e6531fb0bf33f1ca", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.892792", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "b19824494536d64db9b9a951a3bc5b7deb5d0636b6c8136d4dd2777d6b739c9c"}}}}
{"instruction": "Compare Paracephazole to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Paracephazole has favorable drug-like properties with MW=219.86 Da and logP=4.26.", "metadata": {"compound": "Paracephazole", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000264-73837401f46ed5d1", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.892867", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "c2fdef6a738758d74279ca68fe147d154d80d9b0305e15abc3a0319ad63b27bc"}}}}
{"instruction": "Describe the molecular properties of Neometholol.", "response": "Neometholol (MW: 226.72 Da, C19H13N1O2) exhibits a logP of 2.77 and TPSA of 100.49 \u0172 with 4 H-bond donors and 1 H-bond acceptors.", "metadata": {"compound": "Neometholol", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000265-39e7520cb76ff102", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.892917", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "6c39e4c8594ac337f24dea038728f84c5c56f35a7d985708cb60373740deeb54"}}}}
{"instruction": "Compare Probenzpine to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Probenzpine has suboptimal drug-like properties with MW=583.45 Da and logP=-0.63.", "metadata": {"compound": "Probenzpine", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000266-cbab02f7f64ce83b", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.892954", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "e63a869cec44a3f8657c4426c3cc4dd774415850638ca4e6d187f583b5cbcd56"}}}}
{"instruction": "What are the pharmacokinetic properties of Paracephcillin?", "response": "The pharmacokinetic properties of Paracephcillin suggest limited absorption potential with TPSA=61.46 \u0172 and MW=535.7 Da.", "metadata": {"compound": "Paracephcillin", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000267-d78843b0f035a3bd", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.893012", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "67085bd931f19580f68b2380bad164a303d4c12f2240c05cf9ffe70f6bf41435"}}}}
{"instruction": "Does Hypomethpril satisfy Lipinski's Rule of Five?", "response": "Hypomethpril satisfies Lipinski's Rule of Five with no violations, suggesting good oral bioavailability potential.", "metadata": {"compound": "Hypomethpril", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "drug_likeness", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000268-f71cf5c4eabbec5c", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.893047", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "c89812a82e51b6a7ddcbb9c89147f30e08018a3a4aec2f036ef9e7eadd08e44c"}}}}
{"instruction": "How many hydrogen bond acceptors does Metafluordone have?", "response": "Metafluordone has 8 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Metafluordone", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000269-9cc635f6b16ef2ba", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.893084", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "60f1e1527ca0865760cb97dc56d167c757f29f7ee93ca9c392ac24933a5e7feb"}}}}
{"instruction": "What is the molecular formula of Epiphenolol?", "response": "The molecular formula of Epiphenolol is C12H27N4O3.", "metadata": {"compound": "Epiphenolol", "batch": 0, "template": "What is the molecular formula of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000270-d9dcb6987e0709d4", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.893115", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "4c3085b3983afa78", "cl_signature": "dfa7afe3acbe958d98cca9c4530eba596ca9cb9633437f12232287c8b0d62295"}}}}
{"instruction": "What is the TPSA of Neophencillin?", "response": "The topological polar surface area (TPSA) of Neophencillin is 123.56 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Neophencillin", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000271-1a7463c8532a0017", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.893159", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "05956ff06e67ef3fe4445a49c747104229736b4b0ffd67af767c2a8ecf342e40"}}}}
{"instruction": "What is the solubility profile of Neofluorstatin?", "response": "Neofluorstatin exhibits high water solubility based on its logP value of -0.73.", "metadata": {"compound": "Neofluorstatin", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000272-bf2a67f0789a700e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.893196", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "735b3748034f315c78f46015fbb9b49cab88e37fdc24ae96f84a9a04d834421a"}}}}
{"instruction": "Compare Isomethmab to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Isomethmab has favorable drug-like properties with MW=329.32 Da and logP=3.84.", "metadata": {"compound": "Isomethmab", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000273-ba91c606fe6bfaeb", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.893265", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "03467c95c14873e1c2d151e7e3e7e55c87b6d4d158406f48d660ab9394c76867"}}}}
{"instruction": "What is the bioavailability of Hypochlorib?", "response": "The predicted oral bioavailability of Hypochlorib is approximately 80% based on its physicochemical properties.", "metadata": {"compound": "Hypochlorib", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000274-33fbb36ec6002315", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.893331", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "e4ff0f55abda3f97641d220db21c2fb969c4d575cd5d72bc2781d2d8fca5b42d"}}}}
{"instruction": "How many hydrogen bond acceptors does Parabenzstatin have?", "response": "Parabenzstatin has 4 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Parabenzstatin", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000275-76fe006f0132c59b", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.893368", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "c77a8658997729c2ce363ed89ce60e0004e63e008c7c72a361fd99c03f2ced23"}}}}
{"instruction": "What is the bioavailability of Paramorphpine?", "response": "The predicted oral bioavailability of Paramorphpine is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Paramorphpine", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000278-6eed0ff6317498fd", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.893468", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "c1eedea55d10eb14dfc08362e61a68ad0e4419fe6733c2baa8ced53d1d2c4798"}}}}
{"instruction": "What is the molecular weight of Hypermorphcillin?", "response": "The molecular weight of Hypermorphcillin is 261.11 Da.", "metadata": {"compound": "Hypermorphcillin", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000279-1e36cdc28a75575e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.893499", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "f13550eaf2d3f9eef51048e5ffd1bdda7c7d0c61fc3c348c032b02db0ae391d4"}}}}
{"instruction": "How many hydrogen bond donors does Hypochlorpine have?", "response": "Hypochlorpine has 4 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Hypochlorpine", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000280-d39a5819ce5edc9d", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.893535", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "5adeffe64067b45bb03bc92571f2ba0740f5d20e1b9409d174bc422ea50688f0"}}}}
{"instruction": "How many hydrogen bond acceptors does Isomorphazole have?", "response": "Isomorphazole has 9 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Isomorphazole", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000281-70afedd425a4f07e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.893571", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "e2346ca509c73d546c51c73c311a7e7128c18dae02051bd5a721f4df008ff249"}}}}
{"instruction": "What are the key structural features of Paramethcillin?", "response": "Key structural features of Paramethcillin include 2 aromatic rings, 4 rotatable bonds, and a molecular weight of 350.56 Da.", "metadata": {"compound": "Paramethcillin", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000282-36d9752edbc50976", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.893608", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "d57a5360893eff667fde053ec285bc6cec7645a39d2170d6e6651b386a2ec6fa"}}}}
{"instruction": "Does Synsulfcillin satisfy Lipinski's Rule of Five?", "response": "Synsulfcillin has 1 Lipinski violations: MW=510.71 > 500. This may affect oral bioavailability.", "metadata": {"compound": "Synsulfcillin", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "drug_likeness", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000283-0185efea930ff471", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.893652", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "295b99cf013a01b6b1fc84d30bb66aa75e2fca06bd0bd1250a9b530c9c8d42cd"}}}}
{"instruction": "What is the TPSA of Anticephib?", "response": "The topological polar surface area (TPSA) of Anticephib is 90.14 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Anticephib", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000284-9b2b7b6b0b59b5b4", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.893695", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "d591b0bee4c3e92fd628db4bce87c7c3327ef5f0819f7cae9932562d4d9c44dc"}}}}
{"instruction": "What is the TPSA of Hypermorphib?", "response": "The topological polar surface area (TPSA) of Hypermorphib is 72.35 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Hypermorphib", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000285-fcb3ccfa36b34451", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.893737", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "665668b723480f27bb95e52df57acab5154a158514ceba48a7ceee63a027bf2a"}}}}
{"instruction": "What is the TPSA of Synmorphazole?", "response": "The topological polar surface area (TPSA) of Synmorphazole is 117.64 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Synmorphazole", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000286-ab30af137127d7aa", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.893779", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "6c7c8789f897095b0de8ec9701cd644549f5931ddd614957880b47b2e05e97d4"}}}}
{"instruction": "What is the solubility profile of Metacephcillin?", "response": "Metacephcillin exhibits low water solubility based on its logP value of 4.42.", "metadata": {"compound": "Metacephcillin", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000287-970c6542c7a2cc12", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.893816", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "508b7f151f853ee1666aa25d4ca09018052a2f9289d76a01fb879b7646c194d2"}}}}
{"instruction": "Compare Syncycldone to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Syncycldone has favorable drug-like properties with MW=479.31 Da and logP=-0.59.", "metadata": {"compound": "Syncycldone", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000289-2d6c5535bb990475", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.893897", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "18783aff42ff05342326acac1de2db1b0decb786f6eac434bd7445df4811ea4b"}}}}
{"instruction": "What are the pharmacokinetic properties of Metachlorcillin?", "response": "The pharmacokinetic properties of Metachlorcillin suggest limited absorption potential with TPSA=54.95 \u0172 and MW=519.52 Da.", "metadata": {"compound": "Metachlorcillin", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000291-6d83682666c9dcdc", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.893978", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "94473e9212ce0c17b96a5cf3c6d0584e40017c4bfbdddfd54ddd33c3b8e587f2"}}}}
{"instruction": "What is the bioavailability of Parachlordone?", "response": "The predicted oral bioavailability of Parachlordone is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Parachlordone", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000292-5472f2d8f80db229", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.894024", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "ace0b028394dd5996a69d025a7ce4f9ceeb8eedb798dd985dd1bc81852216aec"}}}}
{"instruction": "How many aromatic rings does Parafluorazole have?", "response": "Parafluorazole contains 0 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Parafluorazole", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000293-cb28c4c42b5e3bd0", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.894063", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "5736d1b5782188eb7ed61139de2787eb6e09d9a9ec2060a687bd52bb8af21135"}}}}
{"instruction": "What is the molecular weight of Hypercephazole?", "response": "The molecular weight of Hypercephazole is 441.05 Da.", "metadata": {"compound": "Hypercephazole", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000296-d08e770b8d582a61", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.894242", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "3dba96ddca0e2a6a1b321f7168a896c28765db81f712561c7260e81469298566"}}}}
{"instruction": "Compare Epiphenolol to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Epiphenolol has favorable drug-like properties with MW=429.92 Da and logP=0.07.", "metadata": {"compound": "Epiphenolol", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000297-957b9937648a8eb0", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.894279", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "b632d1b361146386d2cabee598e9377af116f066c341aeaef1ed4b05cfe816be"}}}}
{"instruction": "What is the logP value of Metaphenolol?", "response": "The logP (partition coefficient) of Metaphenolol is -0.7. This indicates good lipophilicity for oral bioavailability.", "metadata": {"compound": "Metaphenolol", "batch": 0, "template": "What is the logP value of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 85.0, "uniqueness_score": 90.0, "total_score": 94.25, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000298-84b6a8395bb26cbe", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.894337", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "f5d0ab06ae0f3868", "cl_signature": "b952a120b79787a7c458b0aa864dc57754957f244ea28309104dab9c14b35890"}}}}
{"instruction": "Does Procyclib satisfy Lipinski's Rule of Five?", "response": "Procyclib satisfies Lipinski's Rule of Five with no violations, suggesting good oral bioavailability potential.", "metadata": {"compound": "Procyclib", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "drug_likeness", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000299-21a6ea8d122d79fd", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.894386", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "a52cd078d84efeae98d21aea72e75e0ff362ab09904ff81e64ccb4dea072ae54"}}}}
{"instruction": "What are the key structural features of Hyposulfazole?", "response": "Key structural features of Hyposulfazole include 4 aromatic rings, 15 rotatable bonds, and a molecular weight of 283.57 Da.", "metadata": {"compound": "Hyposulfazole", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000300-c0dee5f8bec76b07", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.894452", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "f70795bce21c81f322a92ee24ce3aa357ec8e42f0c14533a7cfaace7ee69d78f"}}}}
{"instruction": "How many hydrogen bond donors does Hypobarbpine have?", "response": "Hypobarbpine has 5 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Hypobarbpine", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000301-b8e65c5b81f71edb", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.894511", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "85ba372b298ebd16e72c49f384ee586e4a3b6a5e0ae6e0902cdd76834ae19c2c"}}}}
{"instruction": "What is the molecular formula of Epimorphmycin?", "response": "The molecular formula of Epimorphmycin is C25H45N1O3.", "metadata": {"compound": "Epimorphmycin", "batch": 0, "template": "What is the molecular formula of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000303-6094309dd3e001a1", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.894595", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "4c3085b3983afa78", "cl_signature": "3cdbdc35b7f3bb52df06b2d6e71bb124b948cd487cfe08f8a77faa2ede93511c"}}}}
{"instruction": "Compare Synfluordone to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Synfluordone has favorable drug-like properties with MW=396.32 Da and logP=-1.1.", "metadata": {"compound": "Synfluordone", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000304-0497bf912cc2ecb3", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.894638", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "ce091cd21d9d9bfaf691c55947a22d0c955c49e9166bf3fe6fb1138b634419ba"}}}}
{"instruction": "How many hydrogen bond acceptors does Hyperfluorolol have?", "response": "Hyperfluorolol has 2 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Hyperfluorolol", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000305-aa6e1df77cf63925", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.894675", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "e2f563e983c09dc09408964e723f6371f9f49b38bf0090f005fd00f94db04a53"}}}}
{"instruction": "What are the key structural features of Hypercepholol?", "response": "Key structural features of Hypercepholol include 0 aromatic rings, 13 rotatable bonds, and a molecular weight of 323.79 Da.", "metadata": {"compound": "Hypercepholol", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000306-aea8f3f44fe95687", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.894714", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "274eca55580b895d4b19c3718ef0e50943b61c0ba07590f275c153648f2fe8a1"}}}}
{"instruction": "How many hydrogen bond donors does Parafluorazole have?", "response": "Parafluorazole has 4 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Parafluorazole", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000307-c8baf54c1bc3b687", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.894750", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "10241fd25f83b36b9119baf1cbf5076d9d79ade0c4eb51f2201d15414ac895d1"}}}}
{"instruction": "What are the key structural features of Syncyclazole?", "response": "Key structural features of Syncyclazole include 4 aromatic rings, 4 rotatable bonds, and a molecular weight of 384.2 Da.", "metadata": {"compound": "Syncyclazole", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000308-23cdb247b5e22546", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.894788", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "fa789ae5533698da919e4b05fc42e445eff35d0c81be5b8bf965b7fcf38b4ec7"}}}}
{"instruction": "How many hydrogen bond acceptors does Paracyclcillin have?", "response": "Paracyclcillin has 5 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Paracyclcillin", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000309-7ad26a3064629dc3", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.894839", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "cbc922549196ac1fc8946562c037ffc6f243cdcfe7c48045e7fbf25a2cc27753"}}}}
{"instruction": "How many aromatic rings does Hypobarbdone have?", "response": "Hypobarbdone contains 2 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Hypobarbdone", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000310-99e8e5b46f4c46a6", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.894876", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "b84363c07aec71c76d061b334645c1265ad3792f1a759cd9e287e12cfaa8c1a6"}}}}
{"instruction": "What are the key structural features of Hyposulfcillin?", "response": "Key structural features of Hyposulfcillin include 3 aromatic rings, 7 rotatable bonds, and a molecular weight of 545.59 Da.", "metadata": {"compound": "Hyposulfcillin", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000312-69818673a1d87e83", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.894950", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "914c91418bb673229513cc7e641a7d8c12576b2882c5b02cad97420696c73043"}}}}
{"instruction": "What is the bioavailability of Hypermethmycin?", "response": "The predicted oral bioavailability of Hypermethmycin is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Hypermethmycin", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000313-9dd245f46139615a", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.894985", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "95c5f987365e62b9a542c483881d4d4bdb5525626b6157131779213ca5896001"}}}}
{"instruction": "What are the key structural features of Isofluorolol?", "response": "Key structural features of Isofluorolol include 2 aromatic rings, 4 rotatable bonds, and a molecular weight of 185.63 Da.", "metadata": {"compound": "Isofluorolol", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000314-e1dae0c38017c247", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.895023", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "68b190f4ae5702f15cb73ff11d5ca2760e024e5849a2ac9138d208342ab9efb7"}}}}
{"instruction": "What is the molecular formula of Epichlorcillin?", "response": "The molecular formula of Epichlorcillin is C24H36N1O5.", "metadata": {"compound": "Epichlorcillin", "batch": 0, "template": "What is the molecular formula of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000315-6cb680e9376f0d8b", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.895054", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "4c3085b3983afa78", "cl_signature": "b5f7b8babff4b05263f6c5b936d95f094421c15f70274781990f1ede31b832a6"}}}}
{"instruction": "How many aromatic rings does Isochlorolol have?", "response": "Isochlorolol contains 0 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Isochlorolol", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000316-d87344e88d18d82a", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.895090", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "e51e3a4fcc6c1e0e2ca3977f2aa791633ef29870a2deaaf81a152ad696b4ff57"}}}}
{"instruction": "Compare Metaphenpine to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Metaphenpine has favorable drug-like properties with MW=493.16 Da and logP=4.67.", "metadata": {"compound": "Metaphenpine", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000317-c7506659acb76aa3", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.895138", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "765d3333b689a37768b10eb5d7cdd6330a82e3511ba80fbceb9465741793f008"}}}}
{"instruction": "How many aromatic rings does Prochlorstatin have?", "response": "Prochlorstatin contains 3 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Prochlorstatin", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000319-5ccfa3581eb5d95d", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.895211", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "54bb64370fb807231e244ad38c4f1254d5348e2e6a2ded52190fc9eca2923e2b"}}}}
{"instruction": "What is the bioavailability of Synchlorpine?", "response": "The predicted oral bioavailability of Synchlorpine is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Synchlorpine", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000320-91280d9fa85613be", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.895245", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "d77fed29e3b53c3d045aeced9ddbbe28480b5754eda531aaafb684874dd1635d"}}}}
{"instruction": "What is the molecular formula of Neobarbazole?", "response": "The molecular formula of Neobarbazole is C12H43N4O8.", "metadata": {"compound": "Neobarbazole", "batch": 0, "template": "What is the molecular formula of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000321-065e383638966849", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.895276", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "4c3085b3983afa78", "cl_signature": "99886e3e8e1ca189e5750cb614adb408667b0c0e357b6b4a5e7f9c4f03f175da"}}}}
{"instruction": "What is the solubility profile of Synbenzazole?", "response": "Synbenzazole exhibits low water solubility based on its logP value of 4.94.", "metadata": {"compound": "Synbenzazole", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000322-d4c269b634a6452c", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.895313", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "24609411f4bafb615a8fd2e8318999fe20967c6b8cb355c9b76c93e29a86facc"}}}}
{"instruction": "How many hydrogen bond donors does Antifluormab have?", "response": "Antifluormab has 5 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Antifluormab", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000325-173589f963169ef6", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.895421", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "f69a21d144fee8c79cb0196351be4df9d88aa0a6996354aa59fcbfa0ec78df9d"}}}}
{"instruction": "Describe the molecular properties of Hyposulfazole.", "response": "Hyposulfazole (MW: 335.89 Da, C12H16N2O1) exhibits a logP of 2.99 and TPSA of 112.45 \u0172 with 2 H-bond donors and 10 H-bond acceptors.", "metadata": {"compound": "Hyposulfazole", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000327-a86b88478361f3ae", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.895519", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "4ea8079293cdb36b718eba7a7c8c0bc2a41600f245463427ac300bd4a8848781"}}}}
{"instruction": "What is the molecular weight of Neocyclmab?", "response": "The molecular weight of Neocyclmab is 209.76 Da.", "metadata": {"compound": "Neocyclmab", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000328-a31a4463603b44ca", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.895560", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "61f127dde59a41103acc95be8f4cc1c8a413f965582e552c2e5a4572f7118a05"}}}}
{"instruction": "How many aromatic rings does Metamorphpine have?", "response": "Metamorphpine contains 0 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Metamorphpine", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000329-afc26e334d7b8452", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.895595", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "9cbaf4f7dca458b354b4c1e855e48755ea68d241cbb77dd58cb586844e9908f4"}}}}
{"instruction": "Describe the molecular properties of Metachlorstatin.", "response": "Metachlorstatin (MW: 166.4 Da, C27H19N1O4) exhibits a logP of 0.75 and TPSA of 38.96 \u0172 with 4 H-bond donors and 2 H-bond acceptors.", "metadata": {"compound": "Metachlorstatin", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000330-5315dbb26a21ad26", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.895642", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "d5738dba3c42e83ae1cc28cfb69235e82cffcce93f27e4ad31d51d2281d4caf7"}}}}
{"instruction": "How many hydrogen bond acceptors does Isochlorazole have?", "response": "Isochlorazole has 7 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Isochlorazole", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000333-f18b7b83b5870ab2", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.895740", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "4c1b440406d1934946fa51977df8cb16cf0782d43b9919871e544dead29d16fa"}}}}
{"instruction": "How many hydrogen bond donors does Synphenstatin have?", "response": "Synphenstatin has 1 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Synphenstatin", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000334-8aa2547fda92c14b", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.895774", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "9effa01cc39260b838dcb24b70ee6a16a414ac4fc208865f98cc58df690fdf65"}}}}
{"instruction": "Compare Hypercephstatin to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Hypercephstatin has suboptimal drug-like properties with MW=576.42 Da and logP=1.99.", "metadata": {"compound": "Hypercephstatin", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000335-f50ea241a99bced4", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.895811", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "8b3b85955f1249281eae012a02b2ffaef30bb8f3dc2c00d8bb4f5d409435749d"}}}}
{"instruction": "What are the pharmacokinetic properties of Metacyclpine?", "response": "The pharmacokinetic properties of Metacyclpine suggest good absorption potential with TPSA=79.93 \u0172 and MW=154.2 Da.", "metadata": {"compound": "Metacyclpine", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000336-9c122b7df1f4a0a1", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.895855", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "28414720d6b9e16d5513117b1916cf1eadbe489f7c7b81a58bd0fe32f6ca1802"}}}}
{"instruction": "How many hydrogen bond donors does Neochlorolol have?", "response": "Neochlorolol has 2 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Neochlorolol", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000337-b406dfda518b3197", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.895900", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "6d787743d90a9cc400c9f53427dc7adb0c5d487484ea9b25858b36ffa9ec232d"}}}}
{"instruction": "What is the molecular weight of Hypophenpine?", "response": "The molecular weight of Hypophenpine is 564.95 Da.", "metadata": {"compound": "Hypophenpine", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000338-2a147550cd9f4533", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.895930", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "f14c7e9bcfd5db3a586e4e746e9ebb45aa59a1c9a12228a77f9642594ab739e9"}}}}
{"instruction": "What are the pharmacokinetic properties of Synsulfmycin?", "response": "The pharmacokinetic properties of Synsulfmycin suggest good absorption potential with TPSA=134.47 \u0172 and MW=201.46 Da.", "metadata": {"compound": "Synsulfmycin", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000339-fb46ffcce27eda03", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.895974", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "97c42aadf6d59a4cd43f41b19cd43fec7020c30ddd4a3a6bde8e300be10d7584"}}}}
{"instruction": "Describe the molecular properties of Metasulfpril.", "response": "Metasulfpril (MW: 161.24 Da, C22H26N5O10) exhibits a logP of -1.97 and TPSA of 123.3 \u0172 with 2 H-bond donors and 1 H-bond acceptors.", "metadata": {"compound": "Metasulfpril", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000341-e4bc2ca5303f1a3f", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.896057", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "1bec0ca5bfea5c95b919250b2fa84e381684b7234514810c751a2fcb63bc9708"}}}}
{"instruction": "What is the solubility profile of Probarbdone?", "response": "Probarbdone exhibits low water solubility based on its logP value of 3.34.", "metadata": {"compound": "Probarbdone", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000342-e518145e31e6aa3f", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.896093", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "60f2aa6e528de1ce27e3c0f5317d248e6442c105e02729c5e72344ad0ce34dcb"}}}}
{"instruction": "What is the solubility profile of Metabenzpine?", "response": "Metabenzpine exhibits low water solubility based on its logP value of 4.55.", "metadata": {"compound": "Metabenzpine", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000343-ef62ff594ede732a", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.896128", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "71f1952a6a29ac1fbc3265878ed6831908e0b9da90155898e41ee6fa3558c219"}}}}
{"instruction": "How many hydrogen bond acceptors does Promorphstatin have?", "response": "Promorphstatin has 5 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Promorphstatin", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000344-8c5a463bf39def5e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.896164", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "16319dbf8c3266239eca86b5cb8050f95190d1a25586be907d05af1997eacf4a"}}}}
{"instruction": "What is the solubility profile of Procephpine?", "response": "Procephpine exhibits high water solubility based on its logP value of -1.28.", "metadata": {"compound": "Procephpine", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000345-96df53352bf51d2f", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.896207", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "2053f373734f4c3e4b93f8e9737d9150f5eb6ad3cc0ebaa946a652cc24aa3031"}}}}
{"instruction": "What is the solubility profile of Promethib?", "response": "Promethib exhibits moderate solubility based on its logP value of 1.78.", "metadata": {"compound": "Promethib", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000346-a2e685fd5022c796", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.896242", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "e7280c236c207080da1390f8bf39ef3f09809823b106dcf48b0d009e570d498b"}}}}
{"instruction": "What are the key structural features of Antiphenolol?", "response": "Key structural features of Antiphenolol include 0 aromatic rings, 3 rotatable bonds, and a molecular weight of 344.47 Da.", "metadata": {"compound": "Antiphenolol", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000348-e8328da3aca41c5d", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.896313", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "cb097af581ddb607e59eb91034e3db7785088203dfb2bb3e54c7c0aee848292e"}}}}
{"instruction": "Compare Hypochlorpine to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Hypochlorpine has favorable drug-like properties with MW=280.84 Da and logP=-1.24.", "metadata": {"compound": "Hypochlorpine", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000350-585e6113f540b224", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.896385", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "182c807bdbabe92018d140e58e5106348823c8f5bf4d3aa49af71b4f0ad16dc0"}}}}
{"instruction": "How many rotatable bonds does Hyposulfmab have?", "response": "Hyposulfmab has 9 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Hyposulfmab", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000351-662af1c42ce5508e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.896419", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "19b8da1dfd20d4c22b0cd26791959ee164f27262ec143c42b1d2816206f07199"}}}}
{"instruction": "How many hydrogen bond acceptors does Metasulfib have?", "response": "Metasulfib has 7 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Metasulfib", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000352-7e29d554bd83068f", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.896453", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "8ba3c9b196dee477796008f976a5d6477e4819e0b7797e1dd81fac1eafbcdf95"}}}}
{"instruction": "What is the TPSA of Epimetholol?", "response": "The topological polar surface area (TPSA) of Epimetholol is 121.32 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Epimetholol", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000353-6e56e7caf0b8212e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.896494", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "66fd7eee15c9fe0e5bf9c9d472756168d2809a93a0c8c86a64b6b08db09d5d27"}}}}
{"instruction": "What are the key structural features of Hypofluormab?", "response": "Key structural features of Hypofluormab include 0 aromatic rings, 11 rotatable bonds, and a molecular weight of 256.91 Da.", "metadata": {"compound": "Hypofluormab", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000354-20fb7c5c5e92dff4", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.896544", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "798e00f49484c2c43b8f4dfcc723297efa6cb3fb00e7c68d1ca29fcfd05dd814"}}}}
{"instruction": "Describe the molecular properties of Hypercephpril.", "response": "Hypercephpril (MW: 201.9 Da, C15H44N5O5) exhibits a logP of 2.87 and TPSA of 47.68 \u0172 with 0 H-bond donors and 4 H-bond acceptors.", "metadata": {"compound": "Hypercephpril", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000355-891fb8f6eefa29de", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.896604", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "e28ef27e2bcb5ff8ffa5e6b0f00a7c502e1d8e49b77ef45738965bf9d2008250"}}}}
{"instruction": "What are the pharmacokinetic properties of Synchlorolol?", "response": "The pharmacokinetic properties of Synchlorolol suggest good absorption potential with TPSA=44.42 \u0172 and MW=260.95 Da.", "metadata": {"compound": "Synchlorolol", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000358-1b5eeb8894bb35a8", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.896743", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "a97b410b7fa2948b1fb277ba74dc0e3ea82f6308399a9b22754eca80be2b5cc0"}}}}
{"instruction": "What are the pharmacokinetic properties of Hypomorphpine?", "response": "The pharmacokinetic properties of Hypomorphpine suggest good absorption potential with TPSA=92.59 \u0172 and MW=219.47 Da.", "metadata": {"compound": "Hypomorphpine", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000359-89032fc1ee5da69e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.896789", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "25febe4ebe400c7258369eee7f21f9aaa023d9038d093345a99410639d42d2e4"}}}}
{"instruction": "Does Synchlormab satisfy Lipinski's Rule of Five?", "response": "Synchlormab has 1 Lipinski violations: MW=529.65 > 500. This may affect oral bioavailability.", "metadata": {"compound": "Synchlormab", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "drug_likeness", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000360-e3b2ac868584d51c", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.896825", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "6457634099339761be0e1f5a84d61c481d638d60db53f4ea1b0a07cc4ea2f94b"}}}}
{"instruction": "What is the TPSA of Metamorphazole?", "response": "The topological polar surface area (TPSA) of Metamorphazole is 136.19 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Metamorphazole", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000361-7b8ae9a146b3baf1", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.896870", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "3660f8ec417714271e56098ff9934e12c2c4048f677e69da4948dccdc56ec43b"}}}}
{"instruction": "What is the molecular formula of Hypomorphmycin?", "response": "The molecular formula of Hypomorphmycin is C17H33N2O5.", "metadata": {"compound": "Hypomorphmycin", "batch": 0, "template": "What is the molecular formula of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000362-66487c9dc080a73e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.896902", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "4c3085b3983afa78", "cl_signature": "1afb5404f983897c62b9512b6660eeef92f10a3c84ea4561738736c3801043f6"}}}}
{"instruction": "What is the TPSA of Isomorphmab?", "response": "The topological polar surface area (TPSA) of Isomorphmab is 104.06 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Isomorphmab", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000363-69e5baa463f9b2e3", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.896954", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "cb0de842c07fcd85e358021bfac956bb24672681149f483c920b7730abf6593b"}}}}
{"instruction": "Does Epichlorstatin satisfy Lipinski's Rule of Five?", "response": "Epichlorstatin satisfies Lipinski's Rule of Five with no violations, suggesting good oral bioavailability potential.", "metadata": {"compound": "Epichlorstatin", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "drug_likeness", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000364-18a3b41c4c995f14", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.896999", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "eec8210cbeec0819f932dd4f67bcfde4ab400bd269858f09e4d8ec80e82b9680"}}}}
{"instruction": "How many hydrogen bond acceptors does Hypofluorcillin have?", "response": "Hypofluorcillin has 8 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Hypofluorcillin", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000365-583354e1d1859999", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.897036", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "7b509c7dc6c36899ffce1b4678ebb2f754bfac8fa72268f209b84e49b712c0f6"}}}}
{"instruction": "What is the logP value of Epichlormab?", "response": "The logP (partition coefficient) of Epichlormab is -0.4. This indicates good lipophilicity for oral bioavailability.", "metadata": {"compound": "Epichlormab", "batch": 0, "template": "What is the logP value of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 85.0, "uniqueness_score": 90.0, "total_score": 94.25, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000367-4e441e3a1a6c1061", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.897108", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "f5d0ab06ae0f3868", "cl_signature": "51ebf136d7e1f1b864044aff9e63fe32731187f557f3186a2778a0592b278ab3"}}}}
{"instruction": "What is the TPSA of Hypomethdone?", "response": "The topological polar surface area (TPSA) of Hypomethdone is 29.89 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Hypomethdone", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000368-5f981b4e13383803", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.897151", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "daa6a4fc2d80a906e0b5ffeeb64ecdcd09c2c1f5b770afa1136bb16e4be46475"}}}}
{"instruction": "How many rotatable bonds does Episulfazole have?", "response": "Episulfazole has 3 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Episulfazole", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000369-a006e2868a4328a1", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.897186", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "569e43213a5e325f9c15a20ef19aa3a12ab892ff670d24567e7f9f3f3e421dd0"}}}}
{"instruction": "What is the molecular formula of Hypercyclpril?", "response": "The molecular formula of Hypercyclpril is C28H24N3O4.", "metadata": {"compound": "Hypercyclpril", "batch": 0, "template": "What is the molecular formula of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000370-9d864c36c87b1912", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.897218", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "4c3085b3983afa78", "cl_signature": "cb1fbff7c9e75e384cf662076acf83ca97bd13e559c3ba856d0453acfccefaff"}}}}
{"instruction": "How many hydrogen bond acceptors does Neosulfmab have?", "response": "Neosulfmab has 10 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Neosulfmab", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000371-78fddf23beb68ebb", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.897265", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "9fe4eb24ec1368754e984f065158234f6c111c0befd74e01be4d65befe511bb0"}}}}
{"instruction": "What is the molecular weight of Antifluorpine?", "response": "The molecular weight of Antifluorpine is 583.26 Da.", "metadata": {"compound": "Antifluorpine", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000372-75bf9f7600e6f1f6", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.897296", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "9ef5756311427e7d89415ad28f25fece4c57ffb9ca0fa45823e05c990ee322aa"}}}}
{"instruction": "What is the solubility profile of Hypocyclib?", "response": "Hypocyclib exhibits high water solubility based on its logP value of -0.96.", "metadata": {"compound": "Hypocyclib", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000373-d0518f34d028ee6b", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.897332", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "cd286bf331ca79d29f55fbd1a0881181508ddd302b7f737f3434d6744eccb986"}}}}
{"instruction": "What is the molecular formula of Procephpril?", "response": "The molecular formula of Procephpril is C13H24N4O8.", "metadata": {"compound": "Procephpril", "batch": 0, "template": "What is the molecular formula of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000374-4f186ca2f0a6cd90", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.897363", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "4c3085b3983afa78", "cl_signature": "6f3ce6dfde4a91ed3f6bb14799463f184b167ef58da51a151c15a162e7025f82"}}}}
{"instruction": "What is the molecular weight of Epimethdone?", "response": "The molecular weight of Epimethdone is 242.77 Da.", "metadata": {"compound": "Epimethdone", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000376-892208dfff42be21", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.897423", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "8f247e0f17bebb868cbcd7906494a807e08d23483e0faca376a85817bd3050ff"}}}}
{"instruction": "Describe the molecular properties of Isophenpril.", "response": "Isophenpril (MW: 563.89 Da, C14H22N1O3) exhibits a logP of -0.45 and TPSA of 101.81 \u0172 with 5 H-bond donors and 1 H-bond acceptors.", "metadata": {"compound": "Isophenpril", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000378-578e496d28bc0cf7", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.897520", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "0165443470ad7ade44854f82caf99f6c4c155b0ae8b2bb68af8afa8f6af93396"}}}}
{"instruction": "What is the molecular weight of Synbarbdone?", "response": "The molecular weight of Synbarbdone is 440.97 Da.", "metadata": {"compound": "Synbarbdone", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000379-82985a9368c4241b", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.897552", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "552401b233b32772cbf3dc46e1a79a3785982762db929f03420e29e41ac0b77c"}}}}
{"instruction": "How many hydrogen bond donors does Metasulfolol have?", "response": "Metasulfolol has 0 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Metasulfolol", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000381-3b977729c0216491", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.897622", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "5e60b4de13d2916abf5535f9f8910170014f1e035ea66ad07e1eb65bc5e07c0f"}}}}
{"instruction": "What is the molecular weight of Metasulfazole?", "response": "The molecular weight of Metasulfazole is 265.01 Da.", "metadata": {"compound": "Metasulfazole", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000382-95e7ec2cc527095d", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.897663", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "cea117e0bae655d60fee34656e13edaefc2057b0181ee36e8e273cb3b03cd2a2"}}}}
{"instruction": "Compare Synmorphcillin to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Synmorphcillin has favorable drug-like properties with MW=194.54 Da and logP=2.98.", "metadata": {"compound": "Synmorphcillin", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000383-0eec1ae036e6d9f6", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.897706", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "904255422376145cab81c2ce74e5030e8de0093f52e61d4eeeb9cc096407fcee"}}}}
{"instruction": "Describe the molecular properties of Hypersulfpine.", "response": "Hypersulfpine (MW: 318.59 Da, C29H39N1O10) exhibits a logP of 4.8 and TPSA of 65.2 \u0172 with 2 H-bond donors and 2 H-bond acceptors.", "metadata": {"compound": "Hypersulfpine", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000385-e896dd4f69a4b682", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.897783", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "8c05daac6f23f2dc1b4176be130fb417d2bbde1f618b591132c3c3be2d95ebd8"}}}}
{"instruction": "Compare Procephazole to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Procephazole has favorable drug-like properties with MW=242.17 Da and logP=0.99.", "metadata": {"compound": "Procephazole", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000386-ef7063d24459ad28", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.897820", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "c783db9f37ca82f7e854900423aff65899a3c9e3c1541e7c98b26165849c5271"}}}}
{"instruction": "What is the molecular formula of Neofluordone?", "response": "The molecular formula of Neofluordone is C30H33N1O8.", "metadata": {"compound": "Neofluordone", "batch": 0, "template": "What is the molecular formula of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000387-9784ba6d6e635d1d", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.897851", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "4c3085b3983afa78", "cl_signature": "66cbdde96d63466f804c1d3b36f47e656556ef800d38d4e2a432c37fdd6d0eae"}}}}
{"instruction": "What is the logP value of Syncepholol?", "response": "The logP (partition coefficient) of Syncepholol is 3.96. This indicates good lipophilicity for oral bioavailability.", "metadata": {"compound": "Syncepholol", "batch": 0, "template": "What is the logP value of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 85.0, "uniqueness_score": 90.0, "total_score": 94.25, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000388-d58e1f2217022f96", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.897885", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "f5d0ab06ae0f3868", "cl_signature": "560381779a8bfc7061104fd679452e09f09e1674cac826a946991612344142c2"}}}}
{"instruction": "What is the TPSA of Hypobarbazole?", "response": "The topological polar surface area (TPSA) of Hypobarbazole is 92.87 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Hypobarbazole", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000389-249363ecd3e73fcb", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.897926", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "8eb0602a531c31d07fd5984e686c23ff2b5b3df78f72c5b25819177a51b6a853"}}}}
{"instruction": "How many hydrogen bond acceptors does Hypochlorcillin have?", "response": "Hypochlorcillin has 8 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Hypochlorcillin", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000390-439fec4d6e8e2465", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.897972", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "e0a1300168d8d6c5256cabc25cdab5c9d18bcf74d9d5cd3a090d5a9797ccf408"}}}}
{"instruction": "How many rotatable bonds does Metabarbpine have?", "response": "Metabarbpine has 1 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Metabarbpine", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000391-12f6a83152233193", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.898007", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "3836088c134d9515669b248effc0fee0fb22e38030dd30e649aebc528cd56f21"}}}}
{"instruction": "How many aromatic rings does Neobarbmycin have?", "response": "Neobarbmycin contains 4 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Neobarbmycin", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000392-d7fc1c322b865bf5", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.898043", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "2751776308b5839de7eec6ddb053c1554eb901b27c957a68cfc0fc06b107117b"}}}}
{"instruction": "How many rotatable bonds does Metachlorpril have?", "response": "Metachlorpril has 3 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Metachlorpril", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000393-daa90886f6368252", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.898077", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "c6d638a3483ef1feb77bc09fcc3d8199968579c2e8ff1351982c53f986e489ea"}}}}
{"instruction": "How many rotatable bonds does Synmethstatin have?", "response": "Synmethstatin has 2 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Synmethstatin", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000394-ced0cd38474d4812", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.898111", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "6f7ce745202fa8eae5818fc4014f1f43ddfbb686f79011fca89e5a031d1da28b"}}}}
{"instruction": "How many hydrogen bond acceptors does Isocyclmycin have?", "response": "Isocyclmycin has 5 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Isocyclmycin", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000395-a1583b8f4d25ccfa", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.898146", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "300c70c7465584365f64ff01c736de0821748103f6565f71922a52c8d056b94e"}}}}
{"instruction": "What are the key structural features of Antisulfstatin?", "response": "Key structural features of Antisulfstatin include 3 aromatic rings, 6 rotatable bonds, and a molecular weight of 331.77 Da.", "metadata": {"compound": "Antisulfstatin", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000396-0da98c2ab891e6bc", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.898182", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "d6c39288481cc83ef4ba159ade5f3bdf3cf75355a26285fb3831505c1924ad04"}}}}
{"instruction": "Describe the molecular properties of Synmorphmycin.", "response": "Synmorphmycin (MW: 583.89 Da, C26H49N3O1) exhibits a logP of 0.69 and TPSA of 27.67 \u0172 with 1 H-bond donors and 6 H-bond acceptors.", "metadata": {"compound": "Synmorphmycin", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000398-962d4197f57968bd", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.898274", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "da26df257f282cabe857fb7be3ae01352dd58be16c7881f635a8843c62bea209"}}}}
{"instruction": "What is the logP value of Syncephib?", "response": "The logP (partition coefficient) of Syncephib is 1.01. This indicates good lipophilicity for oral bioavailability.", "metadata": {"compound": "Syncephib", "batch": 0, "template": "What is the logP value of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 85.0, "uniqueness_score": 90.0, "total_score": 94.25, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000399-fb3f680979024424", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.898309", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "f5d0ab06ae0f3868", "cl_signature": "a147fb4f577d7ce50b254ca6ca60f87f84049e6503e5fad9debc3117cde0b3bf"}}}}
{"instruction": "How many aromatic rings does Isosulfcillin have?", "response": "Isosulfcillin contains 1 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Isosulfcillin", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000400-e0d76237b644d502", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.898348", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "07b97286611fedf84b56d6c6a4d1df535f8fcc37b81a277202ba57aa7495e468"}}}}
{"instruction": "How many hydrogen bond acceptors does Probarbmycin have?", "response": "Probarbmycin has 2 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Probarbmycin", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000402-74d9de4f0cc1f557", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.898414", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "89e071f9d2038a3eb18a6a0c48caf03a9f97450ad702db088bc143364324cbaa"}}}}
{"instruction": "What is the molecular formula of Promethazole?", "response": "The molecular formula of Promethazole is C16H50O8.", "metadata": {"compound": "Promethazole", "batch": 0, "template": "What is the molecular formula of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000403-f969eae7de721e98", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.898445", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "4c3085b3983afa78", "cl_signature": "188c9f558997200ae86d4d5a439601c44ff41e442304d44402eaef7fab499adb"}}}}
{"instruction": "How many hydrogen bond donors does Parabarbpine have?", "response": "Parabarbpine has 4 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Parabarbpine", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000405-1261d73681f6ec08", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.898526", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "c7fbaec5fa9cdc6c08e15f0cf7ef29b90c386db94e03351665622624032c965d"}}}}
{"instruction": "How many rotatable bonds does Neophenolol have?", "response": "Neophenolol has 1 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Neophenolol", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000406-7e9dd1a5296517c4", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.898561", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "1dd00ed2ce9d2d5d19fe47f1178514ac4c3b038d2e04e8bd481a46b7cfbef29f"}}}}
{"instruction": "What is the bioavailability of Hypocepholol?", "response": "The predicted oral bioavailability of Hypocepholol is approximately 80% based on its physicochemical properties.", "metadata": {"compound": "Hypocepholol", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000407-014f407951394008", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.898606", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "c580675dba6c920430eed5085f2c8b7148e51ddba4ca6ba02fb9a4e1b41a854e"}}}}
{"instruction": "Describe the molecular properties of Hypomethazole.", "response": "Hypomethazole (MW: 221.93 Da, C27H12N2O10) exhibits a logP of 0.12 and TPSA of 31.91 \u0172 with 5 H-bond donors and 4 H-bond acceptors.", "metadata": {"compound": "Hypomethazole", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000408-c33e72629645059f", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.898654", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "0ad914a319b546b7ae7319546476afcad9ce8b8aed3e35fff1c74c2816d4ee29"}}}}
{"instruction": "How many hydrogen bond donors does Neophenolol have?", "response": "Neophenolol has 4 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Neophenolol", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000409-e4f4a350c60c74ef", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.898690", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "7a490c4a36130b914e5854694cbb42be3e237d416ba44c89cd3e91d96c27328c"}}}}
{"instruction": "What is the bioavailability of Metabarbpril?", "response": "The predicted oral bioavailability of Metabarbpril is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Metabarbpril", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000411-476b9f6ed50a3621", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.898794", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "3711b1ef6911eed106e0d2efaf2a13e8060f960cd64862b72b3bb99af04b222f"}}}}
{"instruction": "What is the logP value of Neomethpine?", "response": "The logP (partition coefficient) of Neomethpine is -0.67. This indicates good lipophilicity for oral bioavailability.", "metadata": {"compound": "Neomethpine", "batch": 0, "template": "What is the logP value of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 85.0, "uniqueness_score": 90.0, "total_score": 94.25, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000412-0551e696e9e14433", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.898829", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "f5d0ab06ae0f3868", "cl_signature": "0d8a3dd11f2db0f371a8fb4b232a21cfba0c84a29e95396093c36ab397b2a6c4"}}}}
{"instruction": "Describe the molecular properties of Epichlorib.", "response": "Epichlorib (MW: 464.81 Da, C17H34N2O1) exhibits a logP of 4.06 and TPSA of 54.27 \u0172 with 5 H-bond donors and 1 H-bond acceptors.", "metadata": {"compound": "Epichlorib", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000413-cb09cc2d3180a210", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.898899", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "fbef8536f23d363bcd1f6b6b0058c3eef923e4aebfac0ff616a4d4452581edbf"}}}}
{"instruction": "What is the molecular weight of Hyperfluorcillin?", "response": "The molecular weight of Hyperfluorcillin is 286.39 Da.", "metadata": {"compound": "Hyperfluorcillin", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000414-5acdb859deaadd00", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.898935", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "d44074a21039a07fbb5fbbab68f6f6b9b4c6dd3035bd8962e8fe014ccf89f749"}}}}
{"instruction": "How many hydrogen bond acceptors does Isochlorcillin have?", "response": "Isochlorcillin has 8 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Isochlorcillin", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000416-a9699fe07c3377ac", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.899019", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "a0e77587e187008ca2043e15e644d10d67587dfb585115c64ca794c045c17c61"}}}}
{"instruction": "What is the logP value of Isometholol?", "response": "The logP (partition coefficient) of Isometholol is 3.43. This indicates good lipophilicity for oral bioavailability.", "metadata": {"compound": "Isometholol", "batch": 0, "template": "What is the logP value of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 85.0, "uniqueness_score": 90.0, "total_score": 94.25, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000417-509543b752511a20", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.899055", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "f5d0ab06ae0f3868", "cl_signature": "74f1ac0e6c3695849909217e54a00338048fd0dada817f98958c017f650e89a3"}}}}
{"instruction": "What are the key structural features of Antifluorcillin?", "response": "Key structural features of Antifluorcillin include 2 aromatic rings, 5 rotatable bonds, and a molecular weight of 473.76 Da.", "metadata": {"compound": "Antifluorcillin", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000418-809b6e417e74befe", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.899093", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "a8653b0a7aead4daa0bbd4cf098af172b97ddfe46b71917932cd9e49c157e54e"}}}}
{"instruction": "How many aromatic rings does Neophenpine have?", "response": "Neophenpine contains 0 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Neophenpine", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000419-f66b5dd6e0003762", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.899130", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "8417ca8c4fc26da0ea5b6fe40d99408640fdf05fa2abfdcbed0cc5420217c7f7"}}}}
{"instruction": "What is the molecular formula of Prosulfdone?", "response": "The molecular formula of Prosulfdone is C27H15N4O5.", "metadata": {"compound": "Prosulfdone", "batch": 0, "template": "What is the molecular formula of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000420-8f7c6469c681db68", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.899162", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "4c3085b3983afa78", "cl_signature": "1e7797b21567a1c7b511a0fdc86fdcd50b7808226e39afcfeb55c20712e8a406"}}}}
{"instruction": "How many aromatic rings does Epimethstatin have?", "response": "Epimethstatin contains 2 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Epimethstatin", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000421-95b93d3f7edc84e5", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.899198", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "3b4f643e169563b0d733cc1e37f93e7c9011cc702ec744fc665b1f37f27a51a2"}}}}
{"instruction": "Describe the molecular properties of Anticepholol.", "response": "Anticepholol (MW: 484.92 Da, C22H22N4O4) exhibits a logP of -0.51 and TPSA of 107.25 \u0172 with 4 H-bond donors and 10 H-bond acceptors.", "metadata": {"compound": "Anticepholol", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000422-8c968a88166316a6", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.899247", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "6d85bad184fb3756682fc74a1646f254801b2bee1a83365f852681cb2779ae1b"}}}}
{"instruction": "Describe the molecular properties of Metafluordone.", "response": "Metafluordone (MW: 517.91 Da, C11H29O4) exhibits a logP of 1.8 and TPSA of 75.27 \u0172 with 5 H-bond donors and 10 H-bond acceptors.", "metadata": {"compound": "Metafluordone", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000426-52d589709f856992", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.899403", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "44c9ca13caf11f3202111feb307e21587d49e1806769f125d10ab571f9b213fe"}}}}
{"instruction": "Describe the molecular properties of Metafluorpril.", "response": "Metafluorpril (MW: 248.53 Da, C23H26O3) exhibits a logP of 0.32 and TPSA of 119.18 \u0172 with 3 H-bond donors and 8 H-bond acceptors.", "metadata": {"compound": "Metafluorpril", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000428-2563f73412d28a2f", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.899493", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "070fd1a655c1aebea01432c0d862091c81c2111b634ffc04cf8f8e54eeda8481"}}}}
{"instruction": "What is the solubility profile of Hyperfluorpril?", "response": "Hyperfluorpril exhibits moderate solubility based on its logP value of 2.2.", "metadata": {"compound": "Hyperfluorpril", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000429-bc3fc55ab0e45113", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.899530", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "c39930595bf5cef008c99c4f615b99dff79565060e191200089e035fd229d136"}}}}
{"instruction": "Compare Hypercyclcillin to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Hypercyclcillin has suboptimal drug-like properties with MW=537.65 Da and logP=4.92.", "metadata": {"compound": "Hypercyclcillin", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000430-698c58bd80741af5", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.899568", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "b82155e732eab4fd2e6917852e2b3e81e38cd08b4499be7c0dbf3cf2d3311fd8"}}}}
{"instruction": "What are the key structural features of Epicyclolol?", "response": "Key structural features of Epicyclolol include 3 aromatic rings, 15 rotatable bonds, and a molecular weight of 386.7 Da.", "metadata": {"compound": "Epicyclolol", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000431-5e3e972313ae2a94", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.899605", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "e0abb2d2f48dd65e0a4039b5f2453d1b21be6ccc04231345a383482afc01f9e9"}}}}
{"instruction": "How many hydrogen bond donors does Hyperbenzpine have?", "response": "Hyperbenzpine has 3 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Hyperbenzpine", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000435-c8362778dacf0b44", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.899756", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "1dd7790bb17140fd95ccf6cb9a0efa741e438be2adc9e81f7ef4d91b29040d6a"}}}}
{"instruction": "What are the pharmacokinetic properties of Neomorphazole?", "response": "The pharmacokinetic properties of Neomorphazole suggest good absorption potential with TPSA=48.32 \u0172 and MW=423.74 Da.", "metadata": {"compound": "Neomorphazole", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000436-404580057e963439", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.899804", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "5a712ceb20df848d70a1216f7d51cd56bf2d0368c42f06020ac371efb1e156a8"}}}}
{"instruction": "What are the pharmacokinetic properties of Hypophenstatin?", "response": "The pharmacokinetic properties of Hypophenstatin suggest good absorption potential with TPSA=115.93 \u0172 and MW=483.22 Da.", "metadata": {"compound": "Hypophenstatin", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000437-e07e0f33a8400810", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.899857", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "e0334fd88eee385b823221893163831e94aceaafc34803f75b02b894d4495cb8"}}}}
{"instruction": "Compare Metachlorstatin to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Metachlorstatin has favorable drug-like properties with MW=432.6 Da and logP=-0.46.", "metadata": {"compound": "Metachlorstatin", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000439-88b37788cdb484cf", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.899937", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "f54f5cb9e9fa8badaf0e874973b06b4ec348fbbb51919ac19e95a6d6d1e63e09"}}}}
{"instruction": "What is the TPSA of Metacephstatin?", "response": "The topological polar surface area (TPSA) of Metacephstatin is 29.4 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Metacephstatin", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000441-9807c07ca2d1e680", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.900016", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "2ca164353cc9e75da4bc4c1ef0fc679d01b307174995b95d37c763d4dd6550d9"}}}}
{"instruction": "Does Metamorphpril satisfy Lipinski's Rule of Five?", "response": "Metamorphpril has 1 Lipinski violations: MW=544.92 > 500. This may affect oral bioavailability.", "metadata": {"compound": "Metamorphpril", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "drug_likeness", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000446-2036c65f7c629aa6", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.900174", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "d28885df64d5daf0da8a74a589e9d7b28413394cb0886be48847cf385268c0f9"}}}}
{"instruction": "What is the bioavailability of Epichlorazole?", "response": "The predicted oral bioavailability of Epichlorazole is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Epichlorazole", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000447-806842abc94ce8b8", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.900208", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "4acaa6a688adc1f9086937ba77bcb2547910d78b732cca6adf3a7a23ecbc69d5"}}}}
{"instruction": "How many aromatic rings does Hypobenzcillin have?", "response": "Hypobenzcillin contains 3 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Hypobenzcillin", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000448-07abe1bf3fece517", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.900244", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "ec059c39e707e781d220cbc859b38d2b3a864ffff561f4d25b2fa2fa6703e759"}}}}
{"instruction": "Describe the molecular properties of Isofluormycin.", "response": "Isofluormycin (MW: 587.22 Da, C12H44N2O3) exhibits a logP of -0.95 and TPSA of 64.6 \u0172 with 4 H-bond donors and 5 H-bond acceptors.", "metadata": {"compound": "Isofluormycin", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000449-30d416b19c984d42", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.900292", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "843ed31b4e1a10bd1a453bbe54e6c8726ef1680c49ba42b48065d28ca4d6b322"}}}}
{"instruction": "How many aromatic rings does Neophenmab have?", "response": "Neophenmab contains 3 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Neophenmab", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000450-7dac7ecc8410abbc", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.900337", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "abff3dc7ace3664ef1d54bedcef5bef86910748653becc325d19c8c35e5364ea"}}}}
{"instruction": "What is the TPSA of Paramethdone?", "response": "The topological polar surface area (TPSA) of Paramethdone is 121.22 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Paramethdone", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000451-101914380a10d03c", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.900380", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "7b9902db82e6a9304f1696c9be4b45dfc9da90489003c957427f156fb1de7078"}}}}
{"instruction": "What are the key structural features of Epicyclcillin?", "response": "Key structural features of Epicyclcillin include 4 aromatic rings, 5 rotatable bonds, and a molecular weight of 595.52 Da.", "metadata": {"compound": "Epicyclcillin", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000453-ab5b5bcc6ddc6c8d", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.900455", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "0b0746c7b485e562d59686c3dfbe71776ce62a85a845c90c3ee7deeff0e10d12"}}}}
{"instruction": "How many aromatic rings does Syncyclolol have?", "response": "Syncyclolol contains 3 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Syncyclolol", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000455-9207f76d8beaff67", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.900525", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "4e28312262ceedbe8eb4cb5d539f7a4f549fd64305da7844e15ef7b42e94989c"}}}}
{"instruction": "What is the molecular formula of Parabenzmab?", "response": "The molecular formula of Parabenzmab is C19H23O3.", "metadata": {"compound": "Parabenzmab", "batch": 0, "template": "What is the molecular formula of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000457-abb9e781783f6c5a", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.900598", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "4c3085b3983afa78", "cl_signature": "7f6cf0a7ce4c24bac19a14c550ee60d01d0014ffa29b6a56752d021e166f9643"}}}}
{"instruction": "How many hydrogen bond donors does Antifluorpine have?", "response": "Antifluorpine has 3 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Antifluorpine", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000459-119f69fb7481d3ea", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.900664", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "2ea35c54aaec23912621341b426f0b91b90ce5d3fa5b73d93f21dd8ab9af329b"}}}}
{"instruction": "What is the bioavailability of Epicephazole?", "response": "The predicted oral bioavailability of Epicephazole is approximately 80% based on its physicochemical properties.", "metadata": {"compound": "Epicephazole", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000462-7369aab3822f287d", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.900767", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "c07b67a2a0914ea7834a20d60768bf987e6a7004304d260fa8b327ffb96bbf90"}}}}
{"instruction": "Does Hypofluorib satisfy Lipinski's Rule of Five?", "response": "Hypofluorib has 1 Lipinski violations: MW=592.46 > 500. This may affect oral bioavailability.", "metadata": {"compound": "Hypofluorib", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "drug_likeness", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000463-e11cd586a55f6307", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.900812", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "b3c9604eed30705ed1fae3b24a1a5e6752984fc82929e8c54bc8315ee23eabcb"}}}}
{"instruction": "What is the molecular weight of Procepholol?", "response": "The molecular weight of Procepholol is 451.09 Da.", "metadata": {"compound": "Procepholol", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000464-1a3030161e55e8ae", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.900842", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "510a16db5b71a50cc9fa9c8be0c950b72fb925d8f2375026601d618ed78a7f2c"}}}}
{"instruction": "What is the bioavailability of Isosulfdone?", "response": "The predicted oral bioavailability of Isosulfdone is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Isosulfdone", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000466-e78b4db6344e4b48", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.900924", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "13d58f388af02adeda45afca35fed7d4afef4c79a7251dc9a4759f0c4d3654ff"}}}}
{"instruction": "What is the molecular weight of Profluorpril?", "response": "The molecular weight of Profluorpril is 226.23 Da.", "metadata": {"compound": "Profluorpril", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000468-862c4d917d5f19c9", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.900995", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "e0134efb2f477ffa8ec72386e9a37a66ff468f07d4c189d75b6523dc54d8a0af"}}}}
{"instruction": "Does Epicycldone satisfy Lipinski's Rule of Five?", "response": "Epicycldone satisfies Lipinski's Rule of Five with no violations, suggesting good oral bioavailability potential.", "metadata": {"compound": "Epicycldone", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "drug_likeness", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000470-75a45a9e22807b05", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.901073", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "0c8ddfb3a5061aa96a4cbfbae9f70f6266d7511d3b82d5f595cf4dca2d67e863"}}}}
{"instruction": "What are the pharmacokinetic properties of Metamethcillin?", "response": "The pharmacokinetic properties of Metamethcillin suggest limited absorption potential with TPSA=65.21 \u0172 and MW=544.85 Da.", "metadata": {"compound": "Metamethcillin", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000471-640e7278a1e3056e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.901117", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "f735a5588db8617efe316b98d34ea8414953d739893b5a32439e04fbb05bb966"}}}}
{"instruction": "Compare Metamorphmab to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Metamorphmab has suboptimal drug-like properties with MW=516.83 Da and logP=2.89.", "metadata": {"compound": "Metamorphmab", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000472-5f2261343631f509", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.901154", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "adb3c57b66433829c699b19c2bb72400e42a1e2675959684450ffed2ba8f8eb5"}}}}
{"instruction": "How many aromatic rings does Antimethazole have?", "response": "Antimethazole contains 1 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Antimethazole", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000473-d8ba686d70ed8fe2", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.901199", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "887b9c2c27f818bbbb17432b48abd5a638845b9b5d612f89ea16f1e2f38cfdde"}}}}
{"instruction": "Does Antimethmab satisfy Lipinski's Rule of Five?", "response": "Antimethmab has 1 Lipinski violations: MW=589.48 > 500. This may affect oral bioavailability.", "metadata": {"compound": "Antimethmab", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "drug_likeness", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000474-48be738925e86e43", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.901248", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "20625e990be8468d1ac9e3c441235fbe94147fc0b408ba1448a0111dbd321d4e"}}}}
{"instruction": "How many hydrogen bond acceptors does Epimethstatin have?", "response": "Epimethstatin has 4 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Epimethstatin", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000475-85257a5ad71d145e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.901286", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "fb5b26851449ffc5e3a53214ea68feac706c72e909d1ba1ae1702c632bb80040"}}}}
{"instruction": "Compare Isocyclpine to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Isocyclpine has favorable drug-like properties with MW=479.16 Da and logP=3.99.", "metadata": {"compound": "Isocyclpine", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000476-af08a4ec7610b6e2", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.901440", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "de301fc646fed223ab9398f06c809d16217caf2594761f291935c1d72365c5c9"}}}}
{"instruction": "Compare Antibenzdone to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Antibenzdone has favorable drug-like properties with MW=485.69 Da and logP=-0.54.", "metadata": {"compound": "Antibenzdone", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000478-af0f3f756b9f6070", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.901530", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "27950da38545d71158345068a7c997ac86730c6d5930b92d9b8fb38eed58619a"}}}}
{"instruction": "What is the bioavailability of Syncephstatin?", "response": "The predicted oral bioavailability of Syncephstatin is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Syncephstatin", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000480-f993dbf2b6f22d9d", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.901614", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "fa010a90487bd994e13edd6a6f88dcd36d58207015993ecee0855788569a7bce"}}}}
{"instruction": "What is the TPSA of Hypobarbmycin?", "response": "The topological polar surface area (TPSA) of Hypobarbmycin is 24.83 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Hypobarbmycin", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000481-398a517b127513a4", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.901658", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "fa8cf30a380ea8daefb79e38a6834b9a6bbb3c39290c77e335349818b9d20b45"}}}}
{"instruction": "What is the molecular weight of Neofluormycin?", "response": "The molecular weight of Neofluormycin is 455.18 Da.", "metadata": {"compound": "Neofluormycin", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000482-c3472ca8a28e9236", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.901705", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "963397389611c483a45addeb183d54e6af01ee9f1b73d7dc0fef4817c4b3f8c5"}}}}
{"instruction": "What is the logP value of Paracycldone?", "response": "The logP (partition coefficient) of Paracycldone is -1.36. This indicates good lipophilicity for oral bioavailability.", "metadata": {"compound": "Paracycldone", "batch": 0, "template": "What is the logP value of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 85.0, "uniqueness_score": 90.0, "total_score": 94.25, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000483-ad7ead418b473996", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.901741", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "f5d0ab06ae0f3868", "cl_signature": "6a84b89a2b6f1d08c8cce3f8eab53ae907c22c6cfdb6851f1f93e71b68e3c310"}}}}
{"instruction": "What are the key structural features of Hyperphenmycin?", "response": "Key structural features of Hyperphenmycin include 4 aromatic rings, 1 rotatable bonds, and a molecular weight of 327.43 Da.", "metadata": {"compound": "Hyperphenmycin", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000484-3a17f7e886ac64d5", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.901779", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "1e9728a6787ada3cd40df3d0ad5ca9684a6a1e577e7afa7ae1757a6983aacd59"}}}}
{"instruction": "How many hydrogen bond donors does Hyperbenzolol have?", "response": "Hyperbenzolol has 3 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Hyperbenzolol", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000485-421c5d6ab4b97cdd", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.901816", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "1e6fd2e4ba4c3ffa562877f113502fc4d1099d0f491e9d3f5ab407bba97da770"}}}}
{"instruction": "What is the bioavailability of Hyperchlorcillin?", "response": "The predicted oral bioavailability of Hyperchlorcillin is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Hyperchlorcillin", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000486-794cfff1df7f5671", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.901852", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "dbbea987a800f59b9a5007325a94c9e23fc3a5b830a65a0fbbd8a2d20f972013"}}}}
{"instruction": "What is the TPSA of Synsulfdone?", "response": "The topological polar surface area (TPSA) of Synsulfdone is 93.12 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Synsulfdone", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000487-0b549fce29c2d86c", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.901894", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "3514a105323c9c26d29bf70fda8cfb930874c775739245a5a75223940237c6c4"}}}}
{"instruction": "What is the molecular weight of Antibarbolol?", "response": "The molecular weight of Antibarbolol is 553.04 Da.", "metadata": {"compound": "Antibarbolol", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000489-83bc8b59eef8fdc2", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.901985", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "863988f24df43e0fc9791086dd3e22b54e49add8845f3f925b53afe851674e6e"}}}}
{"instruction": "How many hydrogen bond donors does Hypocyclmab have?", "response": "Hypocyclmab has 5 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Hypocyclmab", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000490-b342950468e00068", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.902032", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "3eed7f50e9e363d99d03c1bc913f58ac23a69cc28379753555efd05f2b14f132"}}}}
{"instruction": "What is the logP value of Hyperbenzcillin?", "response": "The logP (partition coefficient) of Hyperbenzcillin is 1.1. This indicates good lipophilicity for oral bioavailability.", "metadata": {"compound": "Hyperbenzcillin", "batch": 0, "template": "What is the logP value of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 85.0, "uniqueness_score": 90.0, "total_score": 94.25, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000491-203ae635e6832806", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.902080", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "f5d0ab06ae0f3868", "cl_signature": "7269eb963cd0066b54e690ced880c49e88d5dd3228c406bc569337307d39ad73"}}}}
{"instruction": "How many hydrogen bond donors does Metamethmab have?", "response": "Metamethmab has 3 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Metamethmab", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000492-af6d4dbc0215387e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.902117", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "eb406d20f28b141f6264a9d63e8af4762b8327c4f3b880ac440c1e75a4acbd9e"}}}}
{"instruction": "Describe the molecular properties of Isophendone.", "response": "Isophendone (MW: 452.2 Da, C26H22N1O9) exhibits a logP of -0.36 and TPSA of 121.27 \u0172 with 3 H-bond donors and 10 H-bond acceptors.", "metadata": {"compound": "Isophendone", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000493-3c55bc0637579b1b", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.902166", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "b3b5c20edc12a8e670f4e20019230e693eafee3b4edde647ef04e02f3642b306"}}}}
{"instruction": "Compare Hyperchlorstatin to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Hyperchlorstatin has favorable drug-like properties with MW=300.16 Da and logP=-1.18.", "metadata": {"compound": "Hyperchlorstatin", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000494-81807c70e4508907", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.902214", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "e8708e209996fc363ac86ecaca067ec2d53a8aaa8ac94c1abd68bc6a8bfe3491"}}}}
{"instruction": "What is the bioavailability of Metabarbib?", "response": "The predicted oral bioavailability of Metabarbib is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Metabarbib", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000496-0abe5112c2006b1e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.902286", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "f0d6085924bcff53989f2b05d442a87a225ac93d92dcb8df46bf3bd803ed5bcc"}}}}
{"instruction": "What are the key structural features of Parafluorpine?", "response": "Key structural features of Parafluorpine include 4 aromatic rings, 10 rotatable bonds, and a molecular weight of 584.38 Da.", "metadata": {"compound": "Parafluorpine", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000497-099048bbbfae9eeb", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.902323", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "61a6ad5eeb8815fd27cea71c7bc12d783d47df3593b4d357b20c88df814d77c0"}}}}
{"instruction": "How many rotatable bonds does Epichlorcillin have?", "response": "Epichlorcillin has 9 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Epichlorcillin", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000498-2d9153caaaf3514c", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.902371", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "ea374dfa3eab98653716b00a6cafb2d110e3888f78e2ea8904da3032ded71c92"}}}}
{"instruction": "Describe the molecular properties of Procyclazole.", "response": "Procyclazole (MW: 520.74 Da, C26H11N3O3) exhibits a logP of 1.88 and TPSA of 46.74 \u0172 with 0 H-bond donors and 2 H-bond acceptors.", "metadata": {"compound": "Procyclazole", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000499-73279ce75aebab27", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.902420", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "809e27a62908d14af2ddc9a3796ddb43f03e662f6c75fb02631ec0805937df78"}}}}
{"instruction": "How many aromatic rings does Synbenzolol have?", "response": "Synbenzolol contains 3 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Synbenzolol", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000500-c1c40654745cee6b", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.902457", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "b93ec562f7bf6c7b2dfeb53051309dbe9b50889ab8e9470faa899b3c18d7175b"}}}}
{"instruction": "How many rotatable bonds does Isomethmab have?", "response": "Isomethmab has 6 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Isomethmab", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000502-639781046e95ceff", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.902525", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "9f1062d2b31d475415c75a75a37d0afb218eaf7eb09425c736bbd2c8bf94d9c3"}}}}
{"instruction": "What is the solubility profile of Isomorphpril?", "response": "Isomorphpril exhibits low water solubility based on its logP value of 3.19.", "metadata": {"compound": "Isomorphpril", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000503-ecee7975884f606e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.902561", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "f91f3f9487854f95938fcd15a16a98cf324e0528aee2400b3965f7136245ae61"}}}}
{"instruction": "What is the bioavailability of Hyperchlormycin?", "response": "The predicted oral bioavailability of Hyperchlormycin is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Hyperchlormycin", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000505-c2207169125fda78", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.902641", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "b82a49ab9b4d4f484b3dec112b78f7f497d7f650aa14c470fdd29f117cba2cd1"}}}}
{"instruction": "What is the molecular formula of Prosulfpril?", "response": "The molecular formula of Prosulfpril is C12H39N5O3.", "metadata": {"compound": "Prosulfpril", "batch": 0, "template": "What is the molecular formula of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000506-f0e5c56c6619b077", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.902672", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "4c3085b3983afa78", "cl_signature": "6cbf84290d991aadebf23a9da193582de877115263b85f92b3b53da54a83a5c5"}}}}
{"instruction": "What is the molecular weight of Metabenzmab?", "response": "The molecular weight of Metabenzmab is 209.63 Da.", "metadata": {"compound": "Metabenzmab", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000507-366cc8472ad81a27", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.902711", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "8067423deafba4591ef6e093ef92b281eca0c65c93e146e07f6d4e2f25cec119"}}}}
{"instruction": "Describe the molecular properties of Synbarbpine.", "response": "Synbarbpine (MW: 325.1 Da, C22H34N2O6) exhibits a logP of 4.47 and TPSA of 70.0 \u0172 with 2 H-bond donors and 8 H-bond acceptors.", "metadata": {"compound": "Synbarbpine", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000508-3d8203c45ac6e7f7", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.902757", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "161fa4e658b05644509db1fd24d83bb71b204383ea08ae29c4fc0029a2437c1c"}}}}
{"instruction": "How many aromatic rings does Hypophencillin have?", "response": "Hypophencillin contains 1 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Hypophencillin", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000509-903d585e64670509", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.902793", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "546e6117cfed214c4976e4cd8d0e06a22cf3c259d3d39fad1566752c674d68b8"}}}}
{"instruction": "What is the logP value of Antimorphpril?", "response": "The logP (partition coefficient) of Antimorphpril is 2.28. This indicates good lipophilicity for oral bioavailability.", "metadata": {"compound": "Antimorphpril", "batch": 0, "template": "What is the logP value of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 85.0, "uniqueness_score": 90.0, "total_score": 94.25, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000510-b50355b79aaf7240", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.902830", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "f5d0ab06ae0f3868", "cl_signature": "9f4f9aebfa3c83f28fa4a4c485eb472d608486b56d1dd03447b141bd9e16e58d"}}}}
{"instruction": "What is the solubility profile of Neophenmycin?", "response": "Neophenmycin exhibits high water solubility based on its logP value of -0.26.", "metadata": {"compound": "Neophenmycin", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000511-5776cd6cb20dcf92", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.902866", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "6d6adec4de9382202c3a225289881a0064acf97768a23857689e3eec76489c5c"}}}}
{"instruction": "How many rotatable bonds does Hypomethpril have?", "response": "Hypomethpril has 12 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Hypomethpril", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000512-93f25ddf30655c99", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.902904", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "09db53b182148a4b6485b50a33955064439fc0def3b016790015436900d0348a"}}}}
{"instruction": "What is the solubility profile of Isocyclcillin?", "response": "Isocyclcillin exhibits moderate solubility based on its logP value of 0.55.", "metadata": {"compound": "Isocyclcillin", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000513-2a5dcec37b576aeb", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.902940", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "e71b9dc8b1e9115daf52a6df4c052aef8b170c4c6a507fa52896cc939ec9aa8d"}}}}
{"instruction": "What is the molecular weight of Metamethib?", "response": "The molecular weight of Metamethib is 508.77 Da.", "metadata": {"compound": "Metamethib", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000515-6923649322368561", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.903024", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "3f15d68c4ebfbce94a1d58510b2cf8f24e3649941d3582e7a693d3408d9f8bed"}}}}
{"instruction": "Compare Probarbcillin to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Probarbcillin has suboptimal drug-like properties with MW=565.79 Da and logP=-0.72.", "metadata": {"compound": "Probarbcillin", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000516-ad749a1eb42c9b67", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.903062", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "aa89a4b61c5fb62e38225b8068b804771811f80c2fbab0d51dbd7b2ddc282bab"}}}}
{"instruction": "What is the molecular weight of Hyposulfpine?", "response": "The molecular weight of Hyposulfpine is 495.52 Da.", "metadata": {"compound": "Hyposulfpine", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000517-767aa9ea8c7aa6c0", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.903092", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "ebf410a6e1390dbc9e7f0afd5628495a6a3cc0fd7c6d00e34abeef6e9154d42e"}}}}
{"instruction": "Describe the molecular properties of Synbarbolol.", "response": "Synbarbolol (MW: 310.56 Da, C25H46N5O1) exhibits a logP of 1.06 and TPSA of 110.53 \u0172 with 1 H-bond donors and 10 H-bond acceptors.", "metadata": {"compound": "Synbarbolol", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000518-e6b17867cdec0858", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.903140", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "f5730f9b609996db113335c7efb6e930efdea794fbb858e0f9a43026899d8172"}}}}
{"instruction": "How many aromatic rings does Hyperbarbmycin have?", "response": "Hyperbarbmycin contains 2 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Hyperbarbmycin", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000519-0d2f8a8b7e20a257", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.903177", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "ddb922a73d4df3263a27eacf2f3e8e9935e651ae0c314bb0cdd87d0d49c0db60"}}}}
{"instruction": "How many rotatable bonds does Metacyclpine have?", "response": "Metacyclpine has 12 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Metacyclpine", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000520-c21e372ce8265668", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.903212", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "eb2db19f047a84094660c4759a4b5c4d507ad0436b8b20e8523048b8baf525d7"}}}}
{"instruction": "How many rotatable bonds does Paracyclolol have?", "response": "Paracyclolol has 15 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Paracyclolol", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000521-3a75f34dc0868e09", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.903252", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "49d88728add0d1caf976184c3486bdea31c50b86f8addda73594c690716ef5f9"}}}}
{"instruction": "How many hydrogen bond donors does Synchlorpril have?", "response": "Synchlorpril has 2 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Synchlorpril", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000522-1b024bc1e1120fe0", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.903297", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "557ac31e1cdac88333d92d4cbf510c2bd768b850db784560852ec48552a56204"}}}}
{"instruction": "How many rotatable bonds does Synmethpril have?", "response": "Synmethpril has 1 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Synmethpril", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000523-1997ffcbbc4b0f4b", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.903331", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "e45c8faa46799989a377ff3330860caad4e8a800f1f67b6168b4eed580bfaef4"}}}}
{"instruction": "How many hydrogen bond donors does Metamorphmab have?", "response": "Metamorphmab has 5 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Metamorphmab", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000525-d82148336b39df50", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.903397", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "d5ba0dfff1fbd91c330dac6215118cfeb24ffba066790fcbbc466c8a476107c2"}}}}
{"instruction": "How many hydrogen bond acceptors does Isocephmycin have?", "response": "Isocephmycin has 4 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Isocephmycin", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000528-c53bffc5147c3205", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.903505", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "ebad5893b6822e0fffd7f845e02b87004e52b22cdc654ffe60f0a89143bc8102"}}}}
{"instruction": "How many rotatable bonds does Promorphib have?", "response": "Promorphib has 11 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Promorphib", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000529-d74430f39d01e0a2", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.903539", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "7f4534b0bfad97bc51431e3a7b6f3a09fe7f7974c68520b9dafce20b6e0c2773"}}}}
{"instruction": "What is the solubility profile of Prosulfib?", "response": "Prosulfib exhibits moderate solubility based on its logP value of 0.64.", "metadata": {"compound": "Prosulfib", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000530-13560a92a6001d11", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.903575", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "46f96b1e0391d666232c0baa959ea4ec828230e8fc59258646bff79a0a479b28"}}}}
{"instruction": "How many rotatable bonds does Neobenzstatin have?", "response": "Neobenzstatin has 4 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Neobenzstatin", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000531-d06d75db750a0f0f", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.903609", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "3294f2723a0da59e62d55d19d0b961cf0f7e745f9c0af9df7b160930ce617f99"}}}}
{"instruction": "What is the molecular weight of Epifluormab?", "response": "The molecular weight of Epifluormab is 587.46 Da.", "metadata": {"compound": "Epifluormab", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000532-f7eaf9562201058b", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.903648", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "fc607a00883d332709cf419b0ca505d61b9ee5b152b8a0a97a5ea9fda157b5e0"}}}}
{"instruction": "How many rotatable bonds does Neocyclmycin have?", "response": "Neocyclmycin has 0 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Neocyclmycin", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000533-e79649ebdd8c8ec6", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.903682", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "3aaa198f8e7ddb9eab2933242970b916a64e6abaf31134128bf725b1637e007a"}}}}
{"instruction": "What is the bioavailability of Neobarbdone?", "response": "The predicted oral bioavailability of Neobarbdone is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Neobarbdone", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000534-8b83d9909faac3f6", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.903716", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "0a612b42d0cec9515a42d49ade137be9a6c9139f99be3f4ba06c23bbe3e16f7c"}}}}
{"instruction": "Does Synphenmycin satisfy Lipinski's Rule of Five?", "response": "Synphenmycin satisfies Lipinski's Rule of Five with no violations, suggesting good oral bioavailability potential.", "metadata": {"compound": "Synphenmycin", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "drug_likeness", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000535-9494ad967faad3ca", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.903751", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "9a5692f14e673f1b4073065ea749ee0ff98a0f1aa9ce52d8e2bbd36aa87ff7e1"}}}}
{"instruction": "What is the TPSA of Metabarbcillin?", "response": "The topological polar surface area (TPSA) of Metabarbcillin is 58.6 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Metabarbcillin", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000536-4eefb76547ac1b17", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.903793", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "6a6b811ce38f623a231de44a8ae43ee4ed5296cc07b14d38a3eb796c59dd47a7"}}}}
{"instruction": "What are the key structural features of Metafluorstatin?", "response": "Key structural features of Metafluorstatin include 1 aromatic rings, 15 rotatable bonds, and a molecular weight of 327.39 Da.", "metadata": {"compound": "Metafluorstatin", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000537-c73a2cfeee8e0b81", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.903831", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "24540e2ed5eb2d6ef54ea2d7174dd7528b285702ea02f962aeb96bd3c04e3870"}}}}
{"instruction": "How many hydrogen bond donors does Hypercyclmycin have?", "response": "Hypercyclmycin has 0 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Hypercyclmycin", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000538-e666a25cc05d60ec", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.903866", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "1866a0da66afc0501ad86d89e2ad4cccec7cc870b0e0e52d3624bb3346dd91b4"}}}}
{"instruction": "What is the logP value of Antibarbazole?", "response": "The logP (partition coefficient) of Antibarbazole is 1.36. This indicates good lipophilicity for oral bioavailability.", "metadata": {"compound": "Antibarbazole", "batch": 0, "template": "What is the logP value of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 85.0, "uniqueness_score": 90.0, "total_score": 94.25, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000539-ee235a7ec9887aa9", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.903910", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "f5d0ab06ae0f3868", "cl_signature": "4a4705d9584a7cc5e06f3cc75fe07a7d93b9a8fc1593679085e8df0a35e26745"}}}}
{"instruction": "Does Neofluorazole satisfy Lipinski's Rule of Five?", "response": "Neofluorazole satisfies Lipinski's Rule of Five with no violations, suggesting good oral bioavailability potential.", "metadata": {"compound": "Neofluorazole", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "drug_likeness", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000540-4df93289025d3806", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.903944", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "0cbf99c9d44f98d4c87c47aa93989a639f54d67cc64da2d6d9fc49faa5f9bd82"}}}}
{"instruction": "Does Metamorpholol satisfy Lipinski's Rule of Five?", "response": "Metamorpholol satisfies Lipinski's Rule of Five with no violations, suggesting good oral bioavailability potential.", "metadata": {"compound": "Metamorpholol", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "drug_likeness", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000541-f5c13aaffbbe8230", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.903978", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "9dabb80579f2da3633ec659446c4adde7d86cc8d85f9677f1c57051644d97c67"}}}}
{"instruction": "Describe the molecular properties of Isochlorolol.", "response": "Isochlorolol (MW: 315.8 Da, C17H22N2O9) exhibits a logP of -1.4 and TPSA of 102.88 \u0172 with 3 H-bond donors and 8 H-bond acceptors.", "metadata": {"compound": "Isochlorolol", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000542-ede43a8a4737dabf", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.904026", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "f12e813c8b9dfe9f18bae3388fe67401cdcefc7018a5b0a1e48dd7d4ed7965cb"}}}}
{"instruction": "How many rotatable bonds does Epifluorstatin have?", "response": "Epifluorstatin has 15 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Epifluorstatin", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000543-6dcdbed822bb439d", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.904061", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "b6f3de951d77a5b958ce6cc8632adbad626754e1067e555279e036b7f034975b"}}}}
{"instruction": "What is the molecular formula of Prosulfcillin?", "response": "The molecular formula of Prosulfcillin is C27H39N1O9.", "metadata": {"compound": "Prosulfcillin", "batch": 0, "template": "What is the molecular formula of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000544-4861fa200d7c4233", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.904091", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "4c3085b3983afa78", "cl_signature": "3a2302f86c7b7da1ad35d220eaa5f8c19e96f9c866df81dc4c382f1de26cd4c6"}}}}
{"instruction": "Describe the molecular properties of Hypercephazole.", "response": "Hypercephazole (MW: 552.44 Da, C22H36N4O6) exhibits a logP of -0.32 and TPSA of 80.1 \u0172 with 2 H-bond donors and 7 H-bond acceptors.", "metadata": {"compound": "Hypercephazole", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000546-c064a4ff5877632d", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.904175", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "05b618782deaea651d620e2a56b33c00034a00014969980a73f71a9d26dd6d15"}}}}
{"instruction": "How many aromatic rings does Hyposulfib have?", "response": "Hyposulfib contains 1 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Hyposulfib", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000548-4366e22cec679d10", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.904255", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "da172b779560f23ab1fce5d990cf6c1dc84faab6e182b1d737412f39b19e1b42"}}}}
{"instruction": "What is the TPSA of Antimorphib?", "response": "The topological polar surface area (TPSA) of Antimorphib is 132.05 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Antimorphib", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000549-9e89e631ea7d0060", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.904301", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "b0fdab6320e09909b7455611ea9f35078bdeb9cd2eb2912cf074ffca88f0d0a3"}}}}
{"instruction": "What is the bioavailability of Isomorpholol?", "response": "The predicted oral bioavailability of Isomorpholol is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Isomorpholol", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000550-dc21e42db8ae9aac", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.904336", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "86c5b0912d0988efcbf6ddf811b69c318590fafca728a9df3fa85556acf24d2c"}}}}
{"instruction": "What are the pharmacokinetic properties of Metacyclolol?", "response": "The pharmacokinetic properties of Metacyclolol suggest good absorption potential with TPSA=105.23 \u0172 and MW=483.04 Da.", "metadata": {"compound": "Metacyclolol", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000551-3a336edf51bb937a", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.904382", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "5d32d3d2ac3b08eb3c5fea3481a01bf43567d07d29a5de1061fe8a9df0380340"}}}}
{"instruction": "Compare Isobarbolol to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Isobarbolol has favorable drug-like properties with MW=271.51 Da and logP=2.42.", "metadata": {"compound": "Isobarbolol", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000552-7b62152fbd9df724", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.904419", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "3e40a7432fc953e3256c993a72961ed7e5a827f256d2304d8113335f340117b6"}}}}
{"instruction": "Compare Procephpine to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Procephpine has suboptimal drug-like properties with MW=560.69 Da and logP=4.94.", "metadata": {"compound": "Procephpine", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000553-efc356235d5ae95e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.904455", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "31ba0f2edd196349051e2ccf86451211b0aadffdb74f0d5653ccd716d3edd27f"}}}}
{"instruction": "What is the bioavailability of Isophenpine?", "response": "The predicted oral bioavailability of Isophenpine is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Isophenpine", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000554-534d68be3a8641be", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.904488", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "2e20d4adeb1fbd064d4ec4596d136a917e186ae626a30f9c2b7b703a7ae332d8"}}}}
{"instruction": "Describe the molecular properties of Hypobarbmab.", "response": "Hypobarbmab (MW: 456.33 Da, C14H36N2O8) exhibits a logP of 3.53 and TPSA of 67.29 \u0172 with 4 H-bond donors and 1 H-bond acceptors.", "metadata": {"compound": "Hypobarbmab", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000555-4acba83b380df2b9", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.904545", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "96d37648f8ff717d0642181ba2d55571ab44f773935cf460bfc2480bd6cac790"}}}}
{"instruction": "What are the pharmacokinetic properties of Hypobenzazole?", "response": "The pharmacokinetic properties of Hypobenzazole suggest good absorption potential with TPSA=64.03 \u0172 and MW=392.14 Da.", "metadata": {"compound": "Hypobenzazole", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000556-5ca8ea89811329b2", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.904589", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "3c98484afc4084208ad52e5deb35989086b5804e180d9ae7a68580fb793a17e4"}}}}
{"instruction": "What is the solubility profile of Paramorphcillin?", "response": "Paramorphcillin exhibits moderate solubility based on its logP value of 2.31.", "metadata": {"compound": "Paramorphcillin", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000557-119889fdf8e6c66d", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.904624", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "45f620dfbe1991d31070dcf50640e6472eff7d954abdec034dd431303921c72f"}}}}
{"instruction": "What is the solubility profile of Metabenzolol?", "response": "Metabenzolol exhibits low water solubility based on its logP value of 3.8.", "metadata": {"compound": "Metabenzolol", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000558-8ada00b559e0650e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.904660", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "f7b05c5f778632c2c0bb8ec2b2e95dda374f1e780397a76760b6335d45d3c9ce"}}}}
{"instruction": "Describe the molecular properties of Probenzazole.", "response": "Probenzazole (MW: 392.18 Da, C29H41N5O9) exhibits a logP of 4.49 and TPSA of 74.91 \u0172 with 5 H-bond donors and 9 H-bond acceptors.", "metadata": {"compound": "Probenzazole", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000562-d1a4a285bca9046a", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.904829", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "f7127efde20544f863d703fa37a57d4c66ea9d390879bcdb8278b95aec36594e"}}}}
{"instruction": "What is the molecular weight of Prophendone?", "response": "The molecular weight of Prophendone is 273.27 Da.", "metadata": {"compound": "Prophendone", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000563-6f6813e6092282f2", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.904859", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "31c7d7ed21b26ed6de27aa188dd0c3bf23c05e11c75903a527045141403dcadf"}}}}
{"instruction": "Compare Paramethstatin to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Paramethstatin has favorable drug-like properties with MW=430.04 Da and logP=0.67.", "metadata": {"compound": "Paramethstatin", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000564-bcdff962d524e657", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.904895", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "c597e46116a477da2c77214a47a016ec146c6a84069bec15fc779bccdca11559"}}}}
{"instruction": "What are the key structural features of Hypobarbib?", "response": "Key structural features of Hypobarbib include 0 aromatic rings, 14 rotatable bonds, and a molecular weight of 297.36 Da.", "metadata": {"compound": "Hypobarbib", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000565-7ed076943ca22bbb", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.904941", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "8746b25569b500235af044842ab5d9cd2b61c9a59025bda37d35bb4ba3f5bcbc"}}}}
{"instruction": "What is the bioavailability of Metamorphdone?", "response": "The predicted oral bioavailability of Metamorphdone is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Metamorphdone", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000568-e8dfb1c930468e87", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.905041", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "5a8ec85ae24aecc2049ad1b1468667556dbd247e58b0b80a36cd0b1b99121dee"}}}}
{"instruction": "How many hydrogen bond acceptors does Neochlormab have?", "response": "Neochlormab has 1 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Neochlormab", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000569-3028627412c1f806", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.905076", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "c8c6f78a866509accdd440e760adcaf60d64de6070585cb86f27a76fd942ecdc"}}}}
{"instruction": "What is the bioavailability of Hypomethmab?", "response": "The predicted oral bioavailability of Hypomethmab is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Hypomethmab", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000571-40fd8390833a23bf", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.905151", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "6e9a324a80c7a3ff4a5912256e3b25db189451004bbb588972bad197275a34f6"}}}}
{"instruction": "Describe the molecular properties of Epimorphdone.", "response": "Epimorphdone (MW: 451.81 Da, C15H42N3O7) exhibits a logP of -1.77 and TPSA of 135.78 \u0172 with 1 H-bond donors and 10 H-bond acceptors.", "metadata": {"compound": "Epimorphdone", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000572-28e15db21840248f", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.905197", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "f8e1c3f86af88cb36f31589463782888edc9e7305ac45a311d6131ef99eaf1e7"}}}}
{"instruction": "What is the solubility profile of Hypomorphmab?", "response": "Hypomorphmab exhibits moderate solubility based on its logP value of 2.57.", "metadata": {"compound": "Hypomorphmab", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000573-a39daf8673f5450e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.905233", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "dbf15401538e08ebe9cb98750bfacfa6f0b542c6b47400a13a7a4672949b5a8b"}}}}
{"instruction": "What are the pharmacokinetic properties of Antisulfcillin?", "response": "The pharmacokinetic properties of Antisulfcillin suggest good absorption potential with TPSA=68.66 \u0172 and MW=220.31 Da.", "metadata": {"compound": "Antisulfcillin", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000575-9a3486c6c7df6558", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.905311", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "70a9ad6cb99b30eba98ed2f21be331e7d7b6cf652f2f22f737a411fa868f358b"}}}}
{"instruction": "What are the pharmacokinetic properties of Neomethcillin?", "response": "The pharmacokinetic properties of Neomethcillin suggest good absorption potential with TPSA=138.14 \u0172 and MW=448.83 Da.", "metadata": {"compound": "Neomethcillin", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000576-5fc67f3fd5a9e6c8", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.905369", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "16642c70192d9d34ead8f6fd194f1cc9d511fbb5d553adb7041d20e5e5943f12"}}}}
{"instruction": "How many hydrogen bond donors does Neocephazole have?", "response": "Neocephazole has 3 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Neocephazole", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000577-c6a1aae60be97d40", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.905404", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "ee603142f9dad9c97a2e956d8d9b2e9fac7c7d0a1f9f0dda90bccc821f6321a9"}}}}
{"instruction": "How many hydrogen bond acceptors does Neocycldone have?", "response": "Neocycldone has 8 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Neocycldone", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000579-306ef9b58148fae9", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.905485", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "9470caa62d8427271c8ec24263ea919465eb854850d570290943160a851c75ae"}}}}
{"instruction": "Does Isobarbdone satisfy Lipinski's Rule of Five?", "response": "Isobarbdone satisfies Lipinski's Rule of Five with no violations, suggesting good oral bioavailability potential.", "metadata": {"compound": "Isobarbdone", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "drug_likeness", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000580-5729571eb7742091", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.905519", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "8a129aeac7334ffd42986e5c5cbc39de6b28fd5c6ab54b3d27904bb55b99406a"}}}}
{"instruction": "Does Paramethpril satisfy Lipinski's Rule of Five?", "response": "Paramethpril satisfies Lipinski's Rule of Five with no violations, suggesting good oral bioavailability potential.", "metadata": {"compound": "Paramethpril", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "drug_likeness", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000582-1d7bd99271b6bbf3", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.905583", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "ae770a8a153d9b1a7bf3ae00db1177d536b4690994dbcaa7c6da9fed3766da78"}}}}
{"instruction": "How many aromatic rings does Neophendone have?", "response": "Neophendone contains 1 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Neophendone", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000583-aee4e30c0cf9bc56", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.905619", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "f11377ab1e3421b7cd35a5cc017cf0fb9ae026cce3585c078109486b414abd1e"}}}}
{"instruction": "What is the molecular formula of Metachlorpine?", "response": "The molecular formula of Metachlorpine is C10H45N3O8.", "metadata": {"compound": "Metachlorpine", "batch": 0, "template": "What is the molecular formula of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000584-50fed822514835fb", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.905649", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "4c3085b3983afa78", "cl_signature": "cbc5a92ea8159c8e03947d5f594464c4c9567b2bbc2584820e392fa739a66bf1"}}}}
{"instruction": "How many hydrogen bond donors does Isophendone have?", "response": "Isophendone has 0 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Isophendone", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000585-0c6d422f7dfdfaf1", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.905692", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "6434ed88cf6f06d85759e9df7003b604024ac091df2c713e4cc93058172f6003"}}}}
{"instruction": "What is the bioavailability of Epicyclpine?", "response": "The predicted oral bioavailability of Epicyclpine is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Epicyclpine", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000586-e87cd4d48f3d61f4", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.905726", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "85e8926c19186e5d4e710025be0f8f705a0b9d5ab9f5539f515a0fc8f6715f4f"}}}}
{"instruction": "How many hydrogen bond donors does Parachlorpine have?", "response": "Parachlorpine has 4 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Parachlorpine", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000588-6408e59247d1b998", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.905795", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "bbcd1dd761ae36c18b927ae331407cc9c548e1856436d343a537bb5d8ee500ff"}}}}
{"instruction": "How many hydrogen bond acceptors does Epifluormycin have?", "response": "Epifluormycin has 4 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Epifluormycin", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000590-71d4d46bebd41561", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.905863", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "574ea9c17643a24954587f9582240e2232f903a68ab89de1d8a3ffbce3d56362"}}}}
{"instruction": "Compare Antisulfpril to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Antisulfpril has favorable drug-like properties with MW=463.42 Da and logP=1.91.", "metadata": {"compound": "Antisulfpril", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000591-cf08a2d2a8456f2e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.905900", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "8be4dfce56cce0450d6037d1685ddf50c1859e483d477859530aa8ec918691f9"}}}}
{"instruction": "How many hydrogen bond donors does Parabenzmab have?", "response": "Parabenzmab has 4 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Parabenzmab", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000592-47bb0ecc3398f14a", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.905935", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "1e905eae84f9b4b10211154b6ca70cbeaadd60231ff0850c76a6fbc15e7b4358"}}}}
{"instruction": "How many rotatable bonds does Synchlorolol have?", "response": "Synchlorolol has 1 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Synchlorolol", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000593-592644391f96dae0", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.905969", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "dbdf1b70601a299dc59881d9b51a4c32a037c9ca314a41b938381be4f3f7fc14"}}}}
{"instruction": "How many rotatable bonds does Isobenzmab have?", "response": "Isobenzmab has 4 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Isobenzmab", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000597-462ae8849a07c76c", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.906136", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "390bc7c7e218dc2216b52ac29dd7efc0822c79b949abfee53ecbb31d56785a06"}}}}
{"instruction": "What is the bioavailability of Epibarbib?", "response": "The predicted oral bioavailability of Epibarbib is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Epibarbib", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000598-4ee96aee2e222b74", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.906170", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "b5d983b1581960a426e829a10e0de9775d0ecb7e6e3c7580eb77ed02848381c4"}}}}
{"instruction": "What is the bioavailability of Parafluordone?", "response": "The predicted oral bioavailability of Parafluordone is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Parafluordone", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000599-43426493537b2dd4", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.906203", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "5111f2ee44a74d58e9dcc9dc50fdf57e5443614ba406fa07507dc8c744cecce0"}}}}
{"instruction": "Compare Probenzpril to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Probenzpril has favorable drug-like properties with MW=408.59 Da and logP=-0.31.", "metadata": {"compound": "Probenzpril", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000600-f1bf38ca987796a8", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.906240", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "f6102e5286b19e7eb6482b2cd8eadca12c21fc34b57f8b731342143c225c3e74"}}}}
{"instruction": "What is the bioavailability of Syncephdone?", "response": "The predicted oral bioavailability of Syncephdone is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Syncephdone", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000602-bddd2b2ea6b529dd", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.906315", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "cfa4684633e379b87d3f6fe4f7ef19cfb3eec5bfeebd074bb27296d4159d6ce1"}}}}
{"instruction": "How many hydrogen bond donors does Hypocephib have?", "response": "Hypocephib has 0 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Hypocephib", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000603-ebecab7fb6dae4dd", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.906350", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "4b076ae601de45ab1f2546234aeeb8f60fba988351f0ac05b3a8be3f48221942"}}}}
{"instruction": "What is the bioavailability of Antimorphpine?", "response": "The predicted oral bioavailability of Antimorphpine is approximately 80% based on its physicochemical properties.", "metadata": {"compound": "Antimorphpine", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000604-65d7c555145c9e03", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.906389", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "8f2b6accdeb73f44479fc00eb95703bc774f9a7224929b0f8459a056dceaee08"}}}}
{"instruction": "Describe the molecular properties of Antibenzolol.", "response": "Antibenzolol (MW: 533.2 Da, C26H23N5O6) exhibits a logP of 1.87 and TPSA of 129.88 \u0172 with 0 H-bond donors and 1 H-bond acceptors.", "metadata": {"compound": "Antibenzolol", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000605-ac78da8348eb9643", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.906445", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "6a4fab3eff6b9a66953278273001ef92f8a8f84b6f2a6046546a9c665c0a4510"}}}}
{"instruction": "Compare Paramorpholol to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Paramorpholol has favorable drug-like properties with MW=420.86 Da and logP=4.24.", "metadata": {"compound": "Paramorpholol", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000606-f10ac5b93db5eeca", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.906483", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "1c6520c30ae94a459f43156db5e7b1223a0657c9e02062ff40800cedfd07948a"}}}}
{"instruction": "How many hydrogen bond donors does Metamorphdone have?", "response": "Metamorphdone has 3 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Metamorphdone", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000607-9a15a061d4433213", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.906518", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "53da4622023aa5ff050cbe9db74ad1ab2355b142fa36b93c97ed5710fdc8024e"}}}}
{"instruction": "Compare Neophenstatin to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Neophenstatin has favorable drug-like properties with MW=491.76 Da and logP=2.07.", "metadata": {"compound": "Neophenstatin", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000608-1f4438ce973ffb9c", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.906555", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "078994820aecf5f1279dddc95ad47f60b6556f2f9d0bc0ce7e67b66a465e559a"}}}}
{"instruction": "How many rotatable bonds does Epibenzmab have?", "response": "Epibenzmab has 2 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Epibenzmab", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000609-4e89ccbb7c18fa7d", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.906590", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "5d5c33a653583c3b978c27eea128babcfb95ad9549b75b2776b540e3bb05c4de"}}}}
{"instruction": "Compare Parafluorpine to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Parafluorpine has favorable drug-like properties with MW=479.67 Da and logP=3.99.", "metadata": {"compound": "Parafluorpine", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000610-17723e024719d0ee", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.906626", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "04ef4281fa769584c59b306e7871d59ca3382efcfd519c2429836431817bece7"}}}}
{"instruction": "How many hydrogen bond acceptors does Isocyclmycin have?", "response": "Isocyclmycin has 8 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Isocyclmycin", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000611-094e55b63759527e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.906661", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "b4fcb2ee97f69c9acae63e39cd25148c1fdbe2a1e10919afcb5e2c976c925b38"}}}}
{"instruction": "Does Hyperfluorazole satisfy Lipinski's Rule of Five?", "response": "Hyperfluorazole satisfies Lipinski's Rule of Five with no violations, suggesting good oral bioavailability potential.", "metadata": {"compound": "Hyperfluorazole", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "drug_likeness", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000612-67587351a98130fe", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.906705", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "786d58d8afff677eea94b2256e7ca14fcdba71578b3d6fafef994c2c1342a626"}}}}
{"instruction": "Compare Metamorphmab to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Metamorphmab has suboptimal drug-like properties with MW=561.4 Da and logP=4.53.", "metadata": {"compound": "Metamorphmab", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000613-f23d35201760e001", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.906744", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "d0cc588f8f89064540f5690de6d6719a04ead035d0ea6a88440eddc905cd5cde"}}}}
{"instruction": "What is the logP value of Anticephstatin?", "response": "The logP (partition coefficient) of Anticephstatin is 1.51. This indicates good lipophilicity for oral bioavailability.", "metadata": {"compound": "Anticephstatin", "batch": 0, "template": "What is the logP value of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 85.0, "uniqueness_score": 90.0, "total_score": 94.25, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000614-2389cfbd424bc758", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.906780", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "f5d0ab06ae0f3868", "cl_signature": "f7650c5d4849bba605efad88bc1937ee2f1aca3ebf71520ce58e2f7618060528"}}}}
{"instruction": "What is the bioavailability of Epimorphazole?", "response": "The predicted oral bioavailability of Epimorphazole is approximately 80% based on its physicochemical properties.", "metadata": {"compound": "Epimorphazole", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000615-36bf5962d2be78f2", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.906815", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "700a807179b30b9c4d42da22017dad575b0bc9cc7e96889a5db29673fded8af1"}}}}
{"instruction": "What is the bioavailability of Epicephmab?", "response": "The predicted oral bioavailability of Epicephmab is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Epicephmab", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000617-fb4d376a766cdbb9", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.906880", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "2077926e3b8924478edac4ba88e765c71935c041daf46a14b054b7dcd696b907"}}}}
{"instruction": "How many hydrogen bond acceptors does Procephazole have?", "response": "Procephazole has 4 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Procephazole", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000618-53155d63e6c196af", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.906915", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "1ec06753829c2d5ed9fd6b07686031225462c82eff7d9e955edb98610d70aacd"}}}}
{"instruction": "What is the molecular weight of Epimethib?", "response": "The molecular weight of Epimethib is 562.62 Da.", "metadata": {"compound": "Epimethib", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000619-8668c10e76a559d0", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.906946", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "0efee61852e1ab3a4b2d3dd60a13451d05e436504bfc51fe46cf8b64df03c174"}}}}
{"instruction": "What are the key structural features of Hypomethcillin?", "response": "Key structural features of Hypomethcillin include 0 aromatic rings, 1 rotatable bonds, and a molecular weight of 509.65 Da.", "metadata": {"compound": "Hypomethcillin", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000620-776769aa69cdb75f", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.906992", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "f5a28a086a3af2cb09b46d98170a3f307d49f34757cd2b815918dbca0ce385bd"}}}}
{"instruction": "What are the key structural features of Synphenolol?", "response": "Key structural features of Synphenolol include 2 aromatic rings, 15 rotatable bonds, and a molecular weight of 215.11 Da.", "metadata": {"compound": "Synphenolol", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000621-2ef844c191346fa6", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.907030", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "2c91d247161c7db0088259972158df0b2c50cb52ee8029a31bf0a48f9d9e8adb"}}}}
{"instruction": "How many aromatic rings does Parachlormycin have?", "response": "Parachlormycin contains 4 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Parachlormycin", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000623-7e76e2af35eac1cb", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.907102", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "5df0b961ba0c27d531a1b9d9198ebe6182c19b34d3b7441f911e70507a8f0123"}}}}
{"instruction": "What is the molecular formula of Neofluorcillin?", "response": "The molecular formula of Neofluorcillin is C18H17N3O1.", "metadata": {"compound": "Neofluorcillin", "batch": 0, "template": "What is the molecular formula of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000624-d14562d5c638aa64", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.907133", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "4c3085b3983afa78", "cl_signature": "0bbb84872eaf1689f4e7be4d6a11c5bddc53f099ffcb245630eeaae5d26c9863"}}}}
{"instruction": "What is the molecular weight of Paracephpril?", "response": "The molecular weight of Paracephpril is 532.89 Da.", "metadata": {"compound": "Paracephpril", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000626-2f3b8283d82cb394", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.907197", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "43ce7af0b87deb26a0531a3391ef8cdcc328c72914a4a25f5d91274cf807d38b"}}}}
{"instruction": "Describe the molecular properties of Hypobarbazole.", "response": "Hypobarbazole (MW: 408.19 Da, C18H40N4O7) exhibits a logP of 0.13 and TPSA of 136.59 \u0172 with 3 H-bond donors and 3 H-bond acceptors.", "metadata": {"compound": "Hypobarbazole", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000629-4be2bdc79bee1c68", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.907316", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "9f2be282013543ff89e9c9fb206a207106f0f5048be9d91ca770d16efdc403e5"}}}}
{"instruction": "What are the pharmacokinetic properties of Procephmab?", "response": "The pharmacokinetic properties of Procephmab suggest good absorption potential with TPSA=42.85 \u0172 and MW=223.45 Da.", "metadata": {"compound": "Procephmab", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000630-0d616620d206f862", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.907360", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "1a58944861672318308b7e6811a6e784d6e096c91355d0d7987bbdceeab66011"}}}}
{"instruction": "Describe the molecular properties of Hypercyclpine.", "response": "Hypercyclpine (MW: 580.39 Da, C10H11N2O8) exhibits a logP of -0.1 and TPSA of 48.8 \u0172 with 0 H-bond donors and 2 H-bond acceptors.", "metadata": {"compound": "Hypercyclpine", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000631-6d6ff77c4e7f3031", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.907421", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "9378278fff02087d1f214e0951a5f634a2651cf95ca46d86f263b588340eae3e"}}}}
{"instruction": "Does Profluorazole satisfy Lipinski's Rule of Five?", "response": "Profluorazole satisfies Lipinski's Rule of Five with no violations, suggesting good oral bioavailability potential.", "metadata": {"compound": "Profluorazole", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "drug_likeness", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000635-5f0db0bf3b6ab8d1", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.907571", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "51ab89356ad43f307709238e2d7b363f358af80534b4f2566f70a32c9e305a29"}}}}
{"instruction": "What is the TPSA of Parametholol?", "response": "The topological polar surface area (TPSA) of Parametholol is 113.34 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Parametholol", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000636-87328f2f8481191c", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.907615", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "b977ac11c5e150770a168887e4a3df2325ff7a2ebc3bde93b484323ad05f2e61"}}}}
{"instruction": "Does Hypersulfmycin satisfy Lipinski's Rule of Five?", "response": "Hypersulfmycin satisfies Lipinski's Rule of Five with no violations, suggesting good oral bioavailability potential.", "metadata": {"compound": "Hypersulfmycin", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "drug_likeness", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000638-fc731e9cdbab11d4", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.907684", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "faac897d3d62d72b850f11181e34c3293e6bce63cdb9bd832f8ebc568908a155"}}}}
{"instruction": "How many hydrogen bond acceptors does Profluorcillin have?", "response": "Profluorcillin has 10 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Profluorcillin", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000639-77aad3a9728f6fdb", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.907719", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "35d9e3dc76a39f71b90f0c21186f76a3466e0e3a45132324325aa3044c86b55a"}}}}
{"instruction": "What is the logP value of Synphenpril?", "response": "The logP (partition coefficient) of Synphenpril is 4.67. This indicates good lipophilicity for oral bioavailability.", "metadata": {"compound": "Synphenpril", "batch": 0, "template": "What is the logP value of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 85.0, "uniqueness_score": 90.0, "total_score": 94.25, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000640-18a2300abe00f7fe", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.907753", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "f5d0ab06ae0f3868", "cl_signature": "b9390f4f1c57f38959ccf8a9c4eb1c6cb6d84d2fa92b41e05710fc70413d8833"}}}}
{"instruction": "What is the solubility profile of Hyperbenzpril?", "response": "Hyperbenzpril exhibits moderate solubility based on its logP value of 1.25.", "metadata": {"compound": "Hyperbenzpril", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000641-439ef1cb36a48e29", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.907788", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "4c157cf6640498a9f27154d7e3e34dbf71391ec1ecd227458ad9a3f02ad6044f"}}}}
{"instruction": "How many rotatable bonds does Neochlormab have?", "response": "Neochlormab has 12 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Neochlormab", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000643-b1aa7b186ecf89ef", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.907862", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "6326af35c16786d3276848e10e0ad92e8a82bb499fb143d9e629da8c37dab613"}}}}
{"instruction": "How many hydrogen bond acceptors does Epimorpholol have?", "response": "Epimorpholol has 10 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Epimorpholol", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000644-eb8e0ad90f4c1b36", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.907897", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "0cef160e8aee431dcd4d4448de2b3d4aba90a66a79fcc3dbef087af1f2826dc5"}}}}
{"instruction": "What is the molecular weight of Isophenolol?", "response": "The molecular weight of Isophenolol is 305.54 Da.", "metadata": {"compound": "Isophenolol", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000645-96579edb45daea82", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.907927", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "518d72873c3806d6f235c36d55e59039313d8a57e141e20faf7546ad993c4497"}}}}
{"instruction": "How many aromatic rings does Hypocephmycin have?", "response": "Hypocephmycin contains 4 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Hypocephmycin", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000646-96eff44dd6d59ca8", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.907962", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "d910aa376c7910103c7447a233a8a3ba213a29e22e650ae27ada203af30e0919"}}}}
{"instruction": "How many hydrogen bond acceptors does Syncephazole have?", "response": "Syncephazole has 10 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Syncephazole", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000647-83f6653458ecf2a3", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.907997", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "d4b26f53da329da00286a892b799e3780a4ad8f08c58aeebbe44ba6654e0e2a7"}}}}
{"instruction": "How many hydrogen bond acceptors does Metamethpine have?", "response": "Metamethpine has 3 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Metamethpine", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000648-e50211aa5eb8fded", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.908032", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "0abaffc7e5db6b114474484ef0dc7b634b4dc633613d61ee26811a55ff78fedd"}}}}
{"instruction": "What is the molecular formula of Isosulfpril?", "response": "The molecular formula of Isosulfpril is C20H26N1O10.", "metadata": {"compound": "Isosulfpril", "batch": 0, "template": "What is the molecular formula of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000650-adc74d10b7099a4f", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.908097", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "4c3085b3983afa78", "cl_signature": "e43ba8286e2873307e53386781e10f91267bc84debc50f424e846fea8e73b32a"}}}}
{"instruction": "How many hydrogen bond donors does Hypocephib have?", "response": "Hypocephib has 2 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Hypocephib", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000653-36ac00cc6be3224f", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.908208", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "58594ee61553f8d13e2ca1e3de2b35f03112fb911ea7cf2b590e43a37aef73be"}}}}
{"instruction": "Compare Epicyclmycin to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Epicyclmycin has favorable drug-like properties with MW=272.21 Da and logP=3.38.", "metadata": {"compound": "Epicyclmycin", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000654-8c92c7bc52863b89", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.908244", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "624119f7ae2fabb424fb83c5d44b3b854bf764bbe0c5cb9bba0ff3c91a44ff24"}}}}
{"instruction": "How many hydrogen bond acceptors does Hyposulfpine have?", "response": "Hyposulfpine has 9 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Hyposulfpine", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000656-072246e1b0925002", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.908314", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "abb789c46a5856c7352bceaf70c3df4f344a4e599390a62047cc0563113435ab"}}}}
{"instruction": "Compare Profluorazole to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Profluorazole has favorable drug-like properties with MW=486.29 Da and logP=0.34.", "metadata": {"compound": "Profluorazole", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000657-48124ea0fec4905b", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.908350", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "6fcbedf070af9ab65bd0a1ce32a027528a868ca6ca8fb7ac91cd9fbee4f9c768"}}}}
{"instruction": "Describe the molecular properties of Metabenzstatin.", "response": "Metabenzstatin (MW: 405.52 Da, C10H40N5O7) exhibits a logP of -1.51 and TPSA of 109.36 \u0172 with 5 H-bond donors and 8 H-bond acceptors.", "metadata": {"compound": "Metabenzstatin", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000659-fec7276afb817a3c", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.908436", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "1c0d80cc1fa864213fceb3827191f023d2c6605f86a922682b2573a2c238e85c"}}}}
{"instruction": "What is the TPSA of Parabarbolol?", "response": "The topological polar surface area (TPSA) of Parabarbolol is 108.38 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Parabarbolol", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000660-362de1d55b539c7a", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.908479", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "298aaca916aee97118648bf7b50451c25cd9371606c0cb55a57313979f16d6cd"}}}}
{"instruction": "What are the pharmacokinetic properties of Hypobarbcillin?", "response": "The pharmacokinetic properties of Hypobarbcillin suggest good absorption potential with TPSA=128.02 \u0172 and MW=298.13 Da.", "metadata": {"compound": "Hypobarbcillin", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000661-d0361b5745716d32", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.908522", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "a0e8e8284737dcbe88de550e2b28d00898f5ca37bfd3e645582a730a5e530c0a"}}}}
{"instruction": "How many aromatic rings does Epibenzpine have?", "response": "Epibenzpine contains 2 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Epibenzpine", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000664-f7c0b78159f6cf3f", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.908656", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "64976a5058fb43e95c06620092e6db7e3c410db339ca0f82148e0963e1f33b43"}}}}
{"instruction": "What is the logP value of Neochlorazole?", "response": "The logP (partition coefficient) of Neochlorazole is 4.69. This indicates good lipophilicity for oral bioavailability.", "metadata": {"compound": "Neochlorazole", "batch": 0, "template": "What is the logP value of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 85.0, "uniqueness_score": 90.0, "total_score": 94.25, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000665-cdc0ee87d6fd1844", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.908689", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "f5d0ab06ae0f3868", "cl_signature": "b37311c108c44298fefe95fc9f2e86eccb45212b35f390b6cc3f981f39891e91"}}}}
{"instruction": "How many hydrogen bond donors does Synbarbmab have?", "response": "Synbarbmab has 2 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Synbarbmab", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000666-8d6d2adba86ee5ab", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.908724", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "be4bee5b5d837dd291395c0ab034a87d5de9415b8dc3a1498b0592378458bbb6"}}}}
{"instruction": "How many aromatic rings does Hypermethpine have?", "response": "Hypermethpine contains 4 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Hypermethpine", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000667-49dcbfc7da037eb7", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.908760", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "feacbd1207e8661e5eb4210a8f2554dca94dccac6e2e115f1dde1da0a40b1ed4"}}}}
{"instruction": "Does Metamorphib satisfy Lipinski's Rule of Five?", "response": "Metamorphib satisfies Lipinski's Rule of Five with no violations, suggesting good oral bioavailability potential.", "metadata": {"compound": "Metamorphib", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "drug_likeness", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000668-223b32308d88537a", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.908793", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "11e8164410f933ab44ca62fd0c3ab603117ec194b8c022c49f20164f3a15bcc5"}}}}
{"instruction": "What is the bioavailability of Epimorphmab?", "response": "The predicted oral bioavailability of Epimorphmab is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Epimorphmab", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000669-c122cb7380854f30", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.908827", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "e4b74bd3520ab2a5cd968d24d20cd65689bb3ac6fa0bb3a9b53fe945348a2af5"}}}}
{"instruction": "How many hydrogen bond donors does Neocycldone have?", "response": "Neocycldone has 0 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Neocycldone", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000670-fedd1d68d3f38859", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.908862", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "29663b1bd192acd9b23c7f111c6e2be24b53e34a670afefe3e61e2a3f7afd367"}}}}
{"instruction": "Describe the molecular properties of Prochlorpril.", "response": "Prochlorpril (MW: 393.1 Da, C15H15N5O10) exhibits a logP of 1.51 and TPSA of 75.62 \u0172 with 5 H-bond donors and 8 H-bond acceptors.", "metadata": {"compound": "Prochlorpril", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000671-eed0d67909e139b1", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.908917", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "c50ee153a385a6b06b53ebc13c25ed46e1a350643c7e26ea74659e58632403db"}}}}
{"instruction": "How many hydrogen bond donors does Neocephcillin have?", "response": "Neocephcillin has 4 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Neocephcillin", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000673-66a7a3da161e314d", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.908986", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "df06cb3e35c936f71cb4e01386a52774c954ff2475fdf8c6edbb006040ce60f8"}}}}
{"instruction": "What are the key structural features of Epimethcillin?", "response": "Key structural features of Epimethcillin include 0 aromatic rings, 3 rotatable bonds, and a molecular weight of 342.85 Da.", "metadata": {"compound": "Epimethcillin", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000674-104515ae8e4d3fc1", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.909023", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "a34aa6fe9084f25a50c4a1f9ece6f15aa7fc039338c2e6bfb9f8ec6807af7f3c"}}}}
{"instruction": "What is the molecular weight of Metacephazole?", "response": "The molecular weight of Metacephazole is 352.18 Da.", "metadata": {"compound": "Metacephazole", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000675-12884d1d1f268af6", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.909052", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "ccf8813791cdce1253819db7ccc70c3886300b2006ee234a47be96b5a455884f"}}}}
{"instruction": "Does Parabarbcillin satisfy Lipinski's Rule of Five?", "response": "Parabarbcillin satisfies Lipinski's Rule of Five with no violations, suggesting good oral bioavailability potential.", "metadata": {"compound": "Parabarbcillin", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "drug_likeness", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000678-5e04c03c4dd4f762", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.909170", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "7130811b197138f64c7b57ad7f2bc178890337d653e9ed88a5f07574064b0af1"}}}}
{"instruction": "Describe the molecular properties of Synfluormab.", "response": "Synfluormab (MW: 164.12 Da, C22H47N1O8) exhibits a logP of 3.85 and TPSA of 69.96 \u0172 with 3 H-bond donors and 1 H-bond acceptors.", "metadata": {"compound": "Synfluormab", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000679-290f917a6cdfb493", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.909216", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "71dad7bb6f44995c9f35d7d13856ae36f27e2b9c8a604f421b2a01cc1d1918bf"}}}}
{"instruction": "What is the molecular weight of Antibarbmab?", "response": "The molecular weight of Antibarbmab is 583.47 Da.", "metadata": {"compound": "Antibarbmab", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000680-d8d5100ca9c90ff8", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.909247", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "80638b4844a980a57172a680bb0a73febc4b0e40d2a2f786075c663bce681c63"}}}}
{"instruction": "What is the solubility profile of Isophenib?", "response": "Isophenib exhibits moderate solubility based on its logP value of 2.52.", "metadata": {"compound": "Isophenib", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000681-f39ba1247d4d6662", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.909291", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "00a7b1bce69113ccd2181b75c28bdf61e92a62575744a1185b65a4fb1e3772cb"}}}}
{"instruction": "How many hydrogen bond donors does Metachlorolol have?", "response": "Metachlorolol has 1 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Metachlorolol", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000682-92d06c1d199ae0ec", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.909327", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "2a09991ceea3de7653fafb493712b001eaa80c4aa5ed18fe3a7312459f853acd"}}}}
{"instruction": "What are the key structural features of Promorphmab?", "response": "Key structural features of Promorphmab include 4 aromatic rings, 10 rotatable bonds, and a molecular weight of 478.4 Da.", "metadata": {"compound": "Promorphmab", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000683-18a03093f8563785", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.909363", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "9252d4788dd9f18113652109c9b0e2af40717c43a74bcb1687d7b3075c1ff444"}}}}
{"instruction": "Describe the molecular properties of Metacyclpine.", "response": "Metacyclpine (MW: 412.02 Da, C16H28N1O4) exhibits a logP of 3.64 and TPSA of 80.57 \u0172 with 3 H-bond donors and 3 H-bond acceptors.", "metadata": {"compound": "Metacyclpine", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000685-a71c5e14f26e63a2", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.909445", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "17fffca407df5c774bddce0ce61bd58df5ef46c9453d80b345bf48a1b1576dce"}}}}
{"instruction": "What is the molecular weight of Hyperbarbib?", "response": "The molecular weight of Hyperbarbib is 269.57 Da.", "metadata": {"compound": "Hyperbarbib", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000686-e7dc1736ca3c8d5f", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.909480", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "193e14ec4a0d3a56325b0ad3190b01b9b00127524c18ae6071e3c2e11e2c5304"}}}}
{"instruction": "How many aromatic rings does Metaphenpril have?", "response": "Metaphenpril contains 1 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Metaphenpril", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000687-1614c7f1bdb5f15e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.909516", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "a013e6ed01952ff8e19e53817f45b127e27c70296029428979a6b3e75a60c9c2"}}}}
{"instruction": "How many aromatic rings does Prochlormab have?", "response": "Prochlormab contains 1 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Prochlormab", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000689-0b095d07a2660475", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.909585", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "542171b3e2df08426424dd2a13e51df1a4afedf71c7bd575e78cb3c74e1c8ff6"}}}}
{"instruction": "What are the key structural features of Epibenzpril?", "response": "Key structural features of Epibenzpril include 4 aromatic rings, 13 rotatable bonds, and a molecular weight of 388.28 Da.", "metadata": {"compound": "Epibenzpril", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000694-0df71473f0d5e45c", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.909945", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "047840d12f802a15a27825cf70e173815122124f544bd43a7e02e2f35cea497a"}}}}
{"instruction": "Describe the molecular properties of Metabarbcillin.", "response": "Metabarbcillin (MW: 175.39 Da, C19H24N5O9) exhibits a logP of 2.31 and TPSA of 111.79 \u0172 with 5 H-bond donors and 2 H-bond acceptors.", "metadata": {"compound": "Metabarbcillin", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000695-53279299367e2aff", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.909998", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "3881d2b1ea39d6cbd2457be44b840273e1ef534760a6cf979e851884563f266e"}}}}
{"instruction": "Describe the molecular properties of Hypermethazole.", "response": "Hypermethazole (MW: 556.03 Da, C28H34N3O8) exhibits a logP of -1.41 and TPSA of 125.7 \u0172 with 0 H-bond donors and 2 H-bond acceptors.", "metadata": {"compound": "Hypermethazole", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000696-d0eb103f862530c8", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.910048", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "c4383d6e4e448b4815c1d810b540c6cefaf35fda692aa8408c2c967c6da81483"}}}}
{"instruction": "Does Antibenzstatin satisfy Lipinski's Rule of Five?", "response": "Antibenzstatin satisfies Lipinski's Rule of Five with no violations, suggesting good oral bioavailability potential.", "metadata": {"compound": "Antibenzstatin", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "drug_likeness", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000697-5b4645feb9433d37", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.910084", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "419fc5bb1e1ecad33dd0380a6780380b1e75091b0f3ae94034364ff9ba2c0ca7"}}}}
{"instruction": "What is the molecular formula of Neochlormycin?", "response": "The molecular formula of Neochlormycin is C14H40N5O1.", "metadata": {"compound": "Neochlormycin", "batch": 0, "template": "What is the molecular formula of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000700-4360b7f77f55bb2b", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.910207", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "4c3085b3983afa78", "cl_signature": "fbecf97c24b68598bb309fe83e602aa149a00326d82c352e216b8e53017fe864"}}}}
{"instruction": "Describe the molecular properties of Metacephcillin.", "response": "Metacephcillin (MW: 184.62 Da, C25H45N1O1) exhibits a logP of 1.24 and TPSA of 129.89 \u0172 with 2 H-bond donors and 1 H-bond acceptors.", "metadata": {"compound": "Metacephcillin", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000701-6fe788852ea471d7", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.910254", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "873195803b61dc17c43da759d13904c69e831c6583253b83a98f764dfbe5253e"}}}}
{"instruction": "How many aromatic rings does Procephcillin have?", "response": "Procephcillin contains 3 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Procephcillin", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000702-1e5cbf2c3d713f55", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.910291", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "331a5f3a0a5f0cae1facf40224295ddb28d474b6b06b938d9c98eea743d90dbf"}}}}
{"instruction": "What is the solubility profile of Metamethpril?", "response": "Metamethpril exhibits high water solubility based on its logP value of -0.49.", "metadata": {"compound": "Metamethpril", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000704-4ae8619e9e77c3f7", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.910378", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "9047c9d1ce5aed8e34dab042c06befb5a939d511fab105ac22dbebc57761723e"}}}}
{"instruction": "How many rotatable bonds does Neocyclib have?", "response": "Neocyclib has 13 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Neocyclib", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000706-55d4b506b0232ca4", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.910467", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "ddab33267618812b111a84060454340b0e8096bd1cfea49ed0bf5db5ff833611"}}}}
{"instruction": "What is the solubility profile of Metacyclpril?", "response": "Metacyclpril exhibits moderate solubility based on its logP value of 1.68.", "metadata": {"compound": "Metacyclpril", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000707-25ce1d9872a7561a", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.910503", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "5091295095a55f7f0beeeae822a7ff1770ff428e7ccd90deb75c06bdfa6f96ff"}}}}
{"instruction": "How many aromatic rings does Syncephpril have?", "response": "Syncephpril contains 4 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Syncephpril", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000708-7a2c50e85f5bc2dd", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.910540", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "513ab258132471d93cea71555b06ab01e4d4cb5117f9572dc4772f96406e6fea"}}}}
{"instruction": "What is the logP value of Epimorphcillin?", "response": "The logP (partition coefficient) of Epimorphcillin is 1.21. This indicates good lipophilicity for oral bioavailability.", "metadata": {"compound": "Epimorphcillin", "batch": 0, "template": "What is the logP value of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 85.0, "uniqueness_score": 90.0, "total_score": 94.25, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000710-b55c542c217c06d7", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.910611", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "f5d0ab06ae0f3868", "cl_signature": "dda1acfe1e66146173d7b6c7ca0a23c2f4b93d9f11ef2ec00be387658ab67450"}}}}
{"instruction": "How many rotatable bonds does Prosulfdone have?", "response": "Prosulfdone has 6 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Prosulfdone", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000711-f01cffad425fa3ca", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.910646", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "4be6cf1f35d26e2b6bcb9bca5a6cc68069cbb8dc140ea535d1a2ce20c56361a8"}}}}
{"instruction": "How many rotatable bonds does Synfluormycin have?", "response": "Synfluormycin has 3 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Synfluormycin", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000712-3fd0dd27e1932c1b", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.910680", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "f61a0be94b7a34d1af90791609604c04921247130efbe998a42be501422400c2"}}}}
{"instruction": "How many hydrogen bond acceptors does Metabarbdone have?", "response": "Metabarbdone has 2 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Metabarbdone", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000713-ef2570ae58daf786", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.910732", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "c3a1b1dac8175af98e55f0b399f3b3ac5ee86b0fd6a395b2b8be04bfc5baa5c4"}}}}
{"instruction": "Compare Epifluorstatin to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Epifluorstatin has favorable drug-like properties with MW=228.76 Da and logP=-0.46.", "metadata": {"compound": "Epifluorstatin", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000714-e55a43a7288bda6c", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.910771", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "6e6acebe0d89a9589d8773aa492971a153b8371e125522fced474a3575278027"}}}}
{"instruction": "Describe the molecular properties of Metaphenpine.", "response": "Metaphenpine (MW: 486.43 Da, C18H29O6) exhibits a logP of -0.44 and TPSA of 35.49 \u0172 with 3 H-bond donors and 7 H-bond acceptors.", "metadata": {"compound": "Metaphenpine", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000715-453a153ecbde2455", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.910819", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "8110c077819b5cb8b862900d62613617dccdf0e27f254b622ec88b29e0b4db41"}}}}
{"instruction": "Does Metabenzpril satisfy Lipinski's Rule of Five?", "response": "Metabenzpril has 1 Lipinski violations: MW=571.05 > 500. This may affect oral bioavailability.", "metadata": {"compound": "Metabenzpril", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "drug_likeness", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000716-404ecb594c8cce8c", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.910853", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "b5d242986b5fb55550975b9bd2d1612cd2412423d158cc8cae8e24febd25a284"}}}}
{"instruction": "How many hydrogen bond donors does Paramethcillin have?", "response": "Paramethcillin has 0 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Paramethcillin", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000717-d5c1405566018955", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.910889", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "2ff7f134b8f5b68e0036e484e6c8ef14a8f994e20707559f14e039e9b9fe19ae"}}}}
{"instruction": "Describe the molecular properties of Isobenzpril.", "response": "Isobenzpril (MW: 200.43 Da, C11H32O1) exhibits a logP of 1.23 and TPSA of 123.5 \u0172 with 3 H-bond donors and 3 H-bond acceptors.", "metadata": {"compound": "Isobenzpril", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000718-39d1d307136d9c0a", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.910935", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "9281db90e2057e51ea4b7e63739b440a2f136698b4bb60a8818bdc8a9ecdbea9"}}}}
{"instruction": "How many rotatable bonds does Epibarbolol have?", "response": "Epibarbolol has 3 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Epibarbolol", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000719-ea066c6947aad1a2", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.910970", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "c9f70aadd5a2573f4704846e1457ec85c6473bc26685971f4f54215f17a02929"}}}}
{"instruction": "Compare Isosulfpril to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Isosulfpril has favorable drug-like properties with MW=460.91 Da and logP=1.83.", "metadata": {"compound": "Isosulfpril", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000720-8b19d72583935daf", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.911017", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "7dad2a1aa39131e01d0abc868f4e5e56d60e334f63051a5aca6061715e307447"}}}}
{"instruction": "What is the bioavailability of Epibenzstatin?", "response": "The predicted oral bioavailability of Epibenzstatin is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Epibenzstatin", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000721-5d3667eebcc5aacf", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.911052", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "5f21b78cd46b43ee438bf7fe818ac1e2fb64e53d4fe9ac5f621197b9ecc2b898"}}}}
{"instruction": "Compare Probarbazole to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Probarbazole has favorable drug-like properties with MW=469.06 Da and logP=3.41.", "metadata": {"compound": "Probarbazole", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000722-32aeee6f8bb600dd", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.911088", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "551ed52bd772ff9fb25732309a2b0e2571c31944a6960c70fbe3ac9602e60e96"}}}}
{"instruction": "Does Isocephcillin satisfy Lipinski's Rule of Five?", "response": "Isocephcillin satisfies Lipinski's Rule of Five with no violations, suggesting good oral bioavailability potential.", "metadata": {"compound": "Isocephcillin", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "drug_likeness", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000724-8b6ccaa3a00ea8fb", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.911163", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "0811ed261b42b8e0dff9497360c79f6cd7c963ea61d5cac136e817a9998e74b6"}}}}
{"instruction": "What is the molecular formula of Hypocyclcillin?", "response": "The molecular formula of Hypocyclcillin is C29H17N1O3.", "metadata": {"compound": "Hypocyclcillin", "batch": 0, "template": "What is the molecular formula of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000725-cef70308943a5a78", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.911195", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "4c3085b3983afa78", "cl_signature": "f08febb9691d88d374381d090e45eead3a2f40a267b5e8a9973b0399dc7ae9e0"}}}}
{"instruction": "What is the molecular weight of Synmorphib?", "response": "The molecular weight of Synmorphib is 476.96 Da.", "metadata": {"compound": "Synmorphib", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000727-726a1c9b8dbdab37", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.911262", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "d9793963fc9f9bc3771a75c7b870f444186e0562ecbcf602065668353256a5c4"}}}}
{"instruction": "What are the key structural features of Epimorphstatin?", "response": "Key structural features of Epimorphstatin include 2 aromatic rings, 13 rotatable bonds, and a molecular weight of 508.45 Da.", "metadata": {"compound": "Epimorphstatin", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000728-d273c7b4fc54bb0e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.911300", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "c52adf11c901208deb53fe29807c62f0593136de345ec260b789710f3211aff1"}}}}
{"instruction": "Compare Probarbmab to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Probarbmab has favorable drug-like properties with MW=451.4 Da and logP=0.1.", "metadata": {"compound": "Probarbmab", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000729-7e0dd19fbbe0a32a", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.911345", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "0534395ab0aa4b6813d26f02aed1a2c82d9b799fe36de296009d70b7b320f6cd"}}}}
{"instruction": "How many rotatable bonds does Antifluorolol have?", "response": "Antifluorolol has 6 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Antifluorolol", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000730-3a71bcd19d3a8577", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.911381", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "1d697385017e6ca4455911f23e70968b8623fd2dff87dc27793609c8b9e84e29"}}}}
{"instruction": "Describe the molecular properties of Metamorpholol.", "response": "Metamorpholol (MW: 582.09 Da, C10H14N5O8) exhibits a logP of 4.36 and TPSA of 69.55 \u0172 with 0 H-bond donors and 1 H-bond acceptors.", "metadata": {"compound": "Metamorpholol", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000733-8022b2ade82fb232", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.911495", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "2481691d8d306da35fd8ea34f64a5b385fdab2514a7a90e218a02f16fbd255f4"}}}}
{"instruction": "How many hydrogen bond donors does Hyperfluordone have?", "response": "Hyperfluordone has 4 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Hyperfluordone", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000734-7ca32edede7a6245", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.911532", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "0f69b0cc5f0b9d6e75cc0c9919274c329a6fd4a6379eaf59817be694969b46dd"}}}}
{"instruction": "Compare Procephib to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Procephib has favorable drug-like properties with MW=187.89 Da and logP=0.62.", "metadata": {"compound": "Procephib", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000736-a6b08f4ce8f350eb", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.911605", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "7aafcd50838ba252f86c81efac28e3c3aa7b9c4f569cc64e7685ba1e891f7e84"}}}}
{"instruction": "Describe the molecular properties of Hyperbarbpril.", "response": "Hyperbarbpril (MW: 203.58 Da, C26H41N1O1) exhibits a logP of 4.3 and TPSA of 58.48 \u0172 with 1 H-bond donors and 5 H-bond acceptors.", "metadata": {"compound": "Hyperbarbpril", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000737-aea7afee410f322c", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.911653", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "3d0295b71ab91a1fe23c8b00a0f7b6bc1ecce2cd8d3b38712de4edc7b71a77db"}}}}
{"instruction": "How many aromatic rings does Paramorphmab have?", "response": "Paramorphmab contains 4 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Paramorphmab", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000738-c50b231a2d55b9bd", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.911690", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "f6d1768c8de7e3b9ff05f98a55c7276c80f326eb426f6ed0aa60e7fc163c3400"}}}}
{"instruction": "How many rotatable bonds does Paramorphstatin have?", "response": "Paramorphstatin has 13 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Paramorphstatin", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000739-65a8642c88cd2581", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.911734", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "638807e08eef1506f72e374266e2b33b466f07d0054420823bc14a391a279198"}}}}
{"instruction": "Describe the molecular properties of Hypercephib.", "response": "Hypercephib (MW: 454.28 Da, C19H13N5O7) exhibits a logP of 2.5 and TPSA of 22.57 \u0172 with 3 H-bond donors and 3 H-bond acceptors.", "metadata": {"compound": "Hypercephib", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000740-966010aa6bf15cd8", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.911787", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "5b2b488ff031b7d3166bf26cda94300c6b558b0d7ee91405243ff6850c88fc50"}}}}
{"instruction": "How many rotatable bonds does Isofluormycin have?", "response": "Isofluormycin has 2 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Isofluormycin", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000741-c8cb2c48db73fb1e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.911823", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "73bcb32ed42c5bf6481f3065f1ad14aee9ec532772f1d9ce05960254763cfa2a"}}}}
{"instruction": "How many hydrogen bond donors does Antimethmycin have?", "response": "Antimethmycin has 3 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Antimethmycin", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000742-44b5f62c66a7f70e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.911861", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "19e1749cfe3d3d877d19241a4bfb430f645bf59d1055653d5162991eca7f8029"}}}}
{"instruction": "Compare Antichlorpine to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Antichlorpine has favorable drug-like properties with MW=414.52 Da and logP=-1.67.", "metadata": {"compound": "Antichlorpine", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000743-a729761f8dd39f5e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.911899", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "b09cfa6c4a85a53787a30879fab7815752a7fee502f2e534be5abfd783f606bd"}}}}
{"instruction": "Compare Hyperbarbolol to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Hyperbarbolol has favorable drug-like properties with MW=150.03 Da and logP=2.36.", "metadata": {"compound": "Hyperbarbolol", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000744-fe94024d76e54e44", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.911936", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "040bd05a8d602be07b52ccea34f5ba31bbaa483a86e579baa056e577f96a485d"}}}}
{"instruction": "What is the solubility profile of Parafluormab?", "response": "Parafluormab exhibits high water solubility based on its logP value of -1.91.", "metadata": {"compound": "Parafluormab", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000745-d887af55939d3ff3", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.911973", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "ba79a35732ad632633480271e1f4f401df3248ec123aed1b37b5df4cde0abbd7"}}}}
{"instruction": "What is the molecular weight of Paramethmab?", "response": "The molecular weight of Paramethmab is 242.13 Da.", "metadata": {"compound": "Paramethmab", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000746-a1900fd5c3d3015d", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.912014", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "c578cc2818390d09829ba9dc4a3fab3bcfff2fba6d538f35e8544522d3988727"}}}}
{"instruction": "Compare Isophenmycin to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Isophenmycin has favorable drug-like properties with MW=494.65 Da and logP=-1.04.", "metadata": {"compound": "Isophenmycin", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000748-9b9602e52ed33470", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.912092", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "5167a28f1e95eae361b58369c19e8a406b6cf848ac1c73b3283311e279349ea4"}}}}
{"instruction": "What are the pharmacokinetic properties of Neobenzazole?", "response": "The pharmacokinetic properties of Neobenzazole suggest good absorption potential with TPSA=63.57 \u0172 and MW=438.01 Da.", "metadata": {"compound": "Neobenzazole", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000750-01b7c0f295ffe5c6", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.912174", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "a43b76daade97c10300154242abc7ae1b6601a6e10572d04f83f34b502eb8fe8"}}}}
{"instruction": "Describe the molecular properties of Epichlordone.", "response": "Epichlordone (MW: 521.48 Da, C29H34N2O1) exhibits a logP of 3.9 and TPSA of 77.08 \u0172 with 3 H-bond donors and 5 H-bond acceptors.", "metadata": {"compound": "Epichlordone", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000751-19665159a139f4de", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.912221", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "26fbd57df4ca1852ed28cadf4f0f149a9f3bd5a96a66a1d3c1f8138aedcd67ae"}}}}
{"instruction": "How many hydrogen bond acceptors does Paramethpril have?", "response": "Paramethpril has 3 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Paramethpril", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000752-e5dd577728fea974", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.912258", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "23c5740500e5156bb12e25e5863c590376e2925f4bc5923e6f081b139d67c433"}}}}
{"instruction": "How many hydrogen bond acceptors does Metasulfdone have?", "response": "Metasulfdone has 1 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Metasulfdone", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000755-984f50b0d3e74d09", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.912365", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "9c2e8649709608bc6f7083ac374c2fbe49d7fa0c72d9b82db179295cbe19f003"}}}}
{"instruction": "Describe the molecular properties of Epibenzolol.", "response": "Epibenzolol (MW: 482.37 Da, C25H44N5O2) exhibits a logP of 4.18 and TPSA of 34.38 \u0172 with 3 H-bond donors and 9 H-bond acceptors.", "metadata": {"compound": "Epibenzolol", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000756-29a1da262d65faec", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.912412", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "852d05152ee4ab3e2a59bf8aac3a769b46c534fc55735c140b2d96510cddab84"}}}}
{"instruction": "Describe the molecular properties of Parabarbmab.", "response": "Parabarbmab (MW: 461.12 Da, C20H43N3O6) exhibits a logP of 4.27 and TPSA of 129.5 \u0172 with 0 H-bond donors and 4 H-bond acceptors.", "metadata": {"compound": "Parabarbmab", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000758-fac9c085998fe1b7", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.912504", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "7d8113b43e32d2a5da2788d7ef6c09e2f111a88fa03fd47533247ade6dafe43c"}}}}
{"instruction": "What are the key structural features of Metaphenmycin?", "response": "Key structural features of Metaphenmycin include 2 aromatic rings, 3 rotatable bonds, and a molecular weight of 506.41 Da.", "metadata": {"compound": "Metaphenmycin", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000760-c81098f466c47802", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.912576", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "60d6cd5f83c5dbdbe95da7d83e2a072317e3c83f065b2ba13a25b27353070f5b"}}}}
{"instruction": "What is the molecular weight of Metafluorcillin?", "response": "The molecular weight of Metafluorcillin is 218.88 Da.", "metadata": {"compound": "Metafluorcillin", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000764-ae7124d00e2f45e3", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.912716", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "c01a2d9e6c20b5d505c0a3b8740379c26d2ad311515336dae0defc35a081b112"}}}}
{"instruction": "What is the bioavailability of Isophencillin?", "response": "The predicted oral bioavailability of Isophencillin is approximately 80% based on its physicochemical properties.", "metadata": {"compound": "Isophencillin", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000766-dc84fc1636646021", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.912779", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "73185a227367f3dceef7d438c5a2057ea342d103492cce55f4f9da3e99e3ff99"}}}}
{"instruction": "Compare Epicyclstatin to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Epicyclstatin has favorable drug-like properties with MW=387.21 Da and logP=3.04.", "metadata": {"compound": "Epicyclstatin", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000768-619128b1beaf8a0c", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.912858", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "8a3d44986a0ea9dca953288570f284eabb31331656902a0a0985f413525573b7"}}}}
{"instruction": "Compare Hypersulfazole to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Hypersulfazole has favorable drug-like properties with MW=409.1 Da and logP=2.25.", "metadata": {"compound": "Hypersulfazole", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000769-5ef00f18af94a650", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.912894", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "ddb1994ebd660d738b08356c1ae0a2051f6973e40cf50a11367fb3ff2bb152b1"}}}}
{"instruction": "What are the key structural features of Neosulfstatin?", "response": "Key structural features of Neosulfstatin include 3 aromatic rings, 3 rotatable bonds, and a molecular weight of 473.13 Da.", "metadata": {"compound": "Neosulfstatin", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000770-558762310c68d208", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.912931", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "2cc9de9e5b9faa3a65adfc7542c7c7aa3fcd2635faa7873880c39be7c6554043"}}}}
{"instruction": "What is the molecular weight of Hypophenolol?", "response": "The molecular weight of Hypophenolol is 256.84 Da.", "metadata": {"compound": "Hypophenolol", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000771-289ac29c064b57c7", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.912969", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "c51ec8085a45ae15b0a725238ce9393a46684dcdc3335f3412874fd796d21c61"}}}}
{"instruction": "How many hydrogen bond donors does Metacyclib have?", "response": "Metacyclib has 2 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Metacyclib", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000772-de5400a4acd5e888", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.913005", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "3dfec4a6283e0fe5ef92dfc93b1ea8691a4313a0ed04f4cd4139a1f623b50229"}}}}
{"instruction": "Does Metafluormycin satisfy Lipinski's Rule of Five?", "response": "Metafluormycin satisfies Lipinski's Rule of Five with no violations, suggesting good oral bioavailability potential.", "metadata": {"compound": "Metafluormycin", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "drug_likeness", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000773-60107243a1a4d4ff", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.913039", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "5ddba5f64bef2acb1d33ce243f2013095e382cd3d66aaaa29ce7eeec3d1b3aca"}}}}
{"instruction": "What are the pharmacokinetic properties of Parafluorpril?", "response": "The pharmacokinetic properties of Parafluorpril suggest good absorption potential with TPSA=54.75 \u0172 and MW=439.71 Da.", "metadata": {"compound": "Parafluorpril", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000774-d0e82070a668dccd", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.913083", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "f809b9e232b155602d8046a16ee1255d7d0111d049bc60613904c6067d570b50"}}}}
{"instruction": "Compare Epicephpril to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Epicephpril has suboptimal drug-like properties with MW=509.78 Da and logP=1.51.", "metadata": {"compound": "Epicephpril", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000775-5b05efafdc1da674", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.913119", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "1327715c2c90f6328d91494eb9d78ddc1bf66d9bedff7db66eb767287223668a"}}}}
{"instruction": "Does Isomethazole satisfy Lipinski's Rule of Five?", "response": "Isomethazole satisfies Lipinski's Rule of Five with no violations, suggesting good oral bioavailability potential.", "metadata": {"compound": "Isomethazole", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "drug_likeness", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000776-c72a86959ebb7771", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.913153", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "a454f27b7482f213130689a4dedace5b24dfda1d60b98e247844cf40904b8559"}}}}
{"instruction": "What is the bioavailability of Neobarbstatin?", "response": "The predicted oral bioavailability of Neobarbstatin is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Neobarbstatin", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000777-d21e29b026cf6e03", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.913186", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "2b97af55ecb1723464153174d9dd1030ec14f64e4fa624e35aa0c3c118e9c637"}}}}
{"instruction": "Does Synbarbcillin satisfy Lipinski's Rule of Five?", "response": "Synbarbcillin satisfies Lipinski's Rule of Five with no violations, suggesting good oral bioavailability potential.", "metadata": {"compound": "Synbarbcillin", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "drug_likeness", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000778-c9f82c9f39c764ad", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.913228", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "664ab978d3ef07bbacc69106bf85bc298a7a1c77f3845cdc979a7ca840b76951"}}}}
{"instruction": "How many hydrogen bond donors does Neobarbazole have?", "response": "Neobarbazole has 2 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Neobarbazole", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000779-475521e690ed9686", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.913263", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "aa8080fdfa1ea6bd2bbfd7c1ab933b1341393418a11a86e2c224452ab6b7be5b"}}}}
{"instruction": "How many rotatable bonds does Antibarbdone have?", "response": "Antibarbdone has 0 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Antibarbdone", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000780-0109c67e67b8cb99", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.913297", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "39683e0dedc3e4c886c5b3e5584d897a45f076c3cc34c3e5481d37964300ad19"}}}}
{"instruction": "How many hydrogen bond acceptors does Probarbib have?", "response": "Probarbib has 10 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Probarbib", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000781-caf4fafb8fbf88ca", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.913332", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "8887851f1f6d19a941d862731f204866651d14f5a6ae1855a2e6b0d1d883e46a"}}}}
{"instruction": "What is the TPSA of Hypersulfolol?", "response": "The topological polar surface area (TPSA) of Hypersulfolol is 42.93 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Hypersulfolol", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000783-7c2964a9e99ed85b", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.913417", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "496768bbcb55376eba22049968a2aa41014d20d2fa3ad160808835f84f07a06f"}}}}
{"instruction": "How many hydrogen bond acceptors does Neobarbazole have?", "response": "Neobarbazole has 10 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Neobarbazole", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000789-96973815a3a5527d", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.913651", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "4e94b7608e2463f222546efcc0b05b7f56863a31c7f52d40dd4542616f1f5321"}}}}
{"instruction": "What is the molecular formula of Syncyclstatin?", "response": "The molecular formula of Syncyclstatin is C16H12N2O4.", "metadata": {"compound": "Syncyclstatin", "batch": 0, "template": "What is the molecular formula of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000790-e5be0daeb618ac97", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.913682", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "4c3085b3983afa78", "cl_signature": "8b68c8f93a0fe92f7e53e8348921192d72481d1fae58bfa2c1a35eb72f59b137"}}}}
{"instruction": "Compare Profluormycin to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Profluormycin has favorable drug-like properties with MW=194.67 Da and logP=2.54.", "metadata": {"compound": "Profluormycin", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000792-7262d909b3b3e4b2", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.913762", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "962dfd16282b47f4f096a452558247ab43f5bdbb112a4fadd218dd1bc7950ea9"}}}}
{"instruction": "What is the logP value of Isosulfmycin?", "response": "The logP (partition coefficient) of Isosulfmycin is 1.57. This indicates good lipophilicity for oral bioavailability.", "metadata": {"compound": "Isosulfmycin", "batch": 0, "template": "What is the logP value of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 85.0, "uniqueness_score": 90.0, "total_score": 94.25, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000794-b75630676505f88a", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.913854", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "f5d0ab06ae0f3868", "cl_signature": "8c36300f26c4bf744f999e27f5a362094e3f1681c08dd3c5075971757db9c5a3"}}}}
{"instruction": "What are the key structural features of Promethmab?", "response": "Key structural features of Promethmab include 3 aromatic rings, 13 rotatable bonds, and a molecular weight of 434.41 Da.", "metadata": {"compound": "Promethmab", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000795-b6112af014d622fd", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.913891", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "8e2e57029fc3e233f9b1bbaa990b2af0fc857138270b3e48e7299732bf1871bb"}}}}
{"instruction": "What are the pharmacokinetic properties of Hypobarbpril?", "response": "The pharmacokinetic properties of Hypobarbpril suggest limited absorption potential with TPSA=57.86 \u0172 and MW=534.19 Da.", "metadata": {"compound": "Hypobarbpril", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000798-b8060b06701bbfb2", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.914006", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "2cf8c40ae558b648aab1b7e98e4c4e9858720fa28371249ec46823a4afdffef9"}}}}
{"instruction": "What is the logP value of Epicephib?", "response": "The logP (partition coefficient) of Epicephib is 1.26. This indicates good lipophilicity for oral bioavailability.", "metadata": {"compound": "Epicephib", "batch": 0, "template": "What is the logP value of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 85.0, "uniqueness_score": 90.0, "total_score": 94.25, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000803-e4bdbde2fe4375e1", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.914190", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "f5d0ab06ae0f3868", "cl_signature": "dd0f53e33031494d8dadf1b2cda856119ebd3812b97ea7d9f372d3a62b5998c5"}}}}
{"instruction": "What is the molecular weight of Isocyclazole?", "response": "The molecular weight of Isocyclazole is 472.38 Da.", "metadata": {"compound": "Isocyclazole", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000805-167bd066929a06e6", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.914248", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "b411cc50496dcb4d5088080ff7abdc042ceb10e8e47b8eff34217f18d14f0b1d"}}}}
{"instruction": "How many aromatic rings does Epifluorolol have?", "response": "Epifluorolol contains 2 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Epifluorolol", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000806-3da46c7dd5348df0", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.914282", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "3914e293d5dc9e92f4cf927abd669ac1ec632ea8b9a2dbbf1e5c4f7821b891c5"}}}}
{"instruction": "Describe the molecular properties of Hypercephpine.", "response": "Hypercephpine (MW: 507.91 Da, C27H43O10) exhibits a logP of 0.67 and TPSA of 83.22 \u0172 with 2 H-bond donors and 7 H-bond acceptors.", "metadata": {"compound": "Hypercephpine", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000807-306f0dbf052f35ad", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.914335", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "5e345bbe8419e556439203a30cf91a113efa523f2011c783be151892aa9bce6a"}}}}
{"instruction": "What is the logP value of Syncephmycin?", "response": "The logP (partition coefficient) of Syncephmycin is 0.27. This indicates good lipophilicity for oral bioavailability.", "metadata": {"compound": "Syncephmycin", "batch": 0, "template": "What is the logP value of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 85.0, "uniqueness_score": 90.0, "total_score": 94.25, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000808-dcddeb893bff0846", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.914368", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "f5d0ab06ae0f3868", "cl_signature": "cc5ba47fdc36e28a789d21e1e09acd7106a170adacd9c9533e04aeab01672780"}}}}
{"instruction": "Describe the molecular properties of Syncyclmycin.", "response": "Syncyclmycin (MW: 188.33 Da, C27H15O6) exhibits a logP of 1.73 and TPSA of 54.5 \u0172 with 1 H-bond donors and 1 H-bond acceptors.", "metadata": {"compound": "Syncyclmycin", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000809-9b560ee4ac1a1ef8", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.914413", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "e83fc5c0572512de023e64db408f1e34ab1984c729d213c991606804536ab54f"}}}}
{"instruction": "What are the key structural features of Hypochlormycin?", "response": "Key structural features of Hypochlormycin include 4 aromatic rings, 1 rotatable bonds, and a molecular weight of 532.91 Da.", "metadata": {"compound": "Hypochlormycin", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000811-bd6c72295bc2d813", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.914481", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "3e2ad080bc7646de80d174baa41f7a6d4cb2da49bfd281bff4162997c027099d"}}}}
{"instruction": "How many aromatic rings does Probarbolol have?", "response": "Probarbolol contains 4 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Probarbolol", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000813-90344f5d0206701d", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.914547", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "05ecf4589eab31b222eb908a8bc817d073faca7e95a75def52353f00dd095e60"}}}}
{"instruction": "What is the molecular weight of Anticyclib?", "response": "The molecular weight of Anticyclib is 176.95 Da.", "metadata": {"compound": "Anticyclib", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000816-01af3b3dc4e6884f", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.914659", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "a6c5e0927bc4241a4fad90d7d222f0e4e446287aa29446f9574d9f17361a5b30"}}}}
{"instruction": "How many aromatic rings does Syncephcillin have?", "response": "Syncephcillin contains 4 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Syncephcillin", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000818-b4b13a2697bb09dd", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.914719", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "84144dd9a3a137abf2e2aa1d42fdb5f90c8ddd5c62155cb1f88a1e07781156fb"}}}}
{"instruction": "Does Hypocephpril satisfy Lipinski's Rule of Five?", "response": "Hypocephpril satisfies Lipinski's Rule of Five with no violations, suggesting good oral bioavailability potential.", "metadata": {"compound": "Hypocephpril", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "drug_likeness", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000819-f0b38277d0b0ed6d", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.914759", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "56115acf1c1ec54773ac7da159d2350e5994a9ff09d3b7d5f789d10e62ff47f1"}}}}
{"instruction": "What are the pharmacokinetic properties of Parasulfdone?", "response": "The pharmacokinetic properties of Parasulfdone suggest good absorption potential with TPSA=68.34 \u0172 and MW=160.78 Da.", "metadata": {"compound": "Parasulfdone", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000820-fe4d0ab39ed6f2ad", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.914800", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "c35e0f14a3a663385e31bb95c0f21709969f276b0cf1211a353e02f1d3449384"}}}}
{"instruction": "What are the key structural features of Metacyclstatin?", "response": "Key structural features of Metacyclstatin include 1 aromatic rings, 7 rotatable bonds, and a molecular weight of 383.75 Da.", "metadata": {"compound": "Metacyclstatin", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000822-953793642d8e5544", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.914869", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "be60d88fece4815286dddf5883622e57bda7be5f18bec58e8c1fa0d984fbb29c"}}}}
{"instruction": "What are the pharmacokinetic properties of Isophenazole?", "response": "The pharmacokinetic properties of Isophenazole suggest good absorption potential with TPSA=71.67 \u0172 and MW=237.34 Da.", "metadata": {"compound": "Isophenazole", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000824-34c29bec043134b0", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.914948", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "127ce3a72274322daba35f7ac388fecc1b1c5acd97908ab27b7d971dffae6d76"}}}}
{"instruction": "Compare Metabenzstatin to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Metabenzstatin has favorable drug-like properties with MW=293.52 Da and logP=-0.65.", "metadata": {"compound": "Metabenzstatin", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000825-b52abab45a5e2a91", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.914982", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "e4fd24374c8dfb6865682ce5334b95760fcd1229bb6db5fdf979f89600f7b8e4"}}}}
{"instruction": "What is the solubility profile of Epiphenstatin?", "response": "Epiphenstatin exhibits high water solubility based on its logP value of -0.3.", "metadata": {"compound": "Epiphenstatin", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000830-cab4b3d872783846", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.915164", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "66da7697888a93a5f4c91851e157eea7119cd24d2d7e79a62cf6da0c34f5f855"}}}}
{"instruction": "Does Epichlorpine satisfy Lipinski's Rule of Five?", "response": "Epichlorpine satisfies Lipinski's Rule of Five with no violations, suggesting good oral bioavailability potential.", "metadata": {"compound": "Epichlorpine", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "drug_likeness", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000833-91210b78a0329ec7", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.915275", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "18c26a2b0feca4c89f6f0ae38a111334ff08a223b8a399c2f4590d0420cb93d6"}}}}
{"instruction": "What is the bioavailability of Isomethcillin?", "response": "The predicted oral bioavailability of Isomethcillin is approximately 80% based on its physicochemical properties.", "metadata": {"compound": "Isomethcillin", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000834-308abc57148057cf", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.915348", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "fc1c11ccfd42dd5fbe6f9cffc54bf3919ca27c208da581ef9e46de131cd25e85"}}}}
{"instruction": "Compare Paramorphstatin to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Paramorphstatin has suboptimal drug-like properties with MW=568.57 Da and logP=1.89.", "metadata": {"compound": "Paramorphstatin", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000835-178996efdd9f15b0", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.915393", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "7c2a93905d202f457f9540abab0a3970d2f61610abe9bed9e8ae2f92536dd664"}}}}
{"instruction": "What is the bioavailability of Hypocycldone?", "response": "The predicted oral bioavailability of Hypocycldone is approximately 80% based on its physicochemical properties.", "metadata": {"compound": "Hypocycldone", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000836-43891232a8846a4a", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.915430", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "18f012bfca8eed93c9926d50172a3cee037c72c7139b2d4a6802d0534a76af42"}}}}
{"instruction": "How many hydrogen bond donors does Procephmycin have?", "response": "Procephmycin has 0 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Procephmycin", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000837-62b01a4c971a7dda", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.915468", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "16b1624079ba41a537217bdafd562b4ca8d6cb4924184ce841c584858bde6731"}}}}
{"instruction": "How many rotatable bonds does Hypercycldone have?", "response": "Hypercycldone has 0 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Hypercycldone", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000839-0f3465296758383e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.915541", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "302f662780fdb56dbad14504cbd744403ef5b6f35b82660eb8f201e217122b2d"}}}}
{"instruction": "How many rotatable bonds does Hypocephib have?", "response": "Hypocephib has 4 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Hypocephib", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000842-eed366920c66d579", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.915653", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "a1e9a29a261cddcb17135ee8083bb5165f91a2ff523c3754fb547b7392dc3baf"}}}}
{"instruction": "What is the TPSA of Isocephazole?", "response": "The topological polar surface area (TPSA) of Isocephazole is 119.32 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Isocephazole", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000843-0d40b75389178e5a", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.915696", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "f792932379c69203b063aec2b4b3ff15879939de96090044053420645c4f0469"}}}}
{"instruction": "Compare Paracephcillin to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Paracephcillin has favorable drug-like properties with MW=428.84 Da and logP=0.07.", "metadata": {"compound": "Paracephcillin", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000844-04e2ccb56966332f", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.915746", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "29cc1cedb0e4565728f39678e2f872d20fdd31ac98e1ac6b9bef965b51f452fa"}}}}
{"instruction": "What is the molecular formula of Neocephmycin?", "response": "The molecular formula of Neocephmycin is C17H30O4.", "metadata": {"compound": "Neocephmycin", "batch": 0, "template": "What is the molecular formula of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000845-f9553e3b2b39ea15", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.915778", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "4c3085b3983afa78", "cl_signature": "e802684633c3daa453708105f030466e998678143755906091ba63780b79c1ae"}}}}
{"instruction": "How many aromatic rings does Syncyclpril have?", "response": "Syncyclpril contains 3 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Syncyclpril", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000846-1d78a2adef37dfaf", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.915814", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "83053ed78086a20cce8e9a3b965960a0456d39db72007ec336cc42af2b447fdd"}}}}
{"instruction": "Compare Antimorphmab to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Antimorphmab has favorable drug-like properties with MW=165.94 Da and logP=-1.23.", "metadata": {"compound": "Antimorphmab", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000848-bdf605497e06d299", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.915903", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "497390a82aa796e84ba06cf8f9ab47281b525750f6fc356139cf40175a6f78d2"}}}}
{"instruction": "Does Profluorolol satisfy Lipinski's Rule of Five?", "response": "Profluorolol satisfies Lipinski's Rule of Five with no violations, suggesting good oral bioavailability potential.", "metadata": {"compound": "Profluorolol", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "drug_likeness", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000850-b42c358b90a43baf", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.915984", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "04e38f41baca4f0dc00f030eb2c534f3d8692f551ed83266eb7621e5f76050d4"}}}}
{"instruction": "What are the pharmacokinetic properties of Isocephmab?", "response": "The pharmacokinetic properties of Isocephmab suggest limited absorption potential with TPSA=61.66 \u0172 and MW=597.75 Da.", "metadata": {"compound": "Isocephmab", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000852-c9aff792ee862b03", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.916058", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "658e059fc1bbb41469aecdbe3e21610c5f45754baf4e0e0aa891f8c9f35199be"}}}}
{"instruction": "How many hydrogen bond acceptors does Synfluorib have?", "response": "Synfluorib has 1 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Synfluorib", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000853-2b8eac0c7909528c", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.916092", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "ba5882c0011444b9bed4160134ba216439403d4f4b763d12e79976318e454369"}}}}
{"instruction": "How many rotatable bonds does Metafluorazole have?", "response": "Metafluorazole has 5 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Metafluorazole", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000856-299b83b12a1ed90f", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.916206", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "c21b11b3a6b3860558ac0ff3e5f547e9f238a2174c2957a41466ce46334b1df0"}}}}
{"instruction": "Describe the molecular properties of Neochlorcillin.", "response": "Neochlorcillin (MW: 457.19 Da, C25H39O4) exhibits a logP of -1.44 and TPSA of 101.95 \u0172 with 3 H-bond donors and 9 H-bond acceptors.", "metadata": {"compound": "Neochlorcillin", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000857-680440b5b8d448ef", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.916253", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "e540bcfcb3d75b407fd5ab93a46aa4fb1b91005c74332bc2338159b9c85f6954"}}}}
{"instruction": "What are the pharmacokinetic properties of Neocyclcillin?", "response": "The pharmacokinetic properties of Neocyclcillin suggest good absorption potential with TPSA=61.65 \u0172 and MW=156.2 Da.", "metadata": {"compound": "Neocyclcillin", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000858-0762187ebc73eaf8", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.916298", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "6949d6cdaeac82814a00b64ff9b03c422fa3bc1e2eeb9e7c68fa6531fe46e441"}}}}
{"instruction": "How many hydrogen bond acceptors does Neofluorib have?", "response": "Neofluorib has 6 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Neofluorib", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000861-7194379799b6ccd6", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.916401", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "fcf40e4d6c5b7ad7d2b0bc20b539f55732a70160937f036e68ec427af2c9cd61"}}}}
{"instruction": "What is the logP value of Paracyclazole?", "response": "The logP (partition coefficient) of Paracyclazole is 1.72. This indicates good lipophilicity for oral bioavailability.", "metadata": {"compound": "Paracyclazole", "batch": 0, "template": "What is the logP value of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 85.0, "uniqueness_score": 90.0, "total_score": 94.25, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000862-8d91560ef0051adf", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.916435", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "f5d0ab06ae0f3868", "cl_signature": "347ccb019e48a4fee99a7ffd750fbfa2ef9cdc9e85543be40b09b76ef213289c"}}}}
{"instruction": "How many hydrogen bond acceptors does Parafluorazole have?", "response": "Parafluorazole has 8 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Parafluorazole", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000863-ef9d6bdf47be3672", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.916471", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "86794a3198e8e54684380f3d4c59acbe4618958342560b74e1dd422edb77bbdf"}}}}
{"instruction": "Describe the molecular properties of Neobarbmab.", "response": "Neobarbmab (MW: 500.3 Da, C20H10N3O5) exhibits a logP of 2.34 and TPSA of 101.94 \u0172 with 4 H-bond donors and 2 H-bond acceptors.", "metadata": {"compound": "Neobarbmab", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000866-167caab476f1f75b", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.916592", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "3c090527c5f0060eebf1811f415dd553142a6659d89a295f12ea0edfc73afb6d"}}}}
{"instruction": "How many rotatable bonds does Hyperbenzpril have?", "response": "Hyperbenzpril has 15 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Hyperbenzpril", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000868-362586afe2a25ac1", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.916694", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "e2037dd08e47e652415cdf86775c9115a742e6bc2122786c3372c174c1d38693"}}}}
{"instruction": "How many hydrogen bond acceptors does Episulfazole have?", "response": "Episulfazole has 5 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Episulfazole", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000869-210ff545f3d6caf5", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.916730", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "45f054a4988f5008a1750d4455b536b057f6683bbdabd7e27f753d88777dab0e"}}}}
{"instruction": "How many hydrogen bond acceptors does Episulfpril have?", "response": "Episulfpril has 1 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Episulfpril", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000872-eaed1a21bf16b3d4", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.916843", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "34446fc9504656276f77c9553c9da368c679eb6e82de6d7369004277fbd837a0"}}}}
{"instruction": "What is the TPSA of Hypobenzib?", "response": "The topological polar surface area (TPSA) of Hypobenzib is 56.75 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Hypobenzib", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000873-80ceb145f40d20aa", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.916885", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "54154b77536f98b5602d8a78f3a3ff8e1bca545c40871dbcb8ee5212843c431a"}}}}
{"instruction": "Does Antimetholol satisfy Lipinski's Rule of Five?", "response": "Antimetholol satisfies Lipinski's Rule of Five with no violations, suggesting good oral bioavailability potential.", "metadata": {"compound": "Antimetholol", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "drug_likeness", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000874-44a4c6ccc810e194", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.916919", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "b8ad71470be5ec9560c911ae5640b61134a2cee0acc0bb2be9b597653900b001"}}}}
{"instruction": "How many hydrogen bond donors does Metabarbib have?", "response": "Metabarbib has 4 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Metabarbib", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000875-9c2b2578dcab6e7c", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.916956", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "ad769067dc0b6b502920082c1e70d705cac09316ed49ec7a74215ed83206fc7f"}}}}
{"instruction": "How many hydrogen bond acceptors does Synfluorpine have?", "response": "Synfluorpine has 6 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Synfluorpine", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000877-f71f0df969adbb1d", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.917039", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "0af29fb2538b650db2ecab76e48d20fdbd436852d895cbc7a94a9075d90924bd"}}}}
{"instruction": "Does Probenzcillin satisfy Lipinski's Rule of Five?", "response": "Probenzcillin satisfies Lipinski's Rule of Five with no violations, suggesting good oral bioavailability potential.", "metadata": {"compound": "Probenzcillin", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "drug_likeness", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000878-985880d6710be7a4", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.917165", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "d34ebf3b8e9a97dd5536ec0266b9f4e63bf55829c63fcc82d7d61bf310bc8182"}}}}
{"instruction": "What is the logP value of Neophenpril?", "response": "The logP (partition coefficient) of Neophenpril is -1.02. This indicates good lipophilicity for oral bioavailability.", "metadata": {"compound": "Neophenpril", "batch": 0, "template": "What is the logP value of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 85.0, "uniqueness_score": 90.0, "total_score": 94.25, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000879-2324bf2e44ba0bf4", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.917214", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "f5d0ab06ae0f3868", "cl_signature": "60a191738a1338c96fd7ad9b9cf1822b6b42e7b1e8b502a0687a6ae736934d3a"}}}}
{"instruction": "What are the key structural features of Hypocyclazole?", "response": "Key structural features of Hypocyclazole include 0 aromatic rings, 6 rotatable bonds, and a molecular weight of 175.2 Da.", "metadata": {"compound": "Hypocyclazole", "batch": 0, "template": "What are the key structural features of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000880-d8308a1fe0ef4729", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.917257", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "58ce48ca7ae9e024", "cl_signature": "82f6840a38f0efce1b8731bca51e005184d76a8a4e5410a8dfd532a49cd34ebe"}}}}
{"instruction": "What are the pharmacokinetic properties of Procycldone?", "response": "The pharmacokinetic properties of Procycldone suggest good absorption potential with TPSA=57.42 \u0172 and MW=188.83 Da.", "metadata": {"compound": "Procycldone", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000881-46f5f6b63e32e5b0", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.917303", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "66506ec46dbe46fac6ede4787b3f55a6f972e94ab4ac9fcb8a3bfc9f88759f10"}}}}
{"instruction": "How many hydrogen bond acceptors does Synsulfstatin have?", "response": "Synsulfstatin has 7 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Synsulfstatin", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000882-eeb01a42bb754350", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.917340", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "c52e1402e4cefe1c8e9d0ffb5bb7a8137f19a52a40c62406667d94718d4afff9"}}}}
{"instruction": "Compare Paracepholol to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Paracepholol has favorable drug-like properties with MW=442.35 Da and logP=4.3.", "metadata": {"compound": "Paracepholol", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000883-3c05d10bb4b88171", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.917379", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "4c2042f19e29a43c2e782cf304331d46c9bde69fd3111aa01c6266793c1faa35"}}}}
{"instruction": "How many hydrogen bond donors does Isomethmycin have?", "response": "Isomethmycin has 2 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Isomethmycin", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000884-e07fb4624e6acca5", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.917416", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "def0b6a12ddd90308722260992524966fd572343aa47cf25d1e761c6eaabc49f"}}}}
{"instruction": "What are the pharmacokinetic properties of Metabarbolol?", "response": "The pharmacokinetic properties of Metabarbolol suggest good absorption potential with TPSA=64.68 \u0172 and MW=448.7 Da.", "metadata": {"compound": "Metabarbolol", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000888-76197c222095adb5", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.917737", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "e053073a616134ececd47087cb4eac8136aa1c88e628a3967dafe89751b71022"}}}}
{"instruction": "What are the pharmacokinetic properties of Hyperchlorib?", "response": "The pharmacokinetic properties of Hyperchlorib suggest good absorption potential with TPSA=57.01 \u0172 and MW=480.54 Da.", "metadata": {"compound": "Hyperchlorib", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000889-a3db7b580411e329", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.917784", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "d7ebb7799b5df6255ae912673b9f352eee2e9197290151e4e70c2565f27241d1"}}}}
{"instruction": "What is the molecular formula of Hyposulfmycin?", "response": "The molecular formula of Hyposulfmycin is C16H46N1O9.", "metadata": {"compound": "Hyposulfmycin", "batch": 0, "template": "What is the molecular formula of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000890-089717db585f9afb", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.917818", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "4c3085b3983afa78", "cl_signature": "99da0475918b1438d0d69eb623fdac2048ff6da65c8c323bbc3fdcb0a3fdd3d2"}}}}
{"instruction": "How many hydrogen bond acceptors does Hyperfluorazole have?", "response": "Hyperfluorazole has 10 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Hyperfluorazole", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000891-d378eb3104d8ae44", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.917855", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "f8d7e935a99e96a438e422a8c9aa0fb23f914c846b0beaa676d3758c8d045314"}}}}
{"instruction": "How many hydrogen bond acceptors does Metabenzpine have?", "response": "Metabenzpine has 8 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Metabenzpine", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000892-a7d855ab9d11a4ea", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.917891", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "cbe7c4db3c6416b7975425b886dc9b08e76e97c4195e8cb860d1c19101ab2a5e"}}}}
{"instruction": "Describe the molecular properties of Epiphendone.", "response": "Epiphendone (MW: 449.6 Da, C17H18O9) exhibits a logP of -0.11 and TPSA of 138.46 \u0172 with 4 H-bond donors and 1 H-bond acceptors.", "metadata": {"compound": "Epiphendone", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000895-219ee21c65665e8f", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.918016", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "db8c4baaaf07af1fc8d03f77257bda22479780b3ae2c7880e3ba62126dfa4132"}}}}
{"instruction": "How many hydrogen bond acceptors does Synphencillin have?", "response": "Synphencillin has 8 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Synphencillin", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000900-18e7c265637e49cb", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.918202", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "17bd298b855f09881917c87d2312a6ea9a77dcb32705889316a1fec30d36aeed"}}}}
{"instruction": "What is the solubility profile of Epibarbstatin?", "response": "Epibarbstatin exhibits high water solubility based on its logP value of -1.22.", "metadata": {"compound": "Epibarbstatin", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000902-5b385a6b3d2c1727", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.918291", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "67be32acc07242802a2c52351ec8545d01ac89c3e955506265dda49161c6ec7f"}}}}
{"instruction": "How many rotatable bonds does Hyperbenzdone have?", "response": "Hyperbenzdone has 13 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Hyperbenzdone", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000903-5f976294df7e85a0", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.918335", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "258be979b670e081629839507b9696a95bb2d63eca0fc93e1f870473460a640e"}}}}
{"instruction": "What is the TPSA of Isocyclolol?", "response": "The topological polar surface area (TPSA) of Isocyclolol is 50.77 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Isocyclolol", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000905-dc58d1801c992c22", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.918475", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "01213603836bdec51315b9ff97e76c7742612a5e46bb0c27e6cd0191af808e0a"}}}}
{"instruction": "How many rotatable bonds does Hyperfluorazole have?", "response": "Hyperfluorazole has 10 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Hyperfluorazole", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000906-c4d72f9a380f84a4", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.918519", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "97dcbb93d57745ef5413ecae4f0e2727de548f56168f34c4a31cc9fad41dc628"}}}}
{"instruction": "How many hydrogen bond donors does Prophenstatin have?", "response": "Prophenstatin has 5 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Prophenstatin", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000907-972337986308829c", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.918561", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "082c2b7359fc1f358df5e191afb52e326ee26d0a16174847f947c76960a3154a"}}}}
{"instruction": "How many rotatable bonds does Hypermorphpine have?", "response": "Hypermorphpine has 15 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Hypermorphpine", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000912-1095ad4acd96ec12", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.918748", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "494566630e72f6fc32e4c4dfce2b7fd2bb3183d9978aec4e526bd13fde21dab5"}}}}
{"instruction": "Describe the molecular properties of Antisulfib.", "response": "Antisulfib (MW: 166.17 Da, C13H20N4O10) exhibits a logP of 0.08 and TPSA of 135.88 \u0172 with 5 H-bond donors and 8 H-bond acceptors.", "metadata": {"compound": "Antisulfib", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000913-6483995667c07b22", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.918796", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "536cbabfcb130212d7bbb09b2666602bcc926c14a5e3205c4972a44333b55947"}}}}
{"instruction": "How many hydrogen bond acceptors does Hypercephpril have?", "response": "Hypercephpril has 10 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Hypercephpril", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000919-5da2ef24f6a5a88d", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.919056", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "fe849cc5dd8fbce312a2ecb2354100acbbc24762252ace21f6cf25fca0ad7e8e"}}}}
{"instruction": "What are the pharmacokinetic properties of Hypobenzstatin?", "response": "The pharmacokinetic properties of Hypobenzstatin suggest good absorption potential with TPSA=81.51 \u0172 and MW=342.41 Da.", "metadata": {"compound": "Hypobenzstatin", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000923-08ff63a15ec3c22a", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.919212", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "4ce88cb55fe31a077a196bea7886360b8505751887a28739a35f920bae88b963"}}}}
{"instruction": "Describe the molecular properties of Epimethmycin.", "response": "Epimethmycin (MW: 412.28 Da, C30H28N5O8) exhibits a logP of 2.14 and TPSA of 85.73 \u0172 with 1 H-bond donors and 4 H-bond acceptors.", "metadata": {"compound": "Epimethmycin", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000924-dc89bfb67e10e03e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.919257", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "ad5c5c58973d7292fbed84862750102aea6a9047e142ff8472b64cffa646c14f"}}}}
{"instruction": "What is the bioavailability of Metasulfmycin?", "response": "The predicted oral bioavailability of Metasulfmycin is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Metasulfmycin", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000925-f43c75999833cd41", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.919290", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "00f093158b85c5a49a0e01f1824cfac74f888f43fc6c3cec6f0eacb0b420e041"}}}}
{"instruction": "What is the bioavailability of Procyclpril?", "response": "The predicted oral bioavailability of Procyclpril is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Procyclpril", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000927-05acbf5c40fef055", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.919359", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "f983b7b8b7b5243e622d9d7970194c9e9d7c65066c9efbb8ca5da1ecc07ce00f"}}}}
{"instruction": "What is the molecular weight of Neosulfolol?", "response": "The molecular weight of Neosulfolol is 348.92 Da.", "metadata": {"compound": "Neosulfolol", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000930-47dc1629fa3f333e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.919476", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "1f6621a6672055545c060674a5c898d9a84b717b3798c06c5346831f8fb9d53b"}}}}
{"instruction": "What are the pharmacokinetic properties of Synphenazole?", "response": "The pharmacokinetic properties of Synphenazole suggest good absorption potential with TPSA=115.73 \u0172 and MW=436.33 Da.", "metadata": {"compound": "Synphenazole", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000932-fdf0ef9adfd1f3a4", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.919551", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "343301226f0126786052a83b5bbcadff0b9a9a2cdfebdd7c01a0a88a9f786f0e"}}}}
{"instruction": "Does Hypermorphpril satisfy Lipinski's Rule of Five?", "response": "Hypermorphpril satisfies Lipinski's Rule of Five with no violations, suggesting good oral bioavailability potential.", "metadata": {"compound": "Hypermorphpril", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "drug_likeness", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000933-eef36eed93921800", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.919592", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "7a491366d22c77bceadd8494537fcc514a610d58bca02eaa1e5e1175f0a94595"}}}}
{"instruction": "Does Antibenzazole satisfy Lipinski's Rule of Five?", "response": "Antibenzazole satisfies Lipinski's Rule of Five with no violations, suggesting good oral bioavailability potential.", "metadata": {"compound": "Antibenzazole", "batch": 0, "template": "Does {name} satisfy Lipinski's Rule of Five?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "drug_likeness", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000934-9bd18d088c2b8cdf", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.919624", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8972a2bd26b77af0", "cl_signature": "7ee7e81fcba1eb23d840fd1f7923008a8153bd443a109d157422e931193c44d4"}}}}
{"instruction": "Describe the molecular properties of Prophenpril.", "response": "Prophenpril (MW: 596.89 Da, C20H16N3O10) exhibits a logP of -1.85 and TPSA of 129.59 \u0172 with 5 H-bond donors and 2 H-bond acceptors.", "metadata": {"compound": "Prophenpril", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000938-b58d56ada1a9cec6", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.919763", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "2d5e7b70a3a4dacd3d4571d489a74326a75f103277b93c733243977331e8f858"}}}}
{"instruction": "What is the molecular weight of Isocyclpril?", "response": "The molecular weight of Isocyclpril is 368.87 Da.", "metadata": {"compound": "Isocyclpril", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000939-ee4ea6786bd3399b", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.919791", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "c22815b5f6fa4add14bdb1c5871c41569b44e09d22d13b74af242fe08674b276"}}}}
{"instruction": "How many hydrogen bond donors does Isophenstatin have?", "response": "Isophenstatin has 1 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Isophenstatin", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000940-7a485e9546290a3f", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.919824", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "aec18c388d88a1cdab7d03866e189cfbe61f6410554bbed7e57fb729983bbea9"}}}}
{"instruction": "Describe the molecular properties of Neochlorolol.", "response": "Neochlorolol (MW: 375.98 Da, C24H40N2O7) exhibits a logP of 4.08 and TPSA of 28.11 \u0172 with 1 H-bond donors and 1 H-bond acceptors.", "metadata": {"compound": "Neochlorolol", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000943-addff7d47df13d7a", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.919955", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "6d92c8aebc5dde90891d93824dad0417fb40ceab88b615624d7ab4650a5d7e35"}}}}
{"instruction": "What is the TPSA of Promorpholol?", "response": "The topological polar surface area (TPSA) of Promorpholol is 27.74 \u0172. This is within the optimal range for oral bioavailability.", "metadata": {"compound": "Promorpholol", "batch": 0, "template": "What is the TPSA of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000945-15f7584fc619d1ed", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.920031", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "0195749427509517", "cl_signature": "8ee8d7827b8708a774d927064bcaf55910a4a8638514d558b8e9b2057550d124"}}}}
{"instruction": "How many rotatable bonds does Parasulfmab have?", "response": "Parasulfmab has 6 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Parasulfmab", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000946-cf5568c8ae767a1a", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.920072", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "d29b5c9a51b59db5bd00ce1e19e6af52ec1aee7e424b87439ec65e8ef68b5a08"}}}}
{"instruction": "How many hydrogen bond donors does Syncyclstatin have?", "response": "Syncyclstatin has 2 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Syncyclstatin", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000948-e702767625302691", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.920142", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "d1a13b844e0f8783b25d6b040db081f12f090d93d6fb499ab9113844b84fbfbb"}}}}
{"instruction": "Compare Probenzstatin to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Probenzstatin has favorable drug-like properties with MW=357.67 Da and logP=0.14.", "metadata": {"compound": "Probenzstatin", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000956-b7ed5fd552182f51", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.920426", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "40e3538ab830553de0d469d02c968c3a23b8f72b4af48c5fbe6785eb697b8fc6"}}}}
{"instruction": "How many rotatable bonds does Paraphenstatin have?", "response": "Paraphenstatin has 12 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Paraphenstatin", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000958-487aae608e82df01", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.920498", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "48397c20a148d70f6710aab6ffdbb87b7d2786f44d8cb7fb55ccbfc77e976f1f"}}}}
{"instruction": "What is the molecular weight of Neomethazole?", "response": "The molecular weight of Neomethazole is 479.71 Da.", "metadata": {"compound": "Neomethazole", "batch": 0, "template": "What is the molecular weight of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "molecular_properties", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000959-45394f8480a9c12f", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.920528", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "9145b1d787937629", "cl_signature": "0fc7bac9788e8dd93e467799db9c4b5a1375cfd971aafb92cead64f652c2633e"}}}}
{"instruction": "Compare Neocyclolol to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Neocyclolol has favorable drug-like properties with MW=482.96 Da and logP=0.9.", "metadata": {"compound": "Neocyclolol", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000961-5db8961e3f2562d3", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.920607", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "47442bd099f57a212af7502b6236d17c63e37d6fdf4f292d24e5c84ca1bf1fa5"}}}}
{"instruction": "How many aromatic rings does Hyperbarbdone have?", "response": "Hyperbarbdone contains 1 aromatic rings, contributing to its structural stability and interactions.", "metadata": {"compound": "Hyperbarbdone", "batch": 0, "template": "How many aromatic rings does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "general_pharmaceutical", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000962-804b8c995a78135c", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.920641", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "38d49d6988b38d3b", "cl_signature": "ca750bfb5e0eeac2dbab59a91af79e1498b0aebdfe09df3aa27039ff8b48a8c2"}}}}
{"instruction": "What is the bioavailability of Hyperchlordone?", "response": "The predicted oral bioavailability of Hyperchlordone is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Hyperchlordone", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000963-25150975afb5b371", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.920680", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "ced34e9598ee24edb5634437bc5b458c9898f8868e4012a034bfae668e505f9c"}}}}
{"instruction": "Describe the molecular properties of Metafluorpine.", "response": "Metafluorpine (MW: 581.36 Da, C18H22N1O6) exhibits a logP of 1.33 and TPSA of 39.88 \u0172 with 2 H-bond donors and 2 H-bond acceptors.", "metadata": {"compound": "Metafluorpine", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000965-694fa544c4b283ec", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.920757", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "b592ee2f87361b31ade5a7537c9567704ba52bfb50ccf6b3a5625bce114c5022"}}}}
{"instruction": "How many hydrogen bond donors does Synphenmab have?", "response": "Synphenmab has 2 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Synphenmab", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000967-3cc9f4f87c1dd430", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.920819", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "d01b26c9605c2beef373bdb0e5325b8390e6bcff8aeeec615fb34b2f473dc90f"}}}}
{"instruction": "Compare Synbenzstatin to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Synbenzstatin has favorable drug-like properties with MW=272.75 Da and logP=3.85.", "metadata": {"compound": "Synbenzstatin", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000968-62a8a440491fb66e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.920855", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "03decb0518c541d30c5e1b876bd9b87231f02904246cbde728301645b957c58b"}}}}
{"instruction": "What is the bioavailability of Antiphencillin?", "response": "The predicted oral bioavailability of Antiphencillin is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Antiphencillin", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000969-148128967c626510", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.920889", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "512c0489c487847683c0ecf3b6506c4640f6f821e93e6d59c2e995b234f09cb7"}}}}
{"instruction": "Describe the molecular properties of Probarbazole.", "response": "Probarbazole (MW: 565.62 Da, C19H49N3O3) exhibits a logP of 2.11 and TPSA of 50.69 \u0172 with 4 H-bond donors and 1 H-bond acceptors.", "metadata": {"compound": "Probarbazole", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000970-a9f58df6a1e09f64", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.920934", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "d4d19922aa58053316580a236a52e56b1835ec1a1be86ba4a423689b5b0df3bd"}}}}
{"instruction": "What is the solubility profile of Hypofluordone?", "response": "Hypofluordone exhibits moderate solubility based on its logP value of 2.58.", "metadata": {"compound": "Hypofluordone", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000971-44d1dd302da38068", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.920969", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "e13f5721a19d954c15f4e722977c70188a693000339c8d32e2f2598e26bf1a7e"}}}}
{"instruction": "Describe the molecular properties of Metaphenpril.", "response": "Metaphenpril (MW: 398.49 Da, C17H41N4O6) exhibits a logP of 3.3 and TPSA of 43.0 \u0172 with 0 H-bond donors and 7 H-bond acceptors.", "metadata": {"compound": "Metaphenpril", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000972-977daa70cea49fc3", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.921022", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "e55c38a241d43bb49d308a47a4251d9316e64d5386c9a1594ad7f01e5c98994d"}}}}
{"instruction": "How many hydrogen bond donors does Synbenzdone have?", "response": "Synbenzdone has 1 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Synbenzdone", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000974-04d6de0276bf7775", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.921095", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "d1b0c4c6807fd45b0c504056d8adfd5e9e6086458f8fc5a77551ef393b1961b1"}}}}
{"instruction": "What is the logP value of Promorphmycin?", "response": "The logP (partition coefficient) of Promorphmycin is 4.91. This indicates good lipophilicity for oral bioavailability.", "metadata": {"compound": "Promorphmycin", "batch": 0, "template": "What is the logP value of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 85.0, "uniqueness_score": 90.0, "total_score": 94.25, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000975-7a0da39252bf9ade", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.921127", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "f5d0ab06ae0f3868", "cl_signature": "32a153a94270ecafade60daad922d5e841b34228064203a34f92703f507d8a15"}}}}
{"instruction": "How many rotatable bonds does Syncyclmab have?", "response": "Syncyclmab has 0 rotatable bonds. This affects molecular flexibility and bioavailability.", "metadata": {"compound": "Syncyclmab", "batch": 0, "template": "How many rotatable bonds does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000976-48f68d4b051b8a7b", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.921159", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "1fbc18e0cb1d1653", "cl_signature": "c586504c34618e7b7b66a6f1d4c39a62ee8d8c4f94c3a9604626384b8bccb192"}}}}
{"instruction": "What is the solubility profile of Epibenzmycin?", "response": "Epibenzmycin exhibits low water solubility based on its logP value of 3.37.", "metadata": {"compound": "Epibenzmycin", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000977-8425f0f29d2cb8ba", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.921191", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "5386c48eb34071e2ed02c1e1a0e55c501b8aa78ae22237585727fb7c75bdfc50"}}}}
{"instruction": "Describe the molecular properties of Hypomorphmab.", "response": "Hypomorphmab (MW: 432.58 Da, C22H12N3O4) exhibits a logP of 4.36 and TPSA of 121.4 \u0172 with 5 H-bond donors and 7 H-bond acceptors.", "metadata": {"compound": "Hypomorphmab", "batch": 0, "template": "Describe the molecular properties of {name}.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "molecular_properties", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000978-291d32bd67abd05a", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.921233", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e76d68308b286db6", "cl_signature": "2e8aa4f6143ae780e528f3e665bc0461f0df924ae72cdde35e397caf7a9e909e"}}}}
{"instruction": "How many hydrogen bond acceptors does Parafluorolol have?", "response": "Parafluorolol has 6 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Parafluorolol", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000979-9ea43271305c97a1", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.921267", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "12879cec3b14f9f4aaa76adc527f354e2ba6fcb6208f357743f3649af3f5235d"}}}}
{"instruction": "What is the bioavailability of Parabenzpril?", "response": "The predicted oral bioavailability of Parabenzpril is approximately 100% based on its physicochemical properties.", "metadata": {"compound": "Parabenzpril", "batch": 0, "template": "What is the bioavailability of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "pharmacokinetics", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000982-8cf7377baa01edef", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.921417", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "36d205d3e231e677", "cl_signature": "f89371c3f6e7966a3d111c6eee6f9aaaf0e29783a5ad4e4a0a9b4c8d7f7a81db"}}}}
{"instruction": "What is the solubility profile of Hypochlorstatin?", "response": "Hypochlorstatin exhibits high water solubility based on its logP value of -1.19.", "metadata": {"compound": "Hypochlorstatin", "batch": 0, "template": "What is the solubility profile of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 70.0, "uniqueness_score": 90.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "basic", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000984-187c8a0f892eb305", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.921484", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "8a68ea97e16d3f5e", "cl_signature": "eb8d2118dac03256eef4949802963e83db5af0473acdb7c5a193073a2f711f4d"}}}}
{"instruction": "How many hydrogen bond acceptors does Hyperbarbmab have?", "response": "Hyperbarbmab has 6 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Hyperbarbmab", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000985-192a6e48547b8af2", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.921526", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "902b8fca15b3aee47d2917804c579f15659f2f8b049da2a4d64a2123e2627f79"}}}}
{"instruction": "How many hydrogen bond donors does Isocephdone have?", "response": "Isocephdone has 0 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Isocephdone", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000988-739db04ec0d08c0a", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.921624", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "922d3f14fa1f053141ec69f8fa0d6bb29e96dc6ce360ac5753821a14341707ed"}}}}
{"instruction": "What is the molecular formula of Metamethmycin?", "response": "The molecular formula of Metamethmycin is C23H33N3O9.", "metadata": {"compound": "Metamethmycin", "batch": 0, "template": "What is the molecular formula of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000989-54f91af92af8b0ac", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.921653", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "4c3085b3983afa78", "cl_signature": "164bda751d20efb7ed5b2b2c6710fa37d79181bb0509e561f58ee7d980ef6961"}}}}
{"instruction": "Compare Antibenzib to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Antibenzib has favorable drug-like properties with MW=439.86 Da and logP=2.28.", "metadata": {"compound": "Antibenzib", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000990-46334ff263b39845", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.921689", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "b6e8b075d05c756a4d9cf6a3bc8140bb1124434c0a7a4f0a7e133fd27ae6178d"}}}}
{"instruction": "How many hydrogen bond donors does Epibarbmab have?", "response": "Epibarbmab has 5 hydrogen bond donors. This is acceptable for drug-like properties.", "metadata": {"compound": "Epibarbmab", "batch": 0, "template": "How many hydrogen bond donors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 65.0, "total_score": 90.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000991-d2d7dc18a754a190", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.921722", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "fd3a90ce32bf3afb", "cl_signature": "4366465df67b84f37f287cc26523e3e370b15348a8ddb6edffcc9129292f5167"}}}}
{"instruction": "Compare Hyperbenzazole to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Hyperbenzazole has favorable drug-like properties with MW=337.58 Da and logP=2.77.", "metadata": {"compound": "Hyperbenzazole", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 90.0, "total_score": 96.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000992-ae18c2e03ee14a88", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.921771", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "613ca06daf4711252c11e86fc79ed902cee622d3cdd0f70b7fb2867ff1341f85"}}}}
{"instruction": "How many hydrogen bond acceptors does Synmorphpine have?", "response": "Synmorphpine has 7 hydrogen bond acceptors. This is within Lipinski's guidelines.", "metadata": {"compound": "Synmorphpine", "batch": 0, "template": "How many hydrogen bond acceptors does {name} have?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 90.0, "uniqueness_score": 90.0, "total_score": 95.5, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000996-1f61c5c8f2be7b8e", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.921935", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "a20d4772a6d29cd3", "cl_signature": "bcf7a457574f6cc177a987946d48d567f337b0cedd1cec332bc7cfb9b7f3639b"}}}}
{"instruction": "What is the molecular formula of Epiphenazole?", "response": "The molecular formula of Epiphenazole is C25H16N4O7.", "metadata": {"compound": "Epiphenazole", "batch": 0, "template": "What is the molecular formula of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "molecular_properties", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000997-e44d637707f22467", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.921967", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "4c3085b3983afa78", "cl_signature": "d09bdbfb4eb276131d9b5923fd899086e9a810b7a93357d794bdfa74ee6e9c7a"}}}}
{"instruction": "Compare Paraphenstatin to typical pharmaceutical compounds.", "response": "Compared to typical pharmaceutical compounds, Paraphenstatin has favorable drug-like properties with MW=289.12 Da and logP=-1.09.", "metadata": {"compound": "Paraphenstatin", "batch": 0, "template": "Compare {name} to typical pharmaceutical compounds.", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 95.0, "uniqueness_score": 65.0, "total_score": 91.75, "domain": "general_pharmaceutical", "difficulty_level": "advanced", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000998-cd784fae7f64f341", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.922004", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "ef61b89f0abd0240", "cl_signature": "4503427e08d51c526dce5cb26fa3dd875891c585d9e4ced23d1933ed6b7f69a6"}}}}
{"instruction": "What are the pharmacokinetic properties of Isofluorstatin?", "response": "The pharmacokinetic properties of Isofluorstatin suggest good absorption potential with TPSA=76.85 \u0172 and MW=208.31 Da.", "metadata": {"compound": "Isofluorstatin", "batch": 0, "template": "What are the pharmacokinetic properties of {name}?", "crowelogic": {"quality_tier": "GOLD", "scientific_accuracy": 100, "linguistic_quality": 100, "training_value": 80.0, "uniqueness_score": 90.0, "total_score": 93.0, "domain": "pharmacokinetics", "difficulty_level": "intermediate", "recommended_use": ["fine-tuning", "evaluation", "benchmarking", "commercial"], "citation": "CroweLogic Pharmaceutical AI Training Dataset v1.0-crowelogic", "license": "CroweLogic-Proprietary-2025", "_watermark": {"cl_id": "CL-00000999-915ee438544b7f9c", "cl_version": "1.0-crowelogic", "cl_genesis": "2025-11-12", "cl_timestamp": "2025-11-12T11:11:45.922049", "cl_batch_hash": "e9db66e41fb52893", "cl_template_dna": "e52cc313b43239cc", "cl_signature": "08af4b24ba16a8b5487531a96eee6fc5cc3f76bfae6d1da8e4205a0fe9979d3e"}}}}
